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Abstract 
The overall aim to this thesis was to identify if the use of self-regulated 
(SR) rest during high intensity training (HIT) can be used to increase 
endurance and power output measures between males and females. 
 
Study one aimed to determine if males and females can maintain mean 
power output (MPO) during repeated sprints when using self-regulated 
(SR) rest, and identify male and female response in MPO when SR rest is 
reduced. Participants completed four trials of 10 x 6 sec sprints separated 
by SR rest against 7.5% body mass (BM) as a resistance. If the mean 
power output (MPO) for all ten sprints in each trial had a coefficient of 
variation (CV) of ≤ 5.2%, then it was deemed that the participant was able 
to maintain their MPO. In trials 1-4 males significantly maintained their 
MPO greater than females in relation to their respected criterion sprint 
MPO data. In addition to this, only 85% of the participants could maintain 
their MPO when using SR rest (two males and one female failed). When 
SR rest was reduced by 10 and 15% there was no difference in CV 
between these two trials and the original 4 trials. However, MPO 
significantly dropped greater in females than in males SR rest was 
reduced by 15%. Therefore, this study indicates that males can use SR 
rest to maintain their MPO greater than females, and participants may be 
pacing their sprint efforts to maintain a sub-maximal MPO instead of their 
maximal MPO when SR rest is reduced by 15%.  
 
Study two aimed to compare endurance and Wingate power output 
adaptations to HIT with a fixed rest (30 sec) or self-regulated rest, and 
identify if reproducibility of MPO during HIT is correlated to endurance 
and Wingate power output adaptation. Male participants the same HIT 
protocol from Study 1 for six sessions over a two-week period. 
Participants completed the HIT with either SR rest or with a fixed rest 
(FR) of 30 sec between each sprint. Magnitude in change for time to 
exhaustion (TTE), time trial (TT) and Wingate power measures was 
greater in the SR group, whereas VO2 peak increased greater in the FR 
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group. However, no strong correlation between maintaining power output 
and increasing endurance measures or power measures appeared. 
Whereas correlation data indicates that VO2 peak increased for the FR 
group due to a decrease in power output during the trials. Therefore, this 
study indicates that TTE, TT and Wingate power output experience a 
greater increase when rest is SR and with the aim of maintaining MPO 
during HIT.  
 
Study three aimed to compare the magnitude in change in VO2 peak, 
TTE, TT, and critical power (CP) when SR rest is reduced by 15 and 20% 
during HIT between males and females. Participants completed the same 
HIT protocol from the previous studies but completed eight HIT sessions 
over a four week period. Both training groups experienced a significant 
increase in endurance performance as measured via VO2 peak (males 
only), TTE, TT and critical power (20% group only). A larger aerobic 
response during the HIT was significantly correlated to an increase in VO2 
peak in both males and females. Increases in critical power was 
significantly correlated to an improved TT time, which was also 
significantly correlated to increasing TTE. Indicating that TTE and TT 
improved due to an increase in greater power output. Reducing SR rest 
leads to a greater increase in endurance measures compared to non-
reduced SR rest (Study 2), apart from females VO2 peak who saw no 
change.  
 
Conclusion: 
Overall this thesis can conclude that: 1) males appear to maintain their 
MPO greater than females when using SR rest and females experience a 
greater drop in trial MPO when SR rest is reduced. 2) Participants may be 
pacing in trials as CV remains unchanged but MPO decreases. 3) The 
CV method to identify successful SR rest to maintain MPO is unreliable 
and doesn’t take into account potential pacing tactics. 4). SR rest in HIT 
causes a greater increase in TTE, TT and Wingate power output 
measures, however, using a FR leads to greater increases in VO2 peak 
all in males. 5) Reduced SR rest causes a greater increase in TTE, TT 
 v 
and VO2 peak (males only) compared to SR rest, and also increases CP. 
6) Maintaining MPO during HIT is not strongly correlated to increasing 
endurance or power output measures.   
 vi 
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 1 
1 General Introduction – Chapter 1 
1.1 Energy systems 
1.1.1 Adenylate kinase 
During intense bouts of exercise adenosine triphosphate (ATP) can be 
resynthesized through the enzyme adenylate kinase when ATP cannot be 
resynthesized through phosphocreatine (PCr), glycolysis or aerobic metabolism 
(Glaister., 2005). This process involves paring adenosine diphosphate (ADP) to 
create ATP and adenosine monophosphate (Equation 1.1 (Glaister., 2005)). 
 
ADP + ADP ←adenylate kinase→ ATP + AMP 
Equation 1. 1: ATP turnover through adenylate kinase activity. AMP, adenosine 
monophosphate. 
 
Adenosine monophosphate (AMP) is further deaminated to create inosine 
monophosphate (IMP) and ammonia through the reaction of the enzyme AMP 
deaminase (Equation 1.2 (Glaister., 2005)). 
 
AMP + H+ ←AMP deaminase→ IMP + NH4+ 
Equation 1. 2: Role of AMP deaminase to producing AMP and IMP. Where 
NH4+ is ammonia and H+ is hydrogen ion. 
 
1.1.2 Adenosine Triphosphate 
In order for muscular contraction, regardless of intensity, the human body 
obtains energy from ATP hydrolysis from the enzyme ATPase (Equation 1.3). 
 
ATP                    ADP +Pi + energy 
Equation 1. 3: Reduction of ATP to produce energy. Where ADP is adenosine 
diphosphate, and Pi is inorganic phosphate. 
 
ATPase 
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Approximately 20-25 mmol/kg dry muscle ATP is stored within the human body, 
during maximal activity peak ATP turnover is ~ 15 mmol/kg dry muscle per 
second (Gaitanos et al., 1993; Bogdanis et al., 1998; Parolin et al., 1999). This 
is a small amount that is only enough to fuel 1-2sec of maximal activity 
(Gaitanos et al., 1993; Parolin et al., 1999). In order to maintain maximal activity 
the human body uses multiple metabolic processes (Phosphocreatine, 
anaerobic glycolysis, and aerobic metabolism) to resynthesize depleted ATP. 
 
1.1.3 Phosphocreatine 
During high intensity bouts of exercise, phosphocreatine (PCr) and adenosine 
diphosphate (ADP) are important for the resynthesis of ATP (Glaister., 2005). 
PCr converts ADP back to ATP by using it’s phosphate through the enzyme 
creatine kinase to dephosphorylate PCr into creatine (Cr (Equation 1.4)). 
 
PCr + ADP + H+ ←Creatine Kinase→ ATP + Cr 
Equation 1. 4: Using PCr for ATP turnover.  
 
Converting ADP and PCr into ATP is a rapid process which is short lived due to 
the small amounts of PCr stored within skeletal muscle cells (80 mmol/kg dry 
muscle (29, 32-34)). PCr stores are reduced rapidly during intense bouts of 
exercise after 10sec (9 mmol/kg dry muscle/sec (Hultman & Sjöholm., 1983)). 
 
1.1.4 Anaerobic glycolysis 
Anaerobic glycolysis is the breakdown of an immediate reserve of 
carbohydrates, which is stored as muscle glycogen and is used for ATP 
turnover. It is predominately used within slightly less intense bouts of exercise, 
as anaerobic glycolysis involves more reactions/ enzyme steps for ATP 
regeneration than breakdown of stored ATP or PCr (Equation 1.3, 1.4 and 
Figure 1.1). These enzyme steps include phosphorylase, responsible for the 
breakdown of muscle glycogen to glucose 1-phosphate, phosphofructokinase 
(PFK), responsible for the phosphorylation of the glycolytic intermediate 
fructose 6-phosphate, and lactate dehydrogenase (LDH), responsible for the 
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conversion of pyruvate to lactate (MacLaren & Morton., 2012). Anaerobic 
glycolysis is derived from the breakdown of glucose in the form of muscle 
glycogen, which then produces ATP and lactate (Glaister., 2005). After ~5sec of 
maximal intense exercise ATP turnover from anaerobic glycolysis peaks at ~6-9 
mmol/kg dry muscle/sec (Hultman & Sjöholm., 1983; Jones et al., 1985). 
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Figure 1. 1: Anaerobic glycolysis pathway, where NAD+ is nicotinamide adenine 
dinucleotide (oxidised), NADH is nicotinamide adenine dinucleotide, CoA is 
acetoacetate, Acetyl-CoA is Acetyl coenzyme A, and CO2 is carbon dioxide 
(Maughan & Gleeson., 2004). 
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1.1.5 Aerobic metabolism 
Aerobic metabolism or oxidative phosphorylation indicates that ATP turnover 
comes from the breakdown of blood glucose or stored carbohydrates (glycogen) 
and fats (lipids) through oxidative processes within the mitochondria (MacLaren 
& Morton., 2012). Pyruvate, which is formed at the end of glycolysis, is 
converted into Acetyl coenzyme A (acetyl-CoA) and passes onto the 
tricarboxylic acid (TCA) cycle (Figure 1.2 (MacLaren & Morton., 2012)). Due to 
the use of an aerobic process, unlike PCr and glycolysis (anaerobic), there are 
multiple enzyme processes to produce ATP, which leads to a decrease in 
power output (Bogdanis et al., 1996; Gaitanos et al., 1993). Aerobic metabolism 
is more dominant in ATP turnover during lower intensity excise (walking, jogging 
(Hargreaves & Spriet., 2006)) or when a maximal sprint bout exceeds 15sec, 
due to a depletion in PCr and inhibited use of glycolysis (Parolin et al., 1999). 
Even during the first 6sec of a 30sec sprint, aerobic metabolism is responsible 
for ~1.32 mmol/kg dry muscle/sec ATP turnover (Parolin et al., 1999). As a 
30sec sprint continues aerobic metabolism increases its rate of ATP turnover 
but not to the same rate as PCr or glycolysis, resulting in a slower and or less 
powerful sprint (Parolin et al., 1999). During multiple 30sec sprint bouts aerobic 
metabolism responsible for ATP turnover will increase from 29-43% from sprint 
one to sprint three (Bogdanis et al., 1996).  
 6 
 
Figure 1. 2: Aerobic metabolism pathway, where GDP is guanosine 
diphosphate, GTP is guanosine triphosphate, FAD is flavin adenine 
dinucleotide, and FADH is flavin adenine dinucleotide hydroquinone (Powers & 
Howley., 2009). 
 
1.2 Energy consumption during a 30 second sprint 
Figure 1.3 and 1.4 demonstrates ATP turnover rate during a 30sec sprint. 
Bogdanis et al., (1996) identified that the calculated ATP turnover rate during 
two 30sec sprints separated by 4min rest. PCr + ATP are responsible for 23% 
during sprint one which then decreases to 20% in sprint 2 (Bogdanis et al., 
1996). Similarly Glycolysis decreases from 48-36%, with oxidative 
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phosphorylation increasing from 29-43% during the two sprint bouts Bogdanis 
et al., (1996).  
 
Figure 1. 3: Calculated ATP turnover rate (%) from PCr + ATP, glycolysis, and 
oxidative phosphorylation during two 30sec sprints separated by 4min rest. 
From Bodganis et al., (1996). 
 
Parolin et al., (1999) conducted similar research to Bogdanis et al., (1996) but 
identified what is responsible for ATP turnover during 0-6sec, 6-15sec and 15-
30sec sprint periods.  
 
Figure 1. 4: Calculated ATP turnover rate (mmol·kg dry wt-1·s-1) from PCr 
hydrolysis, glycolysis, and oxidative phosphorylation during bout 1 (A) and bout 
3 (B). From Parolin et al., (1999). 
 
During the first 6sec of a 30sec sprint ATP is derived from phosphorylation by 
rapid PCr hydrolysis of approximately 48%, phosphorylation of glycolysis 
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contributes to ~43% ATP turnover, and oxidative phosphorylation is responsible 
for ~9% ATP turnover (Parolin et al., 1999). During 6-15sec of the 30sec sprint, 
power output starts to drop (Figure 1.5) due to the high demand in ATP turnover 
and PCr hydrolysis there is a significant increase in inorganic phosphates (Pi) of 
~240% from rest to 6sec. Pi continues to steadily increase from 6-15sec (~24%) 
and 15-30sec (~5%). This rapid increase in Pi disrupts PCr resynthesis and 
calcium (Ca2+) release (skeletal muscle contraction) and absorption (skeletal 
muscle relaxation) within the sarcoplasmic reticulum (Glaister et al., 2005; 
Ørtenblad et al., 2011; Pilegaard et al., 1999; Westerblad, Allen, Lannergren., 
2002).  
 
Figure 1. 5: Typical Wingate 30sec sprint profile. Y axis represents power 
output (watts), and X axis presents time (sec). 
 
The amount of phosphorylation of PCr steadily drops to ~68%, from resting 
values, whereas phosphorylation of glycolysis stays elevated, with oxidative 
phosphorylation becoming more prominent (Parolin et al., 1999). In the last 
15sec of the 30sec sprint PCr stores are depleted by ~91% from resting values, 
glycolysis becomes inhibited, and oxidative phosphorylation is responsible for > 
50% of ATP turnover (Parolin et al., 1999). 
 
1.3 Energy use during repeat sprint activity 
The majority of ATP resynthesis during a 6 sec sprint is provided by PCr 
degradation, with a significant contribution also from anaerobic glycolysis 
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(Gaitanos et al., 1993; Figure 1.4). However, the metabolic contribution to ATP 
resynthesis during repeated 6 sec sprints is influenced by the recovery duration 
between sprints (Mendez-Villanueva et al., 2012). When performing 10 x 6 sec 
sprints against 7.5% body mass with a 30 sec passive recovery, ATP 
resynthesis had an increase in aerobic contribution (estimated at 13.1 mmol. kg 
dry wt-1. s-1) and a reduction in anaerobic contribution (63% reduction in 
glycogen contribution (Gaitanos et al., 1993)). These changes in metabolic 
contribution result in a decrease in both peak power output (PPO (33.4%)) and 
mean power output (MPO (26.6%)) between sprint one and ten (Gaitanos et al., 
1993). Glycolysis becomes inhibited during repeat sprint activity however, the 
exact mechanism is unknown. The most plausible explanation is that glycolysis 
is inhibited by the progressive depletion of muscle glycogen stores that are 
used during this type of exercise (Balsom et al., 1999; Gaitanos et al., 1993). 
Unlike PCr glycogen stores can only be restored through diet (Glaister., 2005). 
The depletion of glycogen has been shown to impair the release of calcium 
(Ca2+) within the sarcoplasmic reticulum, which decreases muscle activation 
and therefore force produced (Ørtenblad et al., 2011). 
 
1.4 Variables that influence adaptation to HIT 
1.4.1 Manipulating the work to rest ratio 
Tables 1.1 and 1.2 show studies that have used specific work:rest ratios during 
high intensity training (HIT) to improve endurance and power output, with a 1:8 
ratio appearing to be the most commonly used within HIT research. Work:rest 
ratios are designed to manipulate physiological responses to the HIT in order to 
stimulate desired performance improvements (Kavaliauskas, Aspe, Babraj., 
2015). Performance outcomes and goals depend on training: intensity, volume, 
progressive overload, frequency, and appropriate methods for targeted 
performance outcomes (Pincivero et al., 1997). Understanding the energy 
pathways used during repeat sprint ability, explains why manipulating rest times 
can lead to specific training adaptations (Turner & Stewart., 2013). PCr is 
resynthesized with the use of the aerobic system, the length of rest dictates how 
much PCr is resynthesized with approximately 1.3 mmol/kg dry muscle per 
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second being resynthesised (Gaitanos et al., 1993). At least 2 minutes of 
passive recovery is required to synthesize at least 84% PCr normal stored 
levels after dynamic knee extensions at 60% maximal effort until exhaustion 
(Harris et al., 1976; Hultman et al., 1967). Specially in repeat sprint activity it 
has been found that after 10 x 6 sec cycle sprints (separated by 30 sec passive 
recovery against air resistance) that ~83% of PCr is resynthesized following 6 
min of passive rest (Mendez-Villaneuva et al., 2012). A similar amount of PCr 
recovery has been found following a 2 min rest after a single 10 sec (~86%) 
cycle sprint against 7.5% body mass (Bogdanis et al., 1998). However, when 
the duration of the single sprint bout is doubled (20 sec) the amount of PCr 
recovery after a 2 min passive rest is decreased (~76% (Bogdanis et al., 1998)). 
Allowing a longer rest between sprint bouts leads to an increase in PCr 
resynthesis to maintain a higher rate of ATP recovery (Gaitanos et al., 1993) 
during subsequent high-intensity effort, enabling improved sprint speed and or 
power production (Billaut & Bishop., 2009). This has been found by Dawson et 
al., (1997), who compared PCr recovery rate following 10 sec (~55%), 30 sec 
(~69%) and 3 min (~90%) recovery following a single 6 sec cycle sprint against 
7.5% body mass. They also found that PCr recovery was impaired following 5 x 
6 sec sprints (30 sec passive recovery) compared to a single sprint at the same 
recovery time points of 10 sec (~27%), 30 sec (~45%) and 3 min (~84%). Given 
that PCr rate of recovery can be altered due to the rest duration, it may explain 
why using specific work:rest ratios lead to specific performance outcomes 
(Kavaliauskas, Aspe, Babraj., 2015). Altering rest during HIT has previously 
demonstrated to lead to specific performance adaptations (Kavaliauskas, Aspe, 
Babraj., 2015). Kavaliauskas, Aspe, Babraj., (2015) performed 6 x 10sec sprints 
(7.5% body mass resistance) using either a 30sec (1:3), 80sec (1:8) or 120sec 
(1:12) rest. They found that a shorter work:rest ratio (1:3) led to greater 
improvements in VO2 peak (~6.9%), TTE (~6.3%) and TT (~3.1%), compared to 
the 1:8 group (VO2 peak: ~4.7%), TTE: ~4.4%, TT: ~2.4%), and 1:12 group 
(VO2 peak: ~0.3%), TTE: ~1.9%, TT: ~2.4%). However, using a greater work: 
rest ratio led to greater improvements in Wingate PPO (1:8: ~8.5%, 1:12: 
~7.1%) and Wingate MPO (1:8: ~4.6.%, 1:12: ~5.3%), compared to the 1:3 
group (PPO: ~4.3%, MPO: ~0.3%) Kavaliauskas, Aspe, Babraj., (2015) 
suggesting that 1:8 work:rest produce both endurance and power adaptations. 
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Kavaliauskas, Aspe, Babraj., (2015) speculate that increasing aerobic demand 
during recovery from HIT could be a main regulator for increasing endurance 
and vice versa for increasing power output. This can be achieved by 
manipulating the work:rest ratio (Kavaliauskas, Aspe, Babraj., 2015). 
 
1.4.2 Maintenance of power during HIT: 
Some HIT research has speculated at the possibility of maintaining power 
output leads to improvements in endurance and power output regardless of the 
work:rest ratio (Hazell et al., 2010; Jakeman, Adamson, Babraj., 2012; Lloyd 
Jones, Morris, Jakeman., 2017; Yamagishi & Babraj., 2017). Hazell et al., 
(2010) measured maintenance of peak power, average power and minimum 
power output (percentage change from sprint one) over six sessions of HIT (4-6 
x 30sec sprints separated by 4min rest, 4-6 x 10sec sprints separated by 4min 
and 2min rest, all using 7.5% body mass resistance). They found that the 30 
sec sprint group produced a significant less amount of peak power, average 
power and minimum power output compared to the two 10 sec sprint training 
groups. Hazell et al., (2010) speculates that the 10 sec with 4min rest group 
(1:24) improved significantly in all tests (VO2 max: ~9.2%, TT: ~3.5%, PPO: 
~8.5%, MPO: ~6.5%) similar to the 30sec with 4min rest group (1:8 (VO2 max: 
~9.3%, TT: ~5.2%, PPO: ~9.5%, MPO: ~12.1%)) due to a greater maintenance 
of power compared to the 1:8 group. They also speculate that 10sec sprints 
separated by 2min (1:12) of rest led to smaller percentage changes (VO2 max: 
~3.8%, TT: ~3%, PPO: ~4.2%, MPO: ~2.9%) due to a shorter rest which led to 
a slightly reduced mean maintenance of power compared to the 1:24 group. 
  
Yamagishi & Babraj., (2017) compared peak and average power output 
reproducibility percentage between their two training groups (4-6 x 30 sec/15 
sec sprints separated by 4 min/2 min rest, using 7.5% body mass for males and 
6.5% for females as a resistance) in sessions 1, 6, 12 and 18. They found no 
significant difference between the two training groups in maintenance of PPO 
and MPO. With both groups significantly increasing their VO2 peak (15sec: 
~12.1%, 30sec: ~12.8%), TTE (15sec: ~16.2%, 30sec: ~12.8%), TT (15sec: 
 12 
~8.6%, 30sec: ~7.2%) by a similar amount, and the 15sec group significantly 
increasing CP (15sec: ~7.8%, 30sec: ~7.4%). This further suggests that 
maintaining PPO and MPO during HIT could be a key factor that leads to an 
increase in performance adaptations, despite the reduction in HIT by 50% 
(Yamagishi & Babraj., 2017). However, Yamagishi & Babraj., (2017) used active 
recovery between sprints (40% of VO2 peak) which kept cardiovascular demand 
high and may also have been the cause of an improvement in endurance 
measures (Kavaliauskas, Aspe, Babraj., 2015). 
 
If maintaining PPO during HIT is a main regulator for performance adaptations it 
may explain why studies using a 6 sec sprint achieved significant improvements 
in TT testing, given that PPO is usually achieved within 1-5sec of a sprint 
(Jakeman, Adamson, Babraj., 2012; Lloyd Jones, Morris, Jakeman., 2017). 
Jakeman, Adamson, Babraj., (2012) found similar improvements after two 
weeks of HIT (10 x 6sec sprints, 1min rest, against 7.5% body mass resistance 
for six sessions) in TT (~10%) compared to two weeks of 30sec sprint HIT (4-6 
x 30sec sprints, 4min rest, against 7.5% body mass resistance for six sessions) 
in TT (~9.6% (Burgomaster et al., 2006)). Lloyd Jones, Morris, Jakeman., 
(2017) compared 6 sec sprints against 30 sec sprints (both using 1:8 work:rest 
ratio against 7.5% body mass) over a two week period (six sessions) but both 
groups were matched for HIT duration (20 x 6sec sprints, 4 x 30sec sprints). 
After HIT they found a significant improvement in TT testing in both groups 
(6sec: ~5.1%, 30sec: ~6.2%). Both Jakeman, Adamson, Babraj., (2012) and 
Lloyd Jones, Morris, Jakeman., (2017) speculate that performance adaptations 
from HIT could be driven by the early part of a 30 sec sprint, potentially the 
reproducibility of PPO (Hazell et al., 2010). There is the possibility that the early 
part of a 30 sec sprint (0-6 sec) depletes glycogen, as long as there is multiple 
sprints, this depletion in glycogen could be why sprints as short as 6 sec lead to 
improvements in endurance performance (Jakeman, Adamson, Babraj., 2012; 
Knuiman, Hopman, Mensink., 2015; Lloyd Jones, Morris, Jakeman., 2017). It is 
thought that depleting glycogen leads to mitochondrial biogenesis which in turn 
would lead to an enhanced oxygen capacity within the skeletal muscle 
(Knuiman, Hopman, Mensink., 2015). Lloyd Jones, Morris, Jakeman., (2017) 
further speculates that supramaximal bouts of repeated 5-6sec sprints could be 
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linked with an increase in phosphofructokinase and hexokinase enzymes, along 
with an improved recovery period of  PCr. However, none of these studies 
(Hazell et al., 2010; Jakeman, Adamson, Babraj., 2012; Lloyd Jones, Morris, 
Jakeman., 2017; Yamagishi & Babraj., 2017) actively sought to identify if 
maintaining peak, average and or minimum power output leads to an increase 
in performance adaptations. 
 
Table 1.1: Summary of high intensity training studies on the effects of 
endurance capacity and performance 
Study N PA Sprint 
Duration 
Rest 
Duration 
Study 
Duration 
Resistance Performance 
Measures 
Burgomaster et 
al., (2005) 
6M 
2F 
PA 30s 4min 2 weeks 
(6sess) 
7.5% BM TTE↑*, & CS↑* 
Burgomaster et 
al., (2006) 
8M PA 30s 4min 2 weeks 
(6sess) 
7.5% BM TT↑*, & CS↑* 
Burgomaster et 
al., (2008) 
5M 
5F 
PA 30s 4.5min 6 weeks 
(18sess) 
∼500 W VO2 peak↑*↑*, 
& CS↑* 
Creer et al., 
(2004) 
10 CA 30s 4min 4 weeks 
(8sess) 
7.5% BM VO2 max↑ 
Gibala et al., 
(2006) 
8M PA 30s 4min 2 weeks 
(6sess) 
7.5% BM TT↑* 
Hazell et al., 
(2010) 
35M 
13F 
PA 30s, & 10s 4min, & 
2min 
2 weeks 
(6sess) 
7.5% BM TT↑*, & VO2 
max↑*, ↑† 
Jakeman et al., 
(2012) 
6 CA 6s 1min 2 weeks 
(6sess) 
7.5% BM TT↑*, & TTE↑ 
Kavaliauskas et 
al., (2015) 
10M 
14F 
CA 10s 30s, 80s, 
& 120s 
2 weeks 
(6sess) 
7.5% BM VO2 peak↑, 
TTE↑*,↑, & 
TT↑*, ↑, ↑ 
Kavaliauskas et 
al., (2016) 
8F MA 30s 4min 4 weeks 
(8sess) 
7% BM VO2 peak→, 
TTE↑*, TT↑*, & 
CP↑* 
Linossier et al., 
(1993) 
8M 
2F 
MA 5s 55s 7 weeks 
(28sess) 
8% BM VO2 peak→, 
T1↑*, & CS↑ 
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Table 1. 1: N, number of participants; M, Male; F, Female; PA, physically active 
(minimum of 3-hours per week); CA, competitive athletes; MA, moderately 
active (< 3 hours per week); sess, sessions; BM, body mass; ↑, increase; →, no 
change; ↑*, significant increase; ↑†, near significant (P = 0.06); TTE, time to 
exhaustion; CS, citrate synthase activity; TT, time trial; VO2 max, maximal 
oxygen consumption; VO2 peak, peak oxygen consumption; VO2, oxygen 
consumption; CP, critical power; and T1, type I muscle fibres. 
 
Table 1.2 Summary of high intensity training studies on the effects of power 
output 
Study N PA Sprint 
Duration 
Rest 
Duration 
Study 
Duration 
Resistance Performance 
Measures 
Burgomaster et 
al., (2005) 
6M 
2F 
PA 30s 4min 2 weeks 
(6sess) 
7.5% BM TPO↑*, GLY↑*, 
& PCr↑ 
Burgomaster et 
al., (2006) 
8M PA 30s 4min 2 weeks 
(6sess) 
7.5% BM TAP↑*, GLY↑*, 
& PCr↑ 
Burgomaster et 
al., (2008) 
5M 
5F 
PA 30s 4.5min 6 weeks 
(18sess) 
∼500 W TPO↑*, TAP↑*, 
GLY↑*, & 
PCr↑* 
Creer et al., 
(2004) 
10 CA 30s 4min 4 weeks 
(8sess) 
7.5% BM WPO↑*, 
WAP↑*, 
Linnosier et al., 
(1997) 
8M MA 5s 55s 7 weeks 
(28sess) 
8% BM VO2 peak↑*, & 
CS↑ 
Lloyd Jones et 
al., (2017) 
20M PA 30s, & 6s 4min, & 
48s 
2 weeks 
(6sess) 
7.5% BM VO2 max→, & 
TT↑* 
MacDougall et al., 
(1998) 
12M MA 30s 4-2.5min 7 weeks 
(21sess) 
7.5% BM VO2 max↑* 
Perry et al., 
(2008) 
5M 
3F 
MA 4min 2min 6 weeks 
(18sess) 
~90% VO2 
peak 
TTE↑*, & VO2 
peak↑* 
Rodas et al., 
(2000) 
5M MA 15-30s 0.75min-
12min 
2 weeks 
(14sess) 
7.5% BM VO2↑*, & CS↑* 
Yamagishi & 
Babraj., (2017)  
10M 
7F 
PA 30s, & 15s 4min, & 
2min 
9 weeks 
(18sess) 
7.5%, & 6.5% 
BM 
VO2 peak↑*, 
TTE↑*, TT↑*, & 
CP↑*, ↑ 
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RMS↑*, & 
MF↑* 
Forbes et al., 
(2008) 
4M 
3F 
PA 30s 4min 2 weeks 
(6sess) 
7.5% (M) & 
6.5% (F) 
TPO↑*, TAP↑*, 
& TPCr↑* 
Gibala et al., 
(2006) 
8M PA 30s 4min 2 weeks 
(6sess) 
7.5% BM GLY↑* 
Hazell et al., 
(2010) 
35M 
13F 
PA 30s, & 10s 4min, & 
2min 
2 weeks 
(6sess) 
7.5% BM WPO↑*, & 
WAP↑*,→ 
Jakeman et al., 
(2012) 
6 CA 6s 1min 2 weeks 
(6sess) 
7.5% BM TPO↑* 
Kavaliauskas et 
al., (2015) 
10M 
14F 
CA 10s 0.5min, 
1.2min, & 
2min 
2 weeks 
(6sess) 
7.5% BM  WPO↑*,↑,↑, & 
WAP↑*, ↑*, → 
Kavaliauskas et 
al., (2016) 
8F MA 30s 4min 4 weeks 
(8sess) 
7% BM TPO↑*, & 
TAP→ 
Linnosier et al., 
(1993) 
8M 
2F 
MA 5s 55s 7 weeks 
(28sess) 
8% BM WPO↑*, 
WAP→, & 
PCr↑ 
Linnosier et al., 
(1997) 
8M MA 5s 55s 7 weeks 
(28sess) 
8% BM MAC↑* 
Lloyd Jones et 
al., (2017) 
20M PA 30s, & 6s 4min, & 
48s 
2 weeks 
(6sess) 
7.5% BM TPO↑* 
McDougall et al., 
(1998) 
12M MA 30s 4-2.5min 7 weeks 
(21sess) 
7.5% BM TPO↑* 
Ørtenblad et al., 
(2000) 
9M MA 10s 50s 5 weeks 
(15sess) 
8-8.5%BM TAP↑*, PCr→, 
GLY↑, SRv↑*, 
SRCr↑*, & 
SRCu→ 
Perry et al., 
(2008) 
5M 
3F 
MA 4min 2min 6 weeks 
(18sess) 
~90% VO2 
peak 
TAP↑*, GLY↑*, 
& PCr↑* 
Rodas et al., 
(2000) 
5M MA 15-30s 0.75min-
12min 
2 weeks 
(14sess) 
7.5% BM WPO↑, WAP↑, 
GLY↑*, & 
PCr↑* 
Yamagishi & 
Babraj., (2017)  
10M 
7F 
PA 30s, & 15s 4min, & 
2min 
9 weeks 
(18sess) 
7.5%, & 6.5% 
BM 
TPO↑*,↑ 
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Table 1. 2: N, number of participants; M, Male; F, Female; PA, physically active 
(minimum of 3-hours per week); CA, competitive athletes; MA, moderately 
active (< 3 hours per week); sess, sessions; BM, body mass; ↑, increase; →, no 
change; ↑*, significant increase; TPO, training peak power output; WPO, 
Wingate test peak power output; TAP, training average power output; WAP, 
Wingate test average power output; MAC, maximum anaerobic capacity; PCr, 
phosphocreatine; GLY, glycogen content; RMS, root mean square 
(electromyography); MF, mean frequency (electromyography); SRv, 
sarcoplasmic reticulum volume; SRCr, sarcoplasmic reticulum Ca2+ release; 
SRCu, sarcoplasmic reticulum Ca2+ uptake; and TPCr, reduced time take to 
recover phosphocreatine. 
 
1.5 Further adaptations through high intensity training 
1.5.1 Lactate transporter activity 
Anaerobic capacity and skeletal muscle power is regarded as a contributing 
factor for improving endurance performance (Bulbulian et al., 1986; Noakes., 
1988). Increasing activity in factors such as lactate monocarboxylate 
transporters (MTC), specifically MTC1 (associated with type I muscle fibres) and 
MTC4 (associated with type II muscle fibres), are strongly linked with improved 
endurance performance, MPO and PPO performance (Pilegaard et al., 1999). 
Increased MTC1,4 activity leads to an increase in skeletal muscle tissue lactate 
uptake, which is correlated to an increased blood flow (~16% (Gladden., 2000)). 
It is unclear why an increase in blood flow stimulates lactate delivery to the 
muscle (Gladden., 2000). However, when this does occur it promotes an 
intracellular shuttle in lactate from extracellular and increase lactate uptake 
within skeletal muscle (Gladden., 2000). As blood lactate increases 75-80% of 
the lactate is oxidised with the remaining 25-20% been converted into glucose 
and glycogen (Brooks., 2000). Therefore, allowing a greater ATP turnover to 
allow higher muscular contraction rates (Bogdanis et al., 1996; Gaitanos et al., 
1993). Jakeman, Adamson, Babraj., (2012) used 10 x 6 sec sprints separated 
by 60 sec passive recovery and against 7.5% body mass resistance for two 
weeks (six sessions). They found that time to onset blood lactate accumulation 
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(OBLA) had significantly increased and speculated that this was caused by an 
increase in MTC1,4 activity (Burgomaster et al., 2008). It is thought that this 
significant increase in time to OBLA was related to an increased work rate (30 
W), which led to a ~4% increase in time to exhaustion (Jakeman, Adamson, 
Babraj., (2012). 
 
1.5.2 Muscle metabolites and calcium dynamics 
Five weeks of HIT (20 x 10sec sprint with 50sec recovery, 3 times a week, 
against 8-8.5% body mass) has been shown to increase Ca2+ release (~5.5%) 
which is thought to be a reflection of an increase in sarcoplasmic reticulum 
(Ørtenblad et al., 2011). Increasing glycogen stores within skeletal muscle is 
also significantly correlated (r2 = 0.29) to increasing Ca2+ release (Ørtenblad et 
al., 2011). Increasing resting and during exercise stores of muscle glycogen 
(Burgomaster et al., 2005, 2006, 2008) are regulated by an increase in the 
glycolytic flux mechanism (MacLaren & Morton., 2012). The glycolytic flux is 
regulated by glucokinase activity in the liver which is a glucose sensor and 
increases blood glucose levels during exercise (MacLaren & Morton., 2012). 
Increasing phosphofructokinase and fructobisphosphatase activity increases the 
glycolytic shuttle and promotes insulin secretion from the pancreas (MacLaren 
& Morton., 2012). This in turn contributes to ~40% of the total ATP turnover 
during the first 15 sec of a 30 sec sprint (Parolin et all., 1999). Decreases in 
glycogen stores lead to an impairment of Ca2+ release from the sarcoplasmic 
reticulum (Ørtenblad et al., 2011), therefore reducing the rate of muscular 
contraction and decreasing force production (Ørtenblad et al., 2001; 
Westerblad, Allen, Lannergren., 2002).  
 
Increased PCr stores and PCr recovery has been shown after HIT 
(Burgomaster et al., 2006; Forbes, Slade, Meyer., 2008; Rodas et al., 2000). An 
Increase in PCr stores would lead to a reduction in Pi, and increase Ca2+ 
dynamics (release and reabsorption rates) within the sarcoplasmic reticulum, 
which would lead to an increase power output (Gaitanos et al., 1993; Rodas et 
al., 2000; Westerblad, Allen, Lannergren., 2002). A build up in Pi and reduction 
in Ca2+ sensitivity are thought to be causes for peripheral fatigue due to high 
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rates of PCr hydrolysis (Westerblad, Allen, Lannergren., 2002). Thus, 
preventing PCr resynthesis and potentially causing a decrement in power output 
(Westerblad, Allen, Lannergren., 2002). 
 
1.5.3 Muscle fibre recruitment 
HIT (4-6 30sec sprints 4min recovery against 7.5% body mass,15 x 10sec 
sprints with 50sec recovery against 7% body mass, 2-6 x 15 and 30sec sprints 
against 7.5% body mass, 4-6 x 30sec sprints 15-20min recovery against 7.5% 
body mass, 8-13 x 5 sec sprints against 80% optimal force), has previously 
demonstrated an alteration in dominance in muscle fibre recruitment during 
exercise post training (Allemeier et al., 1994; Esbjörnsson et al., 1993; Jacobs 
et al., 1987; Jansson et al., 1990; Linnosier et al., 1993). Alterations include a 
decrease in the recruitment of faster type muscle fibres (type IIX) and an 
increase the recruitment of intermediate fast twitch muscle fibres (type IIA 
(Allemeier et al., 1994; Esbjörnsson et al., 1993; Jacobs et al., 1987; Jansson et 
al., 1990; Pette., 1998; Pette & Staron., 1997; Ross & Leveritt., 2001)). HIT 
research has also found mixed findings with type I muscle fibre recruitment, with 
either a decrease (~9.4% (Jacobs et al., 1987; Jansson et al., 1990)), increase 
(~19%) Linnosier et al., 1993)) or no alteration (Allemeier et al., 1994). 
Increasing the recruitment of type I and II muscle fibres would increase the rate 
of glycolysis, which would increase ATP turnover, improve recovery rates 
through aerobic metabolism (increase PCr recovery), contribution of aerobic 
metabolism to power production, and greater production of force (Kent-Braun & 
Alexander., 2000; Pette., 1985). productions of force (Pette., 1985). 
 
1.5.4 Neural adaptations 
HIT training has been shown to have similar improvements in neural responses 
that is found within resistance strength training (Creer et al., 2004). Neural 
impulse responses are responsible for these alterations, due to the progression/ 
loading of HIT, which alters metabolic homeostasis (Pette., 1985). This results 
in an increased muscle fibre recruitment, firing rate, and motor unit 
synchronisation (Creer et al., 2004). These adaptions allow participants to exert 
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more force (Creer et al., 2004), which has been shown to improve 5km running 
time trial (~6%) by increasing running speed and running economy, despite no 
change in VO2 max (Paavolainen et al., 1999). Neural adaptations, following 4 
weeks HIT (4-10 x 30sec sprints with 4min recovery, twice a week), specifically 
increased motor unit activation in the vastus lateralis (Creer et al., 2004). An 
increase in root mean squared (~28%) and decrease in medium frequency 
(~17%) from surface electromyography, has been linked with increasing PPO 
(~6%), MPO (~6%), and lactate (~7% (Creer et al., 2004)). 
 
1.6 Self-regulation 
1.6.1 Use of self-regulation during repeat sprint activity 
In repeat sprint activity (RSA) studies, participants were asked to self-select 
their rest periods to maintain their maximal standard of performance (Glaister et 
al., 2010; Phillips, Thompson, Oliver., 2014). These self-selected rest periods 
between sprints represent a form of self-regulation (Baumeister & Vohs., 2007; 
Magill., 2010; Schmidt & Wrisberg., 2007). Self-regulation is defined as 
individual’s control of themselves seeking to perform a task with a consistent 
outcome, their emotions, and their instinctive behaviour (Baumeister & Vohs., 
2007). It is thought that the participants in these self-regulation RSA studies 
used closed feedback loops to achieve an objective goal of maintaining their 
maximal performance (sprint speed or power output (Magill., 2010; Schmidt & 
Wrisberg., 2007; Weinberg & Gould., 2006)). 
 
1.6.2 Closed feedback loop 
Closed loop control systems are based on mechanical engineering models 
which can be used to describe the processes of human behaviour, if these 
movements require feedback then this is known as a closed feedback loop 
(Magill., 2010). Baumeister and Vohs. (2007) explains that feedback loops are 
necessary for the success of a task by using feedback. Figure 1.6 illustrates a 
closed feedback loop, an example of a closed feedback loop is a person 
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controlling their skin (shell) temperature to maintain comfort (Brooks, Fahey, 
Baldwin., 2004; Magill., 2010).  
 
 
Figure 1. 6: Schmidt & Wrisberg (2007) chart displaying the mechanisms of a 
closed feedback loop. 
 
If a person’s skin temperature is too cold (Input) the person will seek to adjust 
their skin temperature through their own control (Executive). The person may 
attempt to raise their skin temperature by putting on a jacket or moving towards 
a source of heat (Effector), to raise the skin temperature of the body to maintain 
comfort (Output). The person is continuously assessing whether the skin has 
reached its new desired temperate (Feedback) and will identify if the changes 
made are appropriate in maintaining comfort (Comparator). If the changes are 
not appropriate (Error) then the person will repeat the process or change their 
approach (Input) to suit their needs of maintaining comfort (Brooks, Fahey, 
Baldwin., 2004; Magill., 2010). Similarly, a closed feedback loop can be in 
operation when  participants are instructed to use self-regulated (SR) rest with 
the aim of repeatedly achieving their maximal running speed (12 x 30m running 
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sprints) or MPO (10 x 6 sec cycle sprints against 7.5% body mass resistance) 
(Glaister et al., 2010; Phillips, Thompson, Oliver, 2014). Participants from these 
SR RSA studies may have used a closed loop feedback to judge when they felt 
they were ready to perform their next sprint. These judgment and perception 
behaviours may have been controlled by peripheral sensory also known as 
afferent feedback (Marcora., 2008; Proske., 2005; Schmidt & Wrisberg., 2007). 
Afferent feedback comes from sensory nerves located within muscle spindles 
and Golgi tendon organs (Marcora., 2008; Proske., 2005 (see section 1.6.5 for 
a review)). Participants during SR RSA (with the aim of maintaining sprint speed 
or power output) may feel too much tension in their legs to begin their next 
sprint (Input). The participants may decide (Executive) to rest for a longer period 
of time (Effector), which may allow the feeling of tension in their legs to 
decrease (Output) and possibly indicate that they are ready to begin the next 
sprint (Feedback). After the completion of their next sprint, they will identify if 
the sprint they just performed equalled to what they felt was their maximal 
speed or power output (Comparator). The comparator may also be used when 
participants are comparing the tension in their legs against the lack of tension in 
their legs which they may associate with completing another successful sprint. 
After a sprint participants may then feel too much tension in their legs again to 
immediately begin their next sprint (Error), which then causes this closed 
feedback loop to occur again in order for the participants to decide when to 
begin the next sprint (Magill., 2010). If a sprint was successfully maintained 
(sprint speed or MPO maintenance) during a trial and the participant was 
informed of being successful, then this could be an example of the outcome 
response theory (Wit & Dickinson., 2009). The outcome response theory 
involves a goal (outcome), in this case is maintaining speed or MPO, which 
leads to an action (response (Wit & Dickinson., 2009)). The goal may be 
achieved due to a participant waiting for the tension in their legs to decrease 
before starting their next sprint (outcome response). A successful outcome 
response may lead to a greater perspective of how to maintain sprint speed or 
MPO through the associative-cybernetic model (ACM; Figure 1.7).  
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Figure 1.7: Adapted from Wit & Dickinson (2009), chart displaying mechanisms 
for associative-cybernetic model.  
 
Specifically to SR RSA studies, possibly after a successful trial, the ACM 
explains the participant’s readiness by identifying they are ready to begin their 
next sprint (first unit) with the aim of achieving a repeat of their maximal effort 
(outcome). The participant may feel they are ready to perform their maximal 
effort due to the sense of tension in their legs decreasing (sensory), which leads 
to the participant deciding to sprint (response) and then perform the sprint 
(movement). This ACM model may even explain why two familiarization trials of 
cycle sprints leads to a  greater reliability of power output in following trials 
(Hopkins, Schabort, Hawley., 2001). A learning effect appears to have occurred 
in SR RSA studies, indicated by the reduction in PPO, MPO and sprint speed 
CV in the latter trials compared to the earlier trials (Glaister et al., 2010; Phillips, 
Thompson, Oliver., 2014). The reduction in CV would indicate a greater 
maintenance of power output and sprint speed (Hopkins., 2000). 
 
1.6.3 Self-regulation during repeat sprint activity 
Glaister et al., (2010) asked physically active, repeated-sprint habituated males 
(n = 20) to take part in four trials consisting of 12 x 30m running sprints. 
Participants were instructed to recover after each sprint for as long as they felt 
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was necessary in order to maintain a consistent performance across all 12 
sprints. Results indicated that following two familiarisation trials, participants 
were able to use self-selected recovery to maintain consistent performance 
(within trial coefficient variation (CV) = (< 2.02%) across the 12 sprints. Despite 
the self-selected nature of the recovery duration and the stable sprint 
performance, rated of perceived exertion (RPE) increased significantly between 
sprints 1-12. The authors suggested that the progressive increase in RPE was 
an indication that participants were only just giving themselves sufficient 
recovery time between sprints to maintain their sprint speed repeatedly (Glaister 
et al 2010). However, the nature of the study protocol made elucidation of this 
suggestion impossible as Glaister et al., (2010) did not identify if participants 
were over-estimating their recovery duration. Data from Phillips, Thompson, 
Oliver., (2014) indicate that participants over-estimate their required SR 
recovery by 10% when asked to maintain their MPO. The participants saw no 
difference in maintaining their MPO across ten sprints with SR recovery and 
with a reduction of SR recovery of 10%. If the participants from Glaister et al., 
(2010) are also over-estimating their recovery during by 10% it would indicate 
that the increase in RPE data during a trial is a reflection of peripheral afferent 
feedback from elevated heart rate and oxygen consumption during repeated 
sprints (Pereira et al., 2014). 
 
Phillips, Thompson, Oliver., (2014) recruited physically active males (n = 14) to 
perform four trials of 10 x 6 second cycle sprints using 7.5% body mass as a 
resistance and allowed participants to select their own active recovery time to 
mimic sprint performance across all sprints. The instructions provided to 
participants were identical to those reported by Glaister et al (2010). Analogous 
to Glasiter et al., (2010), participants were able to reliably self-regulate recovery 
duration in order to maintain MPO across all 10 sprints (CV = ≤ 5.2%). 
Participants then completed a fifth trial, where each post-sprint recovery time 
from participants’ most reliable trial from trials 1-4 (based on within-trial lowest 
CV for mean power output) was reduced by 10% in a single-blind fashion. It 
was found that even with the reduced recovery time participants could still 
maintain performance across the 10 sprints; in addition, heart rate and physical 
rated perceived exertion (P-RPE) were also similar to those of reduced rest. 
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This data indicates that participants over estimate their required recovery by at 
least 10%. Phillips, Thompson, Oliver., (2014) also reported increased P-RPE 
with increasing sprint number. They speculate that the increase in P-RPE is 
possibly caused by a progressive increase in intramuscular acidosis and/or 
increased cardiorespiratory demand from the progressive increase in aerobic 
contribution to repeated sprints. However, P-RPE data may not be a reliable 
tool for suggesting an increase in intramuscular acidosis and/or increased 
cardiorespiratory demand. It has been previously found that P-RPE and RPE 
increase linearly the closer participants think they are getting to the end point of 
exercise (Baden et al., 2005; Swart et al., 2012). Participants will display 
symptoms to match their expectations in a term known as symptom belief, 
which has a large influence on perceived symptoms (Pohl et al., 1997). 
Therefore, increases in RPE and P-RPE scores in previous self-regulated 
studies (Glasiter et al., 2010; Phillips, Thompson, Oliver., 2014) are possibly 
due to the participant’s knowledge or expectation of the end point of exercise. 
This assumption is further suggested by Baden et al., (2005), who indicates that 
regulation and fatigue may be a psychological response rather than a 
physiological response. Baden et al., (2005) had participants (male n = 8; and 
female n = 8) running at 75% of their peak treadmill running speed for 20 min 
(trial 1), 10 min then informed to run another 10 min (trial 2), and then not 
informing participants of running duration but still running for 20 min (trial 3). 
RPE measurements were significantly greater in trial 2 compared to trials 1 and 
3 during minutes 11-14. Baden et al., (2005) suggests that in trial 2 at 11-14 min 
time points participants thought they had finished their previous task despite 
running at the same speed as the other two trials. Therefore, the linear increase 
in RPE for Phillips, Thompson, Oliver., (2014) and Glaister et al., (2010) could 
be due to participants having the knowledge of completing the desired amount 
of sprints. RPE/ P-RPE measurements during SR repeat sprint activity may not 
be reliable as participants may increase their RPE/ P-RPE purely because they 
have the knowledge that they have nearly finished the desired amount of sprints 
(Baden et al., 2005). 
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1.6.4 Pacing tactics 
Glaister et al., (2010) and Phillips Thompson, Oliver., (2014) demonstrated that 
participants could use self-regulated (SR) rest periods between running sprints 
and cycle sprints to maintain maximal sprint performance (CV = ≤ 5.2%). 
Glaister et al., (2010) have suggested that participants with a lower level of 
aerobic capacity would choose longer rest periods, that the longer the rest 
period would indicate an increase in fatigue, and this could be used as a 
surrogate indicator for fatigue. However, Phillips, Thompson, Oliver., (2014) 
suggest that participants could be using pacing strategies during self-regulated 
(SR) rest to prevent any homeostatic disturbances or to restore homeostasis to 
avoid early exercise termination (Tucker et al., 2006). It has also been found 
that participants will pace their efforts during a single bout of exercise when 
comparing 5, 15, 30 and 45 sec cycle sprints against 7.5% body mass 
resistance (Wittekind, Micklewright, Beneke., 2011). Despite PPO being 
achieved typically within the first 5 sec of a sprint (Vandewalle, Pérès, Monod., 
1987), a 5 sec sprint appears to produce a significant greater amount of PPO 
compared to a 15, 30 and 45 sec sprints (Wittekind, Micklewright, Beneke., 
2011). It could be possible that when given multiple sprints participants pace 
their efforts similarly to the paced efforts found within a single sprint but with 
different durations (Wittekind, Micklewright, Beneke., 2011). These studies 
suggest that individuals will pace their efforts as a plan to prioritise energy 
expenditure in an attempt not to disturb homeostasis (Edwards & Polman., 
2013). Pre planning will depend on what the nature of the task, the importance 
of the task and the person’s capabilities and willingness to do the task (Edwards 
& Polman., 2013). 
 
1.6.5 Peripheral or central feedback? 
During self-paced cycling exercise, evidence suggests that the exercise is 
regulated through sensory feedback to the central nervous system (CNS) 
through central fatigue (Davis., 1995; Froyd et al 2016; Meeusen et al., 2006; 
Swart et al 2012; Kay et al 2001; Noakes, Peltonen, Rusko., 2001; St Clair 
Gibson et al., 2001; Swart et al 2009; Tucker et al 2006). Central fatigue is 
defined as a reduction in maximal capacity of the CNS to optimally recruit motor 
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units to produce force (Gandevia., 2001). Central fatigue is used to ensure that 
the participant’s peripheral critical threshold is never exceeded (Amann., 2011; 
Amann., 2012). The peripheral critical threshold is thought to be a reduction in 
muscle force output due to paced efforts from an increase in peripheral fatigue 
in an attempt to not disturb homeostasis (Froyd et al., 2016; Hureau et al., 
2014). It is also thought that peripheral fatigue is a regulator for self-paced 
cycling exercise by reducing the amount of muscle recruitment through afferent 
feedback (from peripheral organs: lungs, heart and skeletal muscle (Amann., 
2011; Amann., 2012; Froyd et al 2016)). Afferent feedback comes from sensory 
nerves located within muscle spindles and Golgi tendon organs (Marcora., 
2008; Proske., 2005). These sensory nerves sense tension, position and 
movement, and then send signals through the CNS to give the sense of effort 
(Proske., 2005). Both central and peripheral fatigue are believed to contribute to 
neuromuscular fatigue (Froyd et al 2016). It has been demonstrated that when 
intensity during exercise bouts increase there is also an increase in 
neuromuscular and peripheral fatigue (Amann & Dempsey., 2008). However, 
these studies have used self-paced time trial cycling and not looked at central 
or peripheral fatigue during rest periods. Therefore, the rate of peripheral and 
central fatigue could alter during each rest period as the body recovers during 
HIT. Time trial cycling and HIT may have similar rates of peripheral and central 
fatigue due to an increase in neuromuscular fatigue during the latter stages of 
their respected protocols (Froyd et al., 2016; Mendez-Villanueva et al., 2012). 
What can be highlighted from these studies is that peripheral fatigue occurs 
20% into the time trial and steadily increases as the time trial continues (Froyd, 
Millet, Noakes., 2013). Whereas central fatigue is thought to occur when after 
peripheral fatigue had already developed (Decorte et al., 2012) and only further 
develops depending on the exercise duration (Place et al., 2010). Despite the 
lack of research in central and peripheral fatigue during HIT specifically in 
recovery periods, it could be suggested that peripheral fatigue will play a larger 
role the exercise and may therefore control SR rest. That is to say that SR rest 
during repeat sprint activity could be mainly controlled by afferent feedback. 
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1.7 Sex differences 
While males are typically stronger and more powerful than females there is 
evidence indicating that females have the ability to resist peripheral fatigue to a 
greater extent than males (Billaut & Bishop., 2012; Hunter., 2014; Laurent et al., 
2010; Perez Gomez et al., 2008; Roepstorff et al., 2006; Russ et al., 2005; 
Smith & Billaut., 2012). It is thought that this is due to differences in muscle 
mass (high in males) and fat mass (high in females), muscle fibre type 
distribution and recruitment, and metabolic activity differences during exercise 
(Billaut & Bishop., 2012; Hunter., 2014; Laurent et al., 2010; Perez Gomez et 
al., 2008; Roepstorff et al., 2006; Russ et al., 2005; Smith & Billaut., 2012). 
During repeat sprint exercise, it has been demonstrated that males have a 
larger recruitment in type II muscle fibres whereas females have a larger 
recruitment in type I muscle fibres, with the latter been associated with 
producing less force (Hunter., 2014). The greater muscle mass within males 
has been reported to increase PPO, and a greater fat mass within females have 
been reported to lead to a lower PPO (Perez Gomez et al., 2008). Males also 
have a greater activity of glycolytic enzymes and lower oxidative capacity which 
is in keeping with a greater development of force and recruitment of type II 
fibres (Russ et al., 2005). However, the greater use of glycolytic enzyme activity 
is greatly associated with fatiguing metabolites, such as Pi, which may lead to a 
greater decrement in force for males compared to females (Billaut & Bishop., 
2012; Laurent et al., 2010; Smith & Billaut., 2012). 
 
Research from Billaut & Bishop., (2012) identifies fatigue between sexes in a 
sporting context by comparing results between males and females during 
repeat sprint exercise. The study involved 35 team sport athletes both male (n = 
18) and female (n = 17) completing 20 x 5 sec cycle sprints, using 9% of their 
body mass as a resistance, with a 25 sec rest in between each sprint. 
Mechanical work (J.kg-1) achieved in sprint one and across all 20 sprints was 
higher in men. However, men had a significant decrease in mechanical work 
when compared to women across all sprints (Males: ~35%; and females: 
~24%). Smith & Billaut., (2012) investigated fatigability between sexes during 
repeated sprint exercise. The study consisted of males (n = 10) and females (n 
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= 10) taking part in 10 x 10 sec cycle sprints against a resistance of 9% body 
mass with 30 sec rest. When sexes were matched for initial sprint work (closely 
ranking the results of each participant after a single 10 sec sprint), they had 
similar declines in work output (Males: ~27%; and females: ~30%). Laurent et 
al., (2010) also researched sex differences during repeat sprint activity. The 
study involved male (n = 8) and female (n = 8) participants completing four trials 
involving three bouts of 8 x 30m running sprints. Males (~40 sec) produced 
significantly faster times in all sprints compared to females (~44 sec). However, 
females had significantly lower blood lactate levels (Males: ~8.5-12.2 mmol; and 
females: ~7-9 mmol), and saw less of a decline in their performance (sprint 
time) compared to males (Males: ~5-3%; and females: ~3.5-1.7%). This occurs 
due to a lower use of glycolysis in females (Hunter et al., 2014; Russ et al., 
2005) and a better utilisation of fat (Hunter et al., 2014; Roepstorff et al., 2006). 
Females also experienced a greater cardiac strain (higher heart rate) compared 
to males, although data was not significant it could indicate a greater oxidative 
load and blood flow to the skeletal muscles (Kent-Braun & Alexander., 2000). 
Laurent et al., (2010) concluded that males may be able to produce more power 
in the form of faster times, but women seem to be less fatigable than men and 
may recover faster. The evidence of females experiencing a smaller decline in 
their repeat sprint performance (Billaut & Bishop., 2012; Laurent et al., 2010; 
Smith & Billaut., 2012) could be due to the greater ability to recover PCr within 
females compared to males (Kent-Braun & Alexander., 2000). The female 
ability to resist fatigue greater than males is summarised in Figure 1.8. 
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Figure 1.8: Hunter., (2014) chart displaying potential physiological mechanisms 
for the sex difference in muscle fatigability, indicating that females may be less 
fatigable than males. Not all components from this figure are discussed in this 
study. 
 
1.7.1 Differences between sexes in high intensity training performance 
adaptations 
Tables 1.1 and 1.2 indicate that endurance and power improvements can be 
made in both males and females following as little as two weeks of HIT. 
However, there is research that suggests that females do not see the same 
increases in VO2 max that males experience following HIT (Vigelso, Andersen, 
Dela., 2014). Vigelso, Andersen, Dela., (2014) compared HIT and endurance 
training published research from 1983-2013. They found that there is a positive 
link between citrate synthase activity and VO2 max increasing post HIT and 
endurance training in healthy sedentary or healthy trained young adult males. 
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Vigelso, Andersen, Dela., (2014) speculate that females do not have the same 
link in improving citrate synthase activity along with VO2 max. However, the data 
suggesting that females do not see as strong a link in males in improved citrate 
synthase activity and VO2 max is due to a lack of HIT/ endurance training 
studies that have used females (Vigelso, Andersen, Dela., 2014). Studies used 
within Tables 1.1 (males: n = 140; females: n = 54) and 1.2 (males: n = 234; 
females: n = 57) that identify the sex of their participants further indicates a lack 
of female presence within HIT research. There is also the possibility that the 
commonly prescribed 7.5% body mass resistance (see Tables 1.1 and 1.2) in 
the cycle sprints is too great for females due to morphological profile differences 
in males and females (Perez Gomez et al., 2008). With female morphological 
profile having a greater amount of fat mass compared to males who have a 
greater amount of muscle mass compared to females (Perez Gomez et al., 
2008). Therefore, 7.5% body mass resistance is a greater relative intensity for 
females, compared to males, due to their lower muscle mass and greater fat 
mass (Perez Gomez et al., 2008). Hazell et al., (2010) speculates that 
maintaining peak power output during HIT is a key factor for improving 
endurance capacity and performance. Therefore, the commonly prescribed 
7.5% body mass resistance (see Tables 1.1 and 1.2) might be too great to allow 
females to maintain their peak power output. Kavaliauskas, Steer, Babraj., 
(2016) saw no change in VO2 peak when using only females (n = 8) and a 
reduced (7% body mass) resistance after 2 weeks (6 sessions) of HIT. 
However, there is also the possibility that female participants in Kavaliauskas, 
Steer, Babraj., (2016) didn’t increase there VO2 peak due to the short duration 
(2 weeks) of HIT, with longer studies (3-12 weeks) finding more participants 
improving their VO2 max (Astorino & Schubert., 2014; Bagley et al., 2016; Gurd 
et al., 2016). There is also the possibility that 7% body mass resistance is too 
great, as Yamagishi & Babraj., (2017) found overall improvements, in both HIT 
groups, in VO2 peak in males (n = 10) and females (n = 7) when females used 
6.5% body mass resistance (Table 1.1). However, within Yamagishi & Babraj., 
(2017) there is also the possibility that participants increased their VO2 peak 
due to the long duration (9 weeks) of the study (Astorino & Schubert., 2014). 
Astorino & Schubert., (2014) found that more sedentary participants (males n = 
20, females n = 20) did not increase their VO2 max (~35% of participants) when 
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using a short term HIT protocol (2 weeks), compared against a long term (12 
weeks) HIT protocol (~22% of participants). Therefore, it is possible that female 
participants in Yamagishi & Babraj., (2017) improved their VO2 peak due to a 
long duration study or due to the reduced cycling resistance. 
 
1.8 Ability to self-regulate rest to maintain power and improve 
athletic performance between sexes 
Much is to be explored about the maintenance of power output whilst using SR 
rest during repeat sprint cycle interval training. It is unsure if SR rest during 
repeat sprint training or HIT will lead to any performance adaptation (Glaister et 
al., 2010; Phillips, Thompson, Oliver., 2014). There is also the uncertainty if 
females can SR their rest to maintain performance (sprint speed and MPO). 
Therefore, this thesis will seek to further explore the effects of SR rest during 
HIT, and identify if any performance gains occur whilst using SR rest during HIT 
between sexes. 
 
1.9 Aims 
The key aims to this PhD thesis are: 
 
To determine if males and females maintain mean power output during 
repeated sprints with self-regulated rest. 
 
To identify male and female response in mean power output when self-
regulated rest is reduced  
 
Compare endurance adaptations to HIT with a fixed rest (30 sec) or self-
regulated rest.  
 
To identify if reproducibility of mean power output is correlated to endurance 
and Wingate power output adaptations to HIT. 
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To compare the magnitude in change of VO2 peak, time to exhaustion, 10km 
time trial, and critical power between 15 and 20% reduced self-regulated rest 
during repeat sprint training between males and females. 
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2 Chapter 2 – Study 1 (Sex comparison during repeated cycle sprint 
exercise with self-regulated recovery) 
2.1 Introduction 
Whilst males are typically stronger than females there is evidence of a greater 
resistance to peripheral fatigue in females (Laurent et al., 2010; Smith & Billaut., 
2012). This difference in the rate of peripheral fatigue has been proposed to be 
due to differences in percentage area of skeletal muscle fibre type between 
males and females (Glenmark, Hedberg, Jansson., 1992; Hicks, Kent-Braun, 
Ditor., 2001). Females have been found to have a significantly greater 
percentage area of type I muscle fibres with males showing a significantly 
greater percentage area of type IIa muscle fibres in the vastus lateralis 
(Roepstorff et al., 2006; Staron et al., 2000). The greater percentage area of 
type IIa muscle fibres in males is in keeping with demonstrating a higher 
glycolytic enzyme activity and lower oxidative capacity (Roepstorff et al., 2006; 
Russ et al., 2005) which leads to a greater force development (Russ et al., 
2005). Females utilise glycolytic enzyme activity to a lesser extent and instead 
have a greater fat oxidation capacity due to a higher percentage area of type I 
muscle fibres compared to males (Roepstorff et al., 2006; Staron et al., 2000). 
 
These differences may affect ability to perform sprints (Billaut & Basset., 2007; 
Laurent et al., 2010; Smith & Billaut., 2012), which can be regarded as an 
important aspect of team sport (Billaut & Basset., 2007; Gaitanos et al., 1993; 
Glaister et al., 2008). During both repeated sprint running and cycling bouts, 
males see a larger decrement in speed and power output (Billaut et al., 2011; 
Laurent et al., 2010). This could be due to the greater ability to recover 
phosphocreatine (PCr) after sprints in females compared to males (Kent-Braun 
& Alexander., 2000). Therefore, increasing PCr availability for the next sprint 
during the rest periods which will aid repeatability of sprint performance 
(Gaitanos et al., 1993; Rodas et al., 2000). There is evidence to indicate that 
females have the ability to recover PCr faster than males due to a greater ability 
to utilise oxygen in skeletal muscles (Kent-Braun & Alexander., 2000). Kent-
Braun & Alexander., (2000) findings also suggest a strong link between a higher 
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VO2 peak and a faster PCr recovery. In addition, at the point of exhaustion 
females can recover faster and produce greater amounts of absolute force 
compared to males (Fulco et al. 1999).  This may suggest that in order to 
recover PCr females would require a shorter rest period following maximal 
exertions. 
 
Recently, Glaister et al., (2010) and Phillips, Thompson, Oliver.,  (2014) 
demonstrated that participants could use self-regulated (SR) rest periods 
between running sprints (12 x 30m (Glaister et al., 2010)) and cycle sprints (10 
x 6 seconds, 7.5% body mass resistance (Phillips, Thompson, Oliver., 2014)) to 
maintain maximal sprint performance (defined as a coefficient of variation (CV) 
between sprints ≤ 5.2%)). Glaister et al., (Glaister et al., 2010) have suggested 
that participants with a lower level of aerobic capacity would choose longer rest 
periods, that the longer the rest period would indicate an increase in fatigue, 
and this could be used as a surrogate indicator for fatigue. However, Phillips, 
Thompson, Oliver., (2014) suggests that participants could be using pacing 
strategies during self-regulated (SR) rest to prevent any homeostatic 
disturbances that could lead to early exercise termination (Tucker et al., 2006). 
Phillips, Thompson, Oliver., (2014) main findings identified that male 
participants over-estimated their SR rest period by at least 10%. This suggests 
that individuals will pace their efforts as a plan to prioritise energy expenditure in 
an attempt not to disturb homeostasis (Edwards & Polman., 2012). Pre planning 
will depend on what the task is, the importance of the task and the person’s 
capabilities and willingness to do the task (Edwards & Polman., 2013). During 
maximal exercise, it is suggested that central fatigue in the central nervous 
system is responsible for the regulation of exercise (Davis., 1995; Kay et al., 
2001; Noakes, Peltonen, Rusko., 2001; Romain et al., 2006; Swart et al., 2012; 
St Clair Gibson, Schabort, Noakes., 2001; Swart et al 2009; Tucker et al., 
2006). Suggesting that pacing tactics are used to prevent harm to the body 
when exercise intensity threatens homeostatic control, and that during maximal 
exercise fatigue is controlled by the brain rather than physiological depletion in 
energy sources (Baden et al., 2005; Bassett & Howley., 2000; Billaut et al., 
2011; Costill, Fink, Pollock  1976; Swart et al., 2012).  
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2.1.1 Aims and hypothesis 
Given this over-regulation of SR in males (Phillips, Thompson, Oliver., 2014) 
and potential sex differences in sprint performance (Billaut & Bishop et al., 
2011; Laurent et al., 2010) further studies are required to understand the effects 
of SR rest during repeat sprint exercise in males and females. The aim of this 
study was to investigate the reliability and accuracy of SR repeated sprint 
performance in males and females. It was hypothesised that females would 
require a shorter rest period between sprints than their male counterparts and 
both sexes would over-estimate recovery required by at least 10%. 
 
2.2 Methods 
2.2.1 Participants 
Ten physically active males (180 ± 8 cm, 78 ± 9 kg, and 43 ± 5 VO2peak ml.kg-
1.min-1) and females (169 ± 8 cm, 63 ± 8 kg, and 33 ± 6 VO2peak ml.kg-1.min-1) 
volunteered for this study. Before taking part, participants were given written 
and verbal instructions about the study prior to giving informed consent. 
Participants also completed a physical activity readiness questionnaire to 
ensure there was no known health issues that would put the participants in 
harm by taking part this study. Participants were asked how many hours of 
structured exercise they participate in per week (males = 8 ± 4h, females = 7 ± 
4h), which is more than the American College of Sports Medicine and American 
Heart Association recommended 2.5 hours of moderate physical activity 
(Haskell., 2007). All participants were required to be either competitive or 
recreational athletes, aged 18-35 years and trained > 3 hours per week. Ethical 
approval was received from Abertay University ethics committee and the study 
was carried out in line with the declaration of Helsinki.  
 
2.2.2 Procedures 
2.2.2.1 Baseline testing 
At the beginning of the session, participants’ body mass (BM, kg) and height 
(cm) were recorded using a digital scale (Tanita SA 165A-0950U-3) and digital 
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stadiometer (Seca 264), respectively. The BM measurements were required for 
peak oxygen uptake measurements, and to identify how much resistance would 
be applied during a cycle sprint. 
 
2.2.2.2 Equipment 
Participants completed cycle sprints on a Monark cycle ergometer (Monark 
peak bike 894), mean power output (MPO) for each sprint was calculated using 
the Monark software (Monark Anaerobic Test Software version 2.24.2, Monark 
Exercise AB). MPO was calculated as the overall relative mean average watt 
value (watts / participant’s BM). Further descriptions of how MPO was used is 
listed below. 
 
2.2.2.3 VO2 peak 
Traditionally peak and maximum oxygen uptake (VO2 peak and VO2 max) is 
defined as the highest value oxygen that can be taken up and utilized by the 
body during incremental exercise to exhaustion or time to exhaustion test (TTE 
(Bassett & Howley., 2000)). Both these measures are regarded as an indicator 
for capacity of cardiorespiratory function (Loftin et al., 2004), and commonly 
used to measure exercise capacity changes pre and post intervention testing 
within exercise physiology (Bassett & Howley., 2000; Stevens & Dascombe., 
2015). In order to assess VO2 max researchers waited for a participant’s VO2 to 
plateau (no increase in VO2 despite an increase in TTE) during a TTE (Basset & 
Howley., (1997). However, VO2 does not always plateau during a TTE and has 
to be repeated until a plateau occurs (Basset & Howley., 1997; Rossiter, 
Kowalchuk, Whipp., 2006). Taking 10-30sec averages of the highest VO2 value, 
commonly at the end of a TTE test, is known as the VO2 peak, which is likely to 
be a similar value to the VO2 max (Rossiter, Kowalchuk, Whipp., 2006). 
Therefore, repeating the test until a plateau in VO2 occurs is not necessary to 
assess capacity of cardiorespiratory function (Loftin et al., 2004; Rossiter, 
Kowalchuk, Whipp., 2006). Study 1 involved no intervention but a VO2 peak test 
was conducted at the start of the study to define participants’ aerobic capacity 
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and to enable further exploration of resting and sprinting VO2 data between 
males and females.  
 
Participants were fitted with a heart rate (HR) monitor (Polar) and a mask 
connected to an online expired gas analyser (Cortex Metamax3B). Participants 
then mounted the cycle ergometer (Monark peak bike) and cycled for 4 minutes 
at 60 W. Immediately following this warm up, power output increased by 30 
W·min–1 until volitional exhaustion (Jakeman, Adamson, Babraj., 2012). 
Participants were instructed to maintain a cadence of 60 revolutions per minute 
(RPM) and were verbally encouraged throughout. The test was terminated if a 
participant dropped below a cadence of 60 RPM for more than 5 sec or if the 
participant chose to stop. VO2 peak was determined as the highest 30 sec 
average of VO2 across the test. VO2 peak was determined as the highest 30 sec 
average of VO2 across the test, which has been recommended for detecting the 
highest processed data point (Robergs, Dwyer, Astorino., 2010). 
 
2.2.3 Experimental rational 
2.2.3.1 Sprint resistance 
Participants cycled against 7.5% body mass in accordance to previous HIT 
studies (Burgomaster et al., 2005, 2006, 2008; Hazell et al., 2010; Jakeman, 
Adamson, Babraj., 2012; Kavaliauskas, Aspe, Babraj., 2015; Lloyd Jones, 
Morris, Jakeman., 2017; Yamagishi & Babraj., 2017). There is evidence that 
within HIT that females should adopt a lower resistance, recently Yamagishi & 
Babraj., (2017) and Kavaliauskas, Steer, Babraj., (2016) respectively used 6.5% 
and 7% body mass as a resistance for their female participants. The purpose 
for using a lower resistance in females is due to morphological sex differences 
with a greater fat mass found in females and greater muscle mass found in 
males (Perez-Gomez., 2008). Using a lighter resistance in females might be 
more suitable for producing greater power outputs (Billaut & Bishop., 2009). 
However, one of the aims to this thesis was to maintain MPO using SR rest and 
not produce greater amounts of MPO. With only males shown to maintain their 
MPO using SR rest (Phillips, Thompson, Oliver., 2014). Using the same 
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resistance of body mass for both sexes within this thesis may allow further 
suggestions on appropriate resistance to be used for females. This will be 
achieved by comparing MPO, cardiorespiratory response, and pre and post 
performance testing measures between sexes. 
 
2.2.3.2 Sprint duration 
Traditionally within HIT research, a 30 sec sprint is used (Burgomaster et al., 
2005, 2006, 2008; Hazell et al., 2010; Lloyd Jones, Morris, Jakeman., 2017; 
Yamagishi & Babraj., 2017). However, there is increasing research that 
indicates that a sprint as short as 6 sec during HIT training sees similar 
improvements in endurance and power post training compared to using a 30 
sec sprint (Jakeman, Adamson, Babraj., 2012; Lloyd Jones, Morris, Jakeman., 
2017). It has been speculated that positive performance adaptations post HIT 
may be driven by the early stages of the sprint and possibly explaining similar 
improvements in time trial testing between using a 6 and 30 sec sprint 
(Jakeman, Adamson, Babraj., 2012; Lloyd Jones, Morris, Jakeman., 2017). 
Hazell et al., (2010) also speculates that the reproducibility of power output 
(peak, mean, and minimum) during HIT may also be a key factor for positive 
performance adaptations. If the reproducibility of peak power output during HIT 
is a main regulator for positive performance adaptations then this may be 
achieved using only a 6 sec sprint (Lloyd Jones, Morris, Jakeman., 2017). 
Given that peak power output (PPO) is usually achieved within the first 5 sec of 
a sprint (Vandewalle, Pérès, Monod., 1987). 
 
2.2.3.3 Criterion sprint, fatigue index and coefficient of variation 
After the completion of a VO2 peak test, male and female participants 
completed a criterion sprint (CS) test prior to taking part in fours trials of 10 x 6 
sec sprints separated by self-regulated (SR) rest and cycling against 7.5% BM 
as a resistance. The purpose of the CS was to provide a familiarisation session 
for the participants, and to allow a comparison between a single sprint MPO 
against an average of ten sprints MPO (Phillips, Thompson, Oliver., 2014). 
Phillips, Thompson, Oliver., (2014) also found that SR trials average peak 
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power output (PPO) was significantly less than the CS PPO, MPO between CS 
and SR trials followed a similar pattern but was not significant. They speculate 
that participants may have been pacing their efforts to complete ten maximal 
effort sprints instead of just one sprint despite using SR rest. Within this thesis, 
the CS was used to identify if participants are maintaining their maximum MPO 
across all ten sprints in each SR or reduced rest (RR) trial. Participants were 
informed before the start of their next trial if they had been maintaining their 
MPO (compared to their CS) as part of a feedback loop (Baumeister & Vohs., 
2007; see section 1.6.2). The feedback loop was used to help participants 
understand if what they had done in previous trials or sessions was successful 
in maintaining MPO (Baumeister & Vohs., 2007). Therefore, aid participants in 
keeping within the aim of the study of maintaining MPO across ten sprints. To 
measure a drop in MPO for each participant in each trial fatigue index (FI) was 
used (equation 2.1). 
 
FI = (100 x [total sprint performance / ideal sprint performance]) – 100 
Equation 2.1: Where total sprint performance = sum of MPO from all sprints, 
and ideal sprint performance = number of sprints x greatest MPO (Fitzsommons 
et al., 1993). 
 
The FI measurement appears to be a reliable method for identifying a decrease 
in performance (percentage decrement (Fitzsommons et al., 1993)). FI is 
strongly correlated to percentage decrement in cycling (r = 0.88) and running (r 
= 0.75) repeat sprint activity (Fitzsommons et al., 1993). Percentage change 
between the CS, average MPO, and trials 1-6 MPO to identify if participants 
employed pacing tactics during the trials. The CS test consisted of a single 
maximal effort 6 sec sprint followed by cycling against 1kg for 60 sec at 60 
revolutions per minute (RPM), the MPO for the sprint was recorded, and 
participants then sat quietly for 5 min. This CS test was repeated for a second 
time and if the MPO of CS sprint two was 5% greater than CS sprint one then 
the CS test was repeated until the MPO of the CS failed to increase by 5% 
(Phillips, Thompson, Oliver., 2014). During trials 1-4, participants were informed 
to self-regulate (whilst cycling at 50-60 RPM against no resistance) their rest 
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with the aim of maintaining their MPO across all ten sprints within the trial. 
Maintaining power output during high intensity training (HIT) has been 
speculated as a potential factor for improving performance post HIT (Hazell et 
al., 2010; Lloyd Jones, Morris, Jakeman., 2017). Using SR rest to maintain 
MPO would remove factors based on recovery of PCr (Glaister., 2005) which 
may be different for each participant possibly based off their aerobic fitness 
(Glaister et al., 2010). SR rest may allow participants to maintain their MPO 
rather than using a fixed work:rest ratio. However, there is uncertainty whether 
SR rest during HIT would lead to any performance adaptation due to an 
overestimation in SR rest by at least 10% (Phillips, Thompson, Oliver., 2014). 
Therefore, identifying how long participants overestimate their SR rest by and 
removing this overestimation could perhaps lead to positive performance 
adaptations. Participants were instructed to rest until the point they felt they 
could reproduce the same MPO or greater MPO of their CS. Participants were 
blind to any timing apparatus to ensure SR rest duration was based off their 
personal response to the task (Glaister et al., 2010; Phillips, Thompson, Oliver., 
2014). SR rest duration was defined as the moment a sprint ends until after a 
participant counts down from 3, 2, 1 to start the next sprint, which is in keeping 
with Phillips, Thompson, Oliver., (2014). SR rest duration was recorded in 
seconds using a digital stop watch performed manually by the researcher. To 
identify if participants were maintaining their MPO coefficient of variation (CV) 
was used (equation 2.2), CV had to be ≤ 5.2% to be deemed as a successful 
trial (Capriotti, Sherman, Lamb., 1999; Glaister et al., 2010; Phillips, Thompson, 
Oliver., 2014). CV of ≤ 5.2% was chosen given that the participants were 
unfamiliar with this method of training Capriotti, Sherman, Lamb., (1999). If 
participants were familiar with this method of training or had at least six 
familiarisation trials, it would be expected that MPO CV could be as little as 2.5-
3.3% (Capriotti, Sherman, Lamb., 1999). Therefore, given that participants were 
unfamiliar with this method of training and did not receive six familiarisation 
trials a CV of ≤ 5.2% was deemed an appropriate marker for maintenance of 
MPO during SR and RR trials (Capriotti, Sherman, Lamb., 1999). 
 
CV = (standard deviation of MPO from 10 sprints / average MPO from 10 
sprints) * 100 
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Equation 2.2: Coefficient of variation formula. 
 
CV was used to compare reliability during trials in previous research (Glaister et 
al., 2010; Phillips, Thompson, Oliver., 2014). CV is a commonly used method 
for identifying of typical error that can be used for individual participants, reliably 
compare what is typically percentage error between trials, and is commonly 
used within physical, medical and social sciences (Bai, Wang, Wong., 2011; 
Hopkins., 2000). Sample size (number of participants) or in this case number of 
sprints performed in a trial (ten), can effect CV results (Hopkins., 2000). For 
example degrees of freedom can be > 25 (~5% bias) when using 25 
participants and 2 trials, and could be 7 degrees of freedom (~21% bias) when 
using 8 participants over two trials (Hopkins., 2000). Therefore, within this thesis 
CV of MPO within each trial could vary if more sprints of a similar MPO were 
performed. Participants who were successful in two of the four trials (n = 17) 
progressed onto trial five where 10 x 6 sec sprints were performed again but 
with a 10% reduction in most successful trial mean SR rest (Phillips, Thompson, 
Oliver., 2014). Participants who were successful in trial five (n = 16) then moved 
onto trial six which was similar to trial five but involved a 15% reduction in SR 
rest. 
 
2.2.3.4 Self-regulation  
In all three studies, the participants that had to self-regulate their rest periods 
were left completely in charge and would inform the researcher as to when they 
wanted to begin their next sprint by counting down from three. Allowing this 
much control for the participants is in line with the definition of self-regulation, 
control of one’s self (Baumeister & Vohs., 2007), and follows similar commands 
from previous self-regulated repeat sprint activity (Glaister et al., 2010; Phillips, 
Thompson, Oliver., 2014). In order for participants to understand if they had 
successfully maintain their MPO (CV ≤ 5.2%) the researcher informed the 
participant in order to create a feedback loop for the participant (Baumeister & 
Vohs., 2007; see section 1.6.2). If participants were unsuccessful they have 
taken this feedback and adopted a longer rest period, which would allow a 
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greater resynthesis of ATP and therefore greater MPO (Glaister., 2005). 
However, it is also possible that participants may have taken this feedback and 
paced their efforts or held back to allow their MPO across all ten sprints to be 
similar. Pacing has been shown to occur when comparing single 5, 15, 30 and 
45 sec sprints, with greater PPO been achieved in a 5 sec sprint compared to 
15, 30 and 45 sec sprints (Wittekind, Micklewright, Beneke., 2011). Therefore, 
within this research it could be possible that using ten 6 sec sprints could lead 
to participants pacing their efforts in order to maintain a similar MPO within a 
trial. 
 
2.2.4 Trial procedure 
2.2.4.1 Sprint trials warm-up 
In all trials, participants were required to complete a warm up that consisted of 4 
min cycling at 60 RPM against 1kg as resistance on a cycle ergometer (Monark 
peak bike). Once completed a sprint specific warm up was carried out; 
consisting of 3 x 3 second sprints against 7.5% body mass with an active 45s 
recovery, cycling at 50-60 RPM (with no resistance), between sprints. 
Participants then rested for 4 minutes prior to completing the sprint trials 
(Phillips, Thompson, Oliver., 2014). 
 
2.2.4.2 Trial 1 
Participants completed a 6s all-out effort sprint against 7.5% body mass with 
the resistance dropping once they reached 110 RPM. Participants then cycled 
for 60s against 1kg resistance before dismounting the bike for 300s. The sprint 
was then repeated and if mean power output (MPO) was greater than in sprint 1 
then this was taken as their CS performance. If MPO in the second sprint was ≥ 
5% of the first MPO value, the test was repeated for a third time. The CS 
procedure was repeated until MPO no longer increased (Phillips, Thompson, 
Oliver., 2014). On completion, participants had a 15 minute seated recovery. 
Following the recovery, participants repeated the warm up procedure and 
began their first self-regulated recovery sprint trial, consisting of 10 x 6s sprints 
against 7.5% body mass with the resistance dropping once they reached 110 
 43 
RPM. Participants wore a mask connected to the online gas analyser (Cortex 
metamax 3B) and a HR monitor (Polar) throughout the protocol. 
 
2.2.4.3 Trials 2-4 
Participants completed the same warm up and self-regulated recovery sprint 
trial with a minimum of 48 hours between trials. To progress onto trials 5 and 6 
successful performance was determined as (Phillips, Thompson, Oliver., 2014): 
1. A within-trial CV for MPO of 5.2% or less (the upper CV for this type of 
exercise (Capriotti, Sherman, Lamb., 1999; Glaister., 2005)). Participants 
had to achieve this in three out of the four trials. 
Two males and one female were unable to meet the above criteria, therefore 8 
males (181 ± 9 cm, 78 ± 10 kg, and 44 ± 5 VO2 peak ml.kg-1.min-1) and 9 
females (170 ± 3 cm, 62 ± 6 kg, and 34 ± 6 VO2 peak ml.kg-1.min-1) proceeded to 
trials 5 and 6. 
 
2.2.4.4 Trials 5-6 
In these trials, the same procedure sprint was used except a fixed rest time was 
applied. The fixed rest time was calculated by taking the mean rest time from 
each participant’s most reliable trial, based on within-trial CV for MPO (males 
CV = 2.3% ± 0.7% and females CV = 2.8% ± 1.1%), and reducing it by 10% or 
15%. This was done to determine the extent of over-estimation of required 
recovery duration. One female was unable to meet the above criteria in trial 5 
and did not progress to trial 6. 
 
2.2.5 Assessment of cardiorespiratory response 
2.2.5.1 Equipment 
Participants wore a gas mask that was connected to a gas analyser (Metalyzer 
3B gas analyser, Cortex, Leipzig, Germany) during trials and sessions. The gas 
analyser was calibrated before the use of each trial or session using the lab’s 
air gas mixture of known oxygen (O2) and carbon dioxide (CO2). It was 
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assumed that partial air gas was 20.93% (O2) and 0.03% (CO2). Gas 
connections during calibration was 17.1% (O2) and 5% (CO2). The turbine 
flowmeter for the gas analyser was calibrated using a 3L calibration syringe 
(Hans Rudolph, inc., Kansas city, USA). Cardiac response, in the form of heart 
rate (HR), was measured using a portable HR monitor (Polar Electro, Kempele, 
Finland).  
 
2.2.5.2 Measuring cardiorespiratory response 
Volume of O2 (VO2), volume of CO2 (VCO2), and HR were measured in rest one 
and rest nine for each trial. This allowed a comparison of cardiorespiratory 
response during recovery between the start and end of each trial between 
sexes. Given that participants SR their rest periods, VO2, VCO2 and HR rest 
one and rest nine was normalised as a percentage of total recovery time. With 
overall normalised average (100%) data or smoothing of the data and 
differentiating raw displacement data (cubic spline method (Vint & Hinrichs., 
1996)), for the three measures, been used to compare between sexes, trials, 
and the start and end of each trial. Data was normalised as participants or 
sexes may have had a lower VO2, VCO2 and or HR due to a longer SR rest 
duration, which would allow a greater period of time for these measures to 
return closer to normal resting values (Yamagishi & Babraj., 2016). There is 
also evidence that indicates that participants would over-estimate their rest by 
at least 10% (Phillips, Thompson, Oliver., 2014). Therefore, removing the error 
of certain participants or sex experiencing a lower VO2, VOC2 and or HR value 
due to a longer SR rest duration. VO2, VCO2 and HR values were recorded at 
two sec averages, which may be less reliable than using longer sec averages 
for identifying the most processed data point (Robergs, Dwyer, Astorino., 2010). 
However, due to the uncertainty of when a participant would decide when to 
perform their next sprint this seemed appropriate. 
 
2.2.6 Statistical analyses 
Statistical analysis was analysed on IBM SPSS Version 22.0 software. To 
explore significance between sexes and trials a two-way (sex * trial) analysis of 
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variance (ANOVA) was used. The ANOVA compared the following: mean 
recovery time, MPO, and FI; the CS, participants’ reliable trial (based on within-
trial CV for MPO) based on the first four trials, 10% reduced rest (RR), and the 
15% RR trial; physiological between R1 and R9 for the SR, 10% RR, and 15% 
RR trials. Statistical significance was set up as p ≤ 0.05, and data are mean 
with ± standard deviation (SD). Significant main effects between trials were 
further explored by using Bonferroni post hoc analysis. Significant main effects 
between sexes and groups were further explored by using an independent 
samples T test. In the case of a significant interaction, the data was split by sex, 
the ANOVA test was performed again and significant main effects were 
explored as previously described. If sphericity was violated then Greenhouse-
Geisser corrections were used. A Pearson’s correlation was used to identify a 
link between trial data and cardiorespiratory data. 
 
 
2.3 Results 
2.3.1 Self-regulated rest: 
Table 2.1 shows a comparison between all trials and best trial for SR recovery 
duration, MPO, FI and CV. A significant main effect was present between trials 
for SR recovery duration (F 6,113.262 = 2.967, p < 0.05), post hoc indicates that 
trial 6 recovery time is significantly shorter than trial 4 (p < 0.05). No interaction 
was present in SR recovery (F 1, 20.044, = 0.396, p > 0.05). No significant main 
effect was present between sex in SR recovery time (F 1, 20.007 = 0.386, p > 
0.05). 
 
2.3.2 MPO and MPO % change from the CS 
A significant main effect was present between trials in MPO (F 7, 133.059, = 4.117, 
p < 0.05), post hoc indicates that trial 6 MPO data is significantly lower than the 
criterion sprint and trial 3 (p < 0.05). A significant main effect was also present 
between sex for trial MPO (F 1, 20.019, = 24. 612, p < 0.05), post hoc also 
indicates that male MPO data is significantly higher compared to female MPO 
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across all trials (p < 0.05). An interaction was present in MPO (F 7, 133.051, = 
2.065, p < 0.05), female CS MPO is significantly higher than trials 1, 2, 4, best 
trial and 6 (p < 0.05). A significant main effect was present between trials in 
MPO % change from the CS (F 6, 112.97 = 4.279, p < 0.05), post hoc indicates 
that trial 6 data is significantly greater than trials 3-5 and best SR trial (p < 0.05). 
A significant main effect of sex was also present in MPO % change from the CS 
(F 1, 19.839 = 8.021, p < 0.05), post hoc indicates that female data is significantly 
greater than male data in trials 2-6 and best SR trial (p < 0.05). No significant 
interaction was present in MPO % change from the CS (F 6, 112.97 = 0.738, p > 
0.05). 
 
2.3.3 FI and CV 
FI was significantly different across trials (F 6, 112.049 = 2.237, p < 0.05); post hoc 
indicates that trial 1 FI is significantly greater than best trial (p < 0.05). No 
significant main effect between sex (F 1, 18.405 = 0.015, p > 0.05) or interaction (F 
6, 112.086, = 1.516, p > 0.05) was present for FI. A significant main effect between 
trials was present for CV (F 6, 111.696, = 3.886, p < 0.05), post hoc indicates that 
the best trial was significantly lower than trials 1 and 2 (p < 0.05). No significant 
main effect of sex (F 1, 18.356, = 0.486, p > 0.05) or significant interaction (F 6, 
111.752, = 0.737, p > 0.05) was present in CV. 
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Table 2.1: Performance variables across the 4 trials of self-regulated repeated sprint exercise for both sexes. 
 Criterion 
Sprint  
Trial 1 Trial 2 Trial 3 Trial 4 
 
Best Trial Trial 5 Trial 6 
Recovery time (sec)   
 
      
Male - 88 ± 30 
 
92 ± 31 98 ± 41 112 ± 48 101 ± 48 82 ± 29 77 ± 28‡ 
Female - 102 ± 44 103 ± 40 102 ± 32 108 ± 44 
 
105 ± 42 97 ± 29 88 ± 27‡ 
Mean power output (W.kg -1) 
 
        
Male 
 
11.3 ± 1.3* 11 ± 1.6* 11.2 ± 1.3* 11.5 ± 1.4* 11.4 ± 1.2* 11.4 ± 1.6* 11.4 ± 1.4* 11 ± 1.4*† 
Female 
 
9.3 ± 1.2+ 8.7 ± 1.3 8.5 ± 1.0 8.8 ± 1.1 8.7 ± 1 8.7 ± 1.1 8.9 ± 1.1 8.6 ± 1.4*† 
Mean power output change 
to CS (%) 
 
        
Male 
 
- -2.3 ± 9 -0.1 ± 7.4 2.5 ± 7.9 1.1 ± 7.3 1.3 ± 6.6 2 ± 7 -1.2 ± 8 
Female 
 
- -6.3 ± 8.3 -8.1 ± 6.9 -4.8 ± 5.9 -5.7 ± 7.4 -6.3 ± 6 -4.5 ± 5.7 -9.8 ± 8.6 
Fatigue index (%)  
 
        
Male 
 
- 6.2 ± 4.6ɸ 5.9 ± 3.7 6.9 ± 3.9 6.6 ± 4.8 4.7 ± 3.7 4.9 ± 3.9 5 ± 1.5 
Female  
 
- 8.7 ± 4.4ɸ 8.7 ± 9 5.0 ± 1.9 5.3 ± 2.3 3.6 ± 1.3 4.4 ± 2.3 4.8 ± 2.2 
CV (%) 
 
        
Male 
 
- 4.7 ± 3.8 3.5 ± 1.3 3.6 ± 1.8 3.9 ± 2.4 2.3 ± 0.7** 2.4 ± 1.1 3.3 ± 1.5 
Female - 4.9 ± 2.4 5.1 ± 4.3 3.7 ± 1.0 3.7 ± 1.7 2.8 ± 1.1** 3.1 ± 1.6 3.4 ± 1.5 
 
Table 2.1: ‡Significantly lower than trial 4. * Significantly greater than corresponding female data. † Significantly lower than trial 3 and criterion 
sprint.** Significantly lower than trials 1 and 2. + Interaction, female MPO CS data is significantly greater than trials 1, 2, 4 best trial and 6. ɸ 
significantly greater than best trial.
4
7
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2.3.4 VO2, VCO2 and HR resting data 
Figure 2.1 (A) shows rest 1 and rest 9 normalised VO2 data for the best SR trial, 
10% RR and 15% RR trials for both sexes, (B) normalised VO2 curve data in 
best SR trial for both sexes, (C) normalised VO2 curve data in 10% RR trial for 
both sexes, and (D) normalised VO2 curve data in 15% RR trial for both sexes. 
There was a significant main effect of mean normalised VO2 data in trial/ rest 
period (F 5, 78, = 14.904, p < 0.05), post hoc indicates that all rest 9 data are 
significantly greater than all rest 1 data (p < 0.05). A significant main effect 
between sex was also present (F 1, 15.983, = 70.228, p < 0.05), post hoc indicates 
that male VO2 data is greater than female data across all trials and recovery 
periods (p < 0.05). A significant interaction (sex*trial) was also present (F 5, 78.093 
= 2.647, p < 0.05), post hoc indicates that male SR rest 9 VO2 data is 
significantly greater than all trial rest 1 data (p < 0.05).  
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Figure 2.1: (A) Normalised VO2 in best SR trial, 10% and 15% RR trials, data 
shows rest 1 vs. rest 9, (B) best SR trial curve both sexes, (C) 10% RR trial 
curve both sexes, and (D) 15% RR trial curve both sexes. * Significantly greater 
than females (p < 0.05). + Significantly greater than all rest 1 data. ‡ Significant 
interaction, male SR R9 is greater than R1 data in all trials. 
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Percentage of VO2 peak during best SR trial, 10 and 15% RR trials is shown in 
table 2.2. No significant main effect of sex (F 1, 163.106, = 2.279, p > 0.05) or 
interaction was present (F 5, 78.205, = 1.064, p > 0.05). However, a significant 
main effect of rest number was present (F 5, 78.205, = 16.05, p < 0.05) with post 
hoc indicating that all rest 9 data was significantly greater than all rest 1 data (p 
< 0.05).  
Sex SR R1 SR R9 10% R1 10% R9 15% R1 15% R9 
Male 54 ± 7 66 ± 16* 51 ± 7 65 ± 11* 54 ± 8 68 ± 13* 
Female 50 ± 11 55 ± 9* 49 ± 13 61 ± 8* 49 ± 7 59 ± 8* 
       
Table 2.2: Percentage of VO2 peak during rests 1 and 9 in best SR trial, 10 and 
15% RR trials. * Significantly greater than all rest 1 data. 
Table 2.3 shows correlation values (r) comparing between the sum of MPO in 
each trial and the sum of VO2 in each trial, and overall trials sum of MPO and 
the overall trials sum of VO2. Significant correlations occur in SR MPO vs. SR 
VO2 (p < 0.05), 10% RR MPO vs. 10% RR VO2 (p < 0.05), 15% RR MPO vs. 
15% RR VO2 (p < 0.05), and overall MPO vs. overall VO2 (p < 0.05). 
Measure SR MPO vs. 
SR VO2 
10% RR 
MPO vs. 
10% RR VO2 
15% RR 
MPO vs. 
15% RR VO2 
Overall MPO 
vs. Overall 
VO2 
Correlation r = 0.82* r = 0.66* r = 0.62* r = 0.78* 
 
Table 2.3: Correlation values comparing sum of MPO in each trial and the sum 
of VO2 in each trial, and overall trials sum of MPO and the overall trials sum of 
VO2. Overall MPO is a combination sum of MPO from SR, 10% and 15% RR 
trials. Overall VO2 is a combination sum of normalised average VO2 from rests 1 
and 9 in SR, 10% and 15% RR trials. * Significant correlation (p < 0.05). 
Figure 2.2 (A) shows rest 1 and rest 9 normalised VCO2 data for the best SR 
trial, 10% RR and 15% RR trials for both sexes, (B) normalised VCO2 curve 
data in best SR trial for both sexes, (C) normalised VCO2 curve data in 10% RR 
trial for both sexes, and (D) normalised VCO2 curve data in 15% RR trial for 
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both sexes. There was a significant main effect of mean normalised VCO2 data 
in trial/ rest period (F 5, 78.198, = 11.399, p < 0.05) and between sex (F 1, 16.057, = 
53.715, p < 0.05). Post hoc indicates that rest 9 data in 10% and 15% RR trials 
is significantly greater than all rest 1 data, and SR rest 9 is significantly greater 
than SR rest 1 (p < 0.05). Post hoc between sex indicates that mean 
normalised VCO2 is significantly greater in all trials and rest periods (p < 0.05). 
A significant interaction (sex*trial) was also present (F 5, 78.198 = 2.476, p < 0.05), 
post hoc indicates that male 10% RR rest 9 is significantly greater than SR rest 
1 and 10% RR rest 1 data, and male 15% RR rest 9 data is significantly greater 
than 10% RR rest 1 data (p < 0.05).  
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Figure 2.2: (A) Normalised VCO2 in best SR trial, 10% and 15% RR trials, data 
shows rest 1 vs. rest 9, (B) best SR trial curve both sexes, (C) 10% RR trial 
curve both sexes, and (D) 15% RR trial curve both sexes. * Significantly greater 
than females (p < 0.05). † Significantly greater than SR R1 data. + Significantly 
greater than R1 in all trials. ‡ Significant interaction, male 10% R9 is greater 
than 10% R1 and SR R1, and male 15% R9 is greater than 10% R1. 
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Table 2.4 shows correlation values (r) comparing between the sum of MPO in 
each trial and the sum of VCO2 in each trial, and overall trials sum of MPO and 
the overall trials sum of VCO2. Significant correlations occur in SR MPO vs. SR 
VCO2 (p < 0.05), 10% RR MPO vs. 10% RR VCO2 (p < 0.05), 15% RR MPO vs. 
15% RR VCO2 (p < 0.05), and overall MPO vs. overall VCO2 (p < 0.05). 
Measure SR MPO vs. 
SR VCO2 
10% RR 
MPO vs. 10% 
RR VCO2 
15% RR MPO 
vs. 15% RR 
VCO2 
Overall MPO 
vs. Overall 
VCO2 
Correlation r = 0.77* r = 0.64* r = 0.58* r = 0.73* 
 
Table 2.4: Correlation values comparing sum of MPO in each trial and the sum 
of VCO2 in each trial, and overall trials sum of MPO and the overall trials sum of 
VCO2. Overall MPO is a combination sum of MPO from SR, 10% and 15% RR 
trials. Overall VCO2 is a combination sum of normalised average VCO2 from 
rests 1 and 9 in SR, 10% and 15% RR trials. * Significant correlation (p < 0.05). 
Figure 2.3 (A) shows rest 1 and rest 9 normalised HR data for the best SR trial, 
10% RR and 15% RR trials for both sexes, (B) normalised HR curve data in 
best SR trial for both sexes, (C) normalised HR curve data in 10% RR trial for 
both sexes, and (D) normalised HR curve data in 15% RR trial for both sexes. 
There was a significant main effect of mean normalised HR data in trial/ rest 
period (F 5, 75.424, = 31.566, p < 0.05), post hoc indicates that rest 9 data in all 
trials is significantly greater than all rest 1 data in all trials (p < 0.05). No 
significant main effect was present between sex (F 1, 16.158, = 0.473, p > 0.05) 
and so significant interaction (sex*trial) was present (F 5, 75.424, = 0.345, p > 
0.05).  
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Figure 2.3: (A) Normalised HR in best SR trial, 10% and 15% RR trials, data 
shows rest 1 vs. rest 9, (B) best SR trial curve both sexes, (C) 10% RR trial 
curve both sexes, and (D) 15% RR trial curve both sexes. + Significantly greater 
than all R1 data (p < 0.05). 
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Table 2.5 shows correlation values (r) comparing between the sum of MPO in 
each trial and the sum of HR in each trial, and overall trials sum of MPO and the 
overall trials sum of HR. No significant correlation occurred (p > 0.05). 
Measure SR MPO vs. 
SR HR 
10% RR 
MPO vs. 10% 
RR HR 
15% RR MPO 
vs. 15% RR 
HR 
Overall MPO 
vs. Overall HR 
Correlation r = 0.22 r = -0.06 r = 0.21 r = 0.3 
 
Table 2. 5: Correlation values comparing sum of MPO in each trial and the sum 
of HR in each trial, and overall trials sum of MPO and the overall trials sum of 
HR. Overall MPO is a combination sum of MPO from SR, 10% and 15% RR 
trials. Overall HR is a combination sum of normalised average HR from rests 1 
and 9 in SR, 10% and 15% RR trials. 
 
2.4 Discussion 
The aim of this study was to investigate the reliability and accuracy of SR 
repeated sprint performance in males and females. It was found that males 
require a larger consumption of VO2 and have a higher VCO2 output compared 
to females during SR recovery. FI and CV was not influenced by reducing 
recovery time. However, MPO performance was impaired for both sexes, MPO 
data from trial 6 (15% RR) is significantly less than the CS (males = -1.2 ± 8%, 
females = -9.8 ± 8.6%) and trial 3 (males = 2.5 ± 7.9%, females -4.8 ± 5.9%). A 
significant interaction in MPO (female MPO CS data is significantly higher than 
trials 1-2, 4, 6 and best SR trial) suggests that the main effect MPO data is 
caused by a pacing strategy being employed by females that results in a drop in 
MPO during sessions to maintain consistency. For example, when female 
participants know the number of sprints to be performed, muscle activation 
levels are lower than when they think they are doing half that number (Billuat et 
al., 2011). 
 
No significant difference was found between sexes for SR rest duration (Table 
2.1). It has been suggested that females would require a shorter SR rest 
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duration due to the predominance of type I muscle fibres, a larger use of fat 
oxidation and possibly greater PCr recovery when compared to males 
(Esbjornsson-Lijedahl, Bodin, Jansson., 2002; Kent-Braun & Alexander., 2000; 
Laurent et al., 2010; Roepstorff et al., 2006). The metabolic and morphological 
profile of females can reduce their fatigability during high intensity cycle sprints 
compared to males, which would be expected to translate into shorter recovery 
duration (Esbjornsson-Lijedahl, Bodin, Jansson., 2002; Kent-Braun & 
Alexander., 2000; Laurent et al., 2010; Perez Gomez et al., 2008; Roepstorff et 
al., 2006). However, we see similar SR rest times which may be due to the high 
intensity and cycling exercise selection (Hunter., 2014; Knetchtle et al., 2004; 
Laurent et al., 2010). Knetchtle et al., (2004) found that both sexes experience 
similar lactate levels when cycling at 55% (male: ~1.11, female: ~1.2 mmol x l-
1), 65% (male: ~1.48, female: ~1.49 mmol x l-1) and 75% (male: ~2.15, female: 
~2.11 mmol x l-1) of their VO2 max. However, males have a significantly higher 
amount of carbohydrate (CHO) oxidation than females when cycling at any of 
the VO2 max percentages (55%: male > 100, female > 80; 65%: male > 130, 
female > 90; 75%: male > 145, female > 105 cal*min-1*kg-1 (Knetchtle et al., 
2004)). There is also no significant sex difference in fat oxidation at 75% VO2 
max in cycling (Knetchtle et al., 2004). Therefore, repeat sprint activity (RSA) 
may remove a female dominance in resisting peripheral fatigue at lower 
exercise intensities (Knetchtle et al., 2004), resulting in similar rest periods 
being taken between sexes. 
 
Males produced a significant larger amount of MPO across all trials (Table 2.1). 
It has previously been found that when given an insufficient rest period (30sec) 
males experience a larger decrease in power during repeat sprint training 
compared to females (Billaut & Bishop., 2012). Potentially due to greater 
anaerobic glycolysis leading to inorganic phosphate accumulation (Gaitanos et 
al., 1993; Li et al., 2002). When taking into account both sexes, no significant 
difference was found for MPO data between SR trials and 10% RR trial. This is 
consistent with previous research that male participants over-estimate their 
required SR recovery by at least 10% (Phillips, Thompson, Oliver., 2014). 
However, the current study found that not all participants (2 males, 1 female) 
could successfully maintain MPO between trials 1-4 with a further female 
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participant been unsuccessful at trial 5. Indicating that using SR rest to maintain 
MPO is not as reliable as previously documented (Phillips, Thompson, Oliver., 
2014). The current study also found a significant decline in MPO when SR rest 
was reduced by 15% (trial 6) for both sexes (Table 2.1). Post hoc data indicates 
that the CS and trial 3 MPO is significantly greater than trial 6 for both sexes. 
Therefore, data suggests that the majority (85%) of physically active 
participants over-estimate their SR recovery duration by at least 10% but not 
more than 15%. Female MPO was decreased significantly compared to male 
MPO when SR rest was reduced by 15% and compared to the CS (males: -1.2 
± 8%, females: -9.8 ± 8.6%, p < 0.05). The rate of FI is similar across sexes 
(Table 2.1) which suggests that the rate of decline in power production is not 
different. FI is only significantly greater in trial 1 when compared to the 
participants’ best trial. Similar results occurred with CV with no difference 
between sex and trials 1-6, but the participants’ best trial CV was significantly 
less compared to trials 1-2 CV. However, MPO data has a significant interaction 
(sex*trial) that indicates that female MPO in trials 1-2, 4, 6 and best trial is 
significantly lower than the female CS. Given that female FI and CV is 
unaffected, it could suggest that females are adopting pacing strategies during 
trials 1-6. Pacing has previously been found within cycling sprint activity using a 
variation in sprint durations (5, 15, 30 and 45 sec (Wittekind, Micklewright, 
Beneke., 2011)). Wittekind, Micklewright, Beneke., (2011) found that peak 
power was significantly greater using a 5 sec sprint compared to 15, 30 and 45 
sec sprints, and peak power was also significantly greater using a 15 sec sprint 
compared to 30 and 45 sec sprints, despite peak power been achieved between 
0-10 sec of a sprint (Vandewalle, Pérès, Monod., 1987). What may have 
happened within the present study is that females may have paced their efforts 
due to having to maintain their MPO from the CS for ten sprints, which may be a 
similar effect from the findings of Wittekind, Micklewright, Beneke., (2011). 
Females may employ a greater amount of pacing strategies or adjusted their 
approach after the CS due to cycling against 7.5% of their BM. This may be 
because 7.5% for females is a greater relative intensity due to their lower 
muscle mass and greater fat mass (Perez Gomez et al., 2008). Suggesting why 
CV and FI were not affected in trials 1-6 for females despite percentage change 
of MPO compared to the CS was always lower (females: -4.8 – -9.8%  
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difference, males: -2.3 – 2% difference (Table 2.1)). Therefore, females may 
require a reduction in resistance to cycle against in order to maintain their CS 
MPO over ten sprints. It would appear that using CV may not be a reliable 
indicator for identifying if a participant is successful at maintaining power output 
or speed as previously documented (Glasiter et al., 2010; Phillips, Thompson, 
Oliver., 2014). Therefore, comparing percentage change between the CS and 
MPO may be a better indicator for successfully maintaining MPO during RSA 
compared to CV as previously used (Glasiter et al., 2010; Phillips, Thompson, 
Oliver., 2014). 
 
VO2 and VCO2 R9 data is significantly greater than all R1 data (best SR, 10% 
and 15% RR trials) for both sexes, suggesting greater aerobic demand for 
recovery from later sprints in both sexes (Figure 2.1 and 2.2). Normalised gas 
data suggests that male participants experience a greater aerobic demand 
compared to females during SR rest and reduced SR rest (10 and 15%). 
However, Table 2.2 indicates that this greater aerobic demand is due to the 
higher VO2 peak in males (43 ml.kg-1.min-1) than in females (33 ml.kg-1.min-1). 
With Table 2.2 showing no significant difference in percentage of VO2 peak 
during rests 1 and 9 for all the measured trials between sexes. Indicating that 
there may be no sex difference in regards to aerobic response during SR repeat 
sprint cycle activity. The significant increase from rest 1 to rest 9 in all measured 
trials for VO2, VCO2 and HR in both sexes could suggest that PCr is recovered 
at a similar rate due to an increase in oxidative phosphorylation (McCartney et 
al., 1986; Spriet et al., 1989). Which is in keeping with a greater ATP turnover to 
regenerate maximal effort (McCartney et al., 1986; Spriet et al., 1989), and 
could suggest why SR rest duration is similar between sexes.  Correlation data 
(Table 2.3, 2.4) indicates that a greater sum of MPO in the trials is significantly 
linked with an increase in VO2 and VCO2 during the recovery for both sexes. 
This significant correlation further indicates SR repeat sprint cycling leads to an 
increased use of aerobic metabolism in order to recover PCr and repeatedly 
generate maximal MPO (McCartney et al., 1986; Spriet et al., 1989). The 
correlation between the gas measures and sum of MPO is at its strongest 
during the best SR trial (VO2: r = 0.82, VCO2: r = 0.77), and at its weakest 
during the 15% RR trial (VO2: r = 0.62, VCO2: r = 0.58). The drop in correlation 
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strength in the 15% RR trial could be a reflection of both sexes dropping their 
MPO (males: ~-1.2%, females: ~-9.8%). Despite a drop in MPO in the 15% RR 
trial percentage of VO2 peak still increases by ~14% and ~10% in males and 
females respectively between rests 1 and 9. This could be due to a shorter 
work:rest ratio in the 15% RR trial which is thought to create a greater aerobic 
response during repeat sprint cycling (Kavaliauskas, Aspe, Babraj., 2015). 
Furthermore, the correlation data could indicate that a greater VO2 peak may be 
vital in maintaining MPO whilst using SR rest. Therefore, females or participants 
with a lower VO2 peak may require a reduction in resistance (< 7.5% BM) to 
maintain their MPO through SR rest. This may remove the possible pacing 
tactics that may have occurred within the female participants in this study. 
 
2.5 Limitations 
The current study indicates that females are unable to maintain their CS MPO 
across ten sprints as well as males, with males producing on average a MPO 
~2.5% greater than their CS in trial 3. The current method for measuring CS 
appears to be only used by Phillips, Thompson, Oliver., (2014) and there is 
limited research to indicate if this CS procedure has been used previously. It is 
thought that a learning effect occurs for participants when they perform repeat 
cycle sprints due to a decrease in CV measures for power output after two trials 
(CV = 0.5-1.9%) compared to completing a third trial (CV = 0.3-0.7% (Hopkins, 
Schabort, Hawley., 2001)). The higher CV values typically found within the first 
two trials of repeated cycle sprints could indicate that the 5% limit used in the 
CS procedure could have error measurement of 0.5-1.9% below or above the 
5% cut off. Not knowing how much accurate measurement of error may be 
present in the 5% CS cut off may have affected the percentage change 
between the CS and MPO trial average for both males and females (Table 2.1). 
Therefore, it is possible that males maintained a MPO closer to their CS in each 
trial compared to females due to an inaccurate measure of the CS. Identifying 
an accurate measurement of error in the CS would lead to more reliable data for 
percentage change between the CS and trial average MPO. 
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During the current study, a number of participants complained about the use of 
the gas mask, with some participants claiming it made them feel claustrophobic. 
Another regular complaint from the participants was the level of discomfort they 
experienced from the bike seat. It is possible that these two factors affected the 
SR rest duration, by possibly selecting a shorter rest period in order to remove 
themselves quicker from the claustrophobic and discomfort conditions.  
 
2.6 Conclusion 
In conclusion, this study shows less reliability of participants maintaining power 
output than previously documented (Phillips, Thompson, Oliver., 2014). 95% of 
participants that could SR their rest to maintain MPO over-estimated their SR 
rest by 10%, which is similar to the finds of Phillips, Thompson, Oliver., (2014). 
However, reducing rest by 15% leads to a loss in power production, more so in 
females than in males. Using 7.5% body mass as a resistance might play a key 
factor in why females cannot maintain power output as greatly as males. There 
is also the possibility that females might be pacing their efforts to protect 
themselves from homeostatic harm. Further research should identify if reducing 
the resistance allows females to better SR their rest to maintain MPO. Using CV 
appears to be an unreliable tool for identifying maintenance of MPO. Instead, 
comparing the percentage change of each MPO in a trial against the CS could 
be more reliable. Further research should also examine if SR RSA leads to any 
performance adaptations and verify if it can be a useful tool for team sport 
athletes as previously advised (Glaister et al., 2010; Phillips, Thompson, Oliver., 
2014). 
 
2.7 Practical implications 
This present study is not consistent with previous research (Glaister et al., 
2010; Phillips Thompson, Oliver., 2014) and that not all participants can SR 
their rest as a reliable tool for maintaining maximal repeat sprint performance, 
with females appearing to pace their efforts more than males when attempting 
to maintain CS MPO. This study has identified 4 practical implications. 1) SR 
rest duration varies between physically active participants and is personal to 
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each individual; athletes should not be influenced by a teammate’s ability to SR 
faster or longer. 2) There is a strong likelihood that SR recovery during power 
testing would not see a decrease in performance when compared to using fixed 
rest periods, and would allow a coach to gain accurate MPO data from each 
athlete. 3) Athletes performing repeat sprint cycle training using SR rest 
between sprints could see an improvement in their neurological response, 
leading to a faster sprint speed due to an improved power output, by repeatedly 
producing maximal effort. Due to the use of longer work to rest ratios during 
high intensity training (Kavaliauskas, Aspe, Babraj., 2015). 4) SR rest periods 
do not replicate the short rest periods typically found within team sports. 
However, males significantly increase their aerobic demand during SR RSA 
which could be a factor for improving endurance (Kavaliauskas, Aspe, Babraj., 
2015). The 10% overestimated SR rest may affect the required aerobic demand 
during RSA that leads to improvements in endurance. Therefore, coaches 
should be aware that improvements in endurance might not occur when using 
SR rest during repeat sprint training. Coaches should understand the potential 
benefits and limitations SR rest can offer athletes, and that the data created 
from this study should be treated as population specific until further research 
has been conducted with an elite athlete population. This will identify if elite 
athletes express similar responses to SR RSA. 
 
2.8 Proceeding research 
The data from the present study suggests that males can SR their rest in order 
to maintain their MPO greater than females. Males also experience a drop in 
their MPO (-1.2 ± 8% compared to CS) when SR rest is reduced by 15%, 
however females experience a greater drop in their MPO (-9.8 ± 8.6% 
compared to CS) when SR rest is reduced by 15%. Therefore, the proceeding 
research will use male participants to identify the effects of using SR rest during 
HIT, given that the maintenance of power output in HIT is a potential key factor 
to increasing endurance and power output adaptations (Hazell et al., 2010; 
Lloyd Jones, Morris, Jakeman., 2017). It is unsure if using SR rest during HIT 
will lead to any positive performance adaptation due to the over-estimation in 
SR rest (Phillips, Thompson, Oliver., 2014). However, despite the over-
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estimation in SR rest, repeated sprints with a greater work:rest ratio will still 
experience an increase in aerobic demand in sprints as long as there are 
multiple sprint bouts (Hazell et al., 2010), which is thought to be a key factor for 
improving endurance measures (Kavaliauskas, Aspe, Babraj., 2015). However, 
Kavaliauskas, Aspe, Babraj., (2015) demonstrate that reducing the rest duration 
in HIT leads to greater endurance adaptations and increasing the rest duration 
leads to greater power output adaptations. Therefore, the proceeding study will 
identify if using SR rest during HIT will lead to any positive endurance and or 
power output adaptations, and compare against using a fixed rest (30 sec, 1:5 
work to rest ratio) in HIT. 
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3 Chapter 3 – Study 2 (Training adaptations with self-recovery 
compared to fixed rest during sprint interval training) 
3.1 Introduction 
3.1.1 Maintenance of power 
There are many studies that suggest that the maintenance of power during 
training is an important contributing factor for improving power output in athletes 
(Baechle & Earle., 2008; Creer et al., 2004; Hazel et al., 2010; Lloyd Jones, 
Morris and Jakeman., 2017; Kavaliauskas, Aspe, and Babraj., 2015). 
Maintaining power allows for a larger response from anaerobic pathways, with 
an increase in PCr and glycogen degradation, and greater neural adaptions 
such as improvement in motor unit recruitment, firing rate and synchronization 
post intervention (Creer et al., 2004; Kraemer, Fleck, Evans., 1996; Rodas et 
al., 2000). High intensity training (HIT), in the form of repeated cycle sprints (4-6 
x 30sec sprint with 4min recovery, 8 sessions), has found to increase motor unit 
activation (Creer et al., 2004), with  an increase in root mean squared (~27.7%) 
and decrease median frequency (~-16.8%) during electromyography (EMG) 
readings within the vastus lateralis muscle (Creer et al., 2004). Creer et al., 
(2004) also found significant increases in peak (~6%) and mean (~6%) power 
output post HIT. Within strength and power training, recruitment of type II 
muscle fibres are essential for maximal efforts and for increasing strength 
(Kraemer, Fleck, Evans., 1996). A number of studies using varied HIT protocols 
(4-6 x 30sec, 4-6 x 10 sec, 6 x 10sec sprints against 7.5% body mass) have 
reported increased power output post training (Creer et al., 2004; Hazell et al., 
2010; Kavaliauskas, Aspe, and Babraj., 2015). It has been suggested that the 
maintenance of power during the training is a contributory factor in this 
adaptation (Hazell et al., 2010; Lloyd Jones, Morris, Jakeman., 2017; 
Yamagashi & Babraj., 2017). 
 
Glaister et al., (2010) and Phillips Thompson, Oliver., (2014) suggest that 
physically active young adult male participants can reliably maintain multiple 
running sprint times and MPO during cycle sprints. This was achieved when 
participants self-regulated (SR) their own recovery periods when performing 12 
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x 30m sprints (Glaister et al., 2010) or 10 x 6 sec cycle sprints (7.5% body mass 
resistance (Phillips Thompson, Oliver., 2014 and Study 1)). However, Phillips 
Thompson, Oliver., (2014) and Study 1 found that physically active participants 
over-estimate their required recovery by at least 10%. In contrast to Glasiter et 
al., (2010) and Phillips Thompson, Oliver., (2014), Study 1 found that not all 
participants (2 males, 1 female) could maintain MPO, and females’ average trial 
MPO was significantly less than their criterion sprint MPO. Indicating that the 
reliability of maintaining MPO using SR rest is not as reliable as previously 
indicated. Seiler & Hetlelid., (2005) found that SR rest (118 ± 23 sec), 1 min 
rest, 2 min rest and 4 min rest between running sprint bouts (6 x 4 min) had 
similar effects in terms of the blood lactate rise post sprint. Running velocity 
increased in sprints following 2 min and SR rest compared to 1 min rest. VO2 
during sprints was significantly higher for 2 min and SR rest compared to both 1 
min and 4 min rest. However, these studies have only looked at the acute 
response during a single session and have not looked at training adaptions with 
SR. It has been suggested recently that work to rest ratio could affect the 
adaption to repeated sprint training, either in terms of power production or 
endurance adaptions (Kavaliauskas, Aspe, Babraj., 2015). 
 
3.1.2 Improving power: 
HIT has been shown to promote increases in both PPO (the highest watt value 
typically during the first 5-10 seconds of a sprint) and MPO (the overall mean 
average watt value during the sprint (Burgomaster et al., 2005; Creer et al., 
2004; Hazell et al., 2010; Kavaliasukas, Aspe, Babraj., 2015; Rodas et al 
2000)). HIT has been shown to increase PCr stores after training, thus allowing 
a faster resynthesize of ATP anaerobically in response to an explosive 
movement (Gaitanos et al., 1993; Rodas et al., 2000). Therefore, allowing larger 
sustainability of MPO and a larger PPO (Rodas et al., 2000; Laursen and 
Jenkins., 2002). The greater PCr stores are thought to be due to delaying the 
onset of a lower pH (~ 0.5 units) in skeletal muscle following training (Balsom et 
al., 1992; MacLaren & Morton., 2012). A build up in Pi and reduction in calcium 
(Ca2+) sensitivity are thought to be causes for peripheral fatigue due to high 
rates of PCr hydrolysis (Westerblad, Allen, Lannergren., 2002). These potential 
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fatiguing factors prevent PCr resynthesis (Westerblad, Allen, Lannergren., 
2002). Increasing PCr stores leads to the reduction in Pi, and the release and 
reabsorption of Ca2+ within the sarcoplasmic reticulum is greater (Westerblad, 
Allen, Lannergren., 2002). HIT has been found to increase glycolytic enzyme 
activity (phosphofructokinase, lactate dehydrogenase) and increase muscle 
glycogen concentration (Rodas et al., 2000). The increased resting and during 
exercise stores of muscle glycogen is regulated by an increase in the glycolytic 
flux mechanism (MacLaren & Morton., 2012). The glycolytic flux is regulated by 
glucokinase activity which is a glucose sensor and increases blood glucose 
levels during exercise (MacLaren & Morton., 2012). Increasing 
phosphofructokinase and fructobisphosphatase activity increases the glycolytic 
shuttle and promotes insulin secretion from the pancreas (MacLaren & Morton., 
2012), and contributes to ~40% ATP turnover during the first 15sec of a 30sec 
sprint (Parolin et all., 1999). Decreases in glycogen stores lead to an 
impairment of Ca2+ release from the SR (Ørtenblad et al., 2011), therefore 
reducing the rate of muscular contraction and decreasing force production 
(Ørtenblad et al., 2001; Westerblad, Allen, Lannergren., 2002). Lactate 
dehydrogenase and acetyl coenzyme A (acetyl CoA) are responsible for 
improving the rate of conversion of lactate back to pyruvate (MacLaren & 
Morton., 2012). Allowing a greater transport of glycogenic intermediates to the 
Krebs cycle and the resynthesis of ATP aerobically (MacLaren & Morton., 
2012). PPO can also increase due to the remodelling of myofibrils following high 
intensity resistance training (Seynnes, de Boer, Narici., 2007). Remodelling of 
the myofibrils can occur after one eccentric session which causes lengthening 
of the myofibrils (Yu, Carlsson, Thornell., 2004). It has also been demonstrated 
that an increase in myofibril (> ~ 2% d-1) and sarcoplasmic (> ~ 2% d-1) protein 
synthesis occurs after one session of HIT (10 x 1min sprints at ~ 95% HR max), 
and remains elevated (myofibril ~ 2% d-1, sarcoplasmic > ~ 1.5% d-1) 24 hours 
after (Bell et al., 2015). Proteins, sirtuin 1 and mitochondrial transcription factor 
A, located within the myofibrils are responsible for mitochondrial biogenesis 
(Little et al., 2010). It has also been found that HIT leads to an increase in 
sirtuin 1, glycogen depletion, and mitochondrial transcription factor A proteins, 
that in turn increases mitochondrial biogenesis (Camera, Hawley, Coffey., 2015; 
Little et al., 2010). With an increase in mitochondrial biogenesis this leads to an 
 66 
increase in ATP production through aerobic metabolism and therefore produce 
a larger amount of energy during exercise (MacLaren & Morton., 2012). 
Therefore, given that HIT leads to improvements in PPO and MPO 
(Burgomaster et al., 2005; Creer et al., 2004; Hazell et al., 2010; Kavaliasukas, 
Aspe, Babraj., 2015; Rodas et al 2000), literature would suggest that the 
increases in sirtuin 1 and mitochondrial transpiration factor A proteins could be 
partly responsible for the increase in PPO and MPO after HIT. 
 
It has also been demonstrated that HIT causes changes in muscle fibre 
distribution, change in Ca2+ dynamics and alters neuromuscular function (Creer 
et al., 2004; Esbjörnsson et al., 1993; Ørtenblad et al., 2000; Pette., 1985; 
Pette., 1998; Pette & Staron., 1997; Ross & Leveritt., 2001). HIT (4-6 30sec 
sprints 4min recovery against 7.5% body mass,15 x 10sec sprints with 50sec 
recovery against 7% body mass, 2-6 x 15 and 30sec sprints against 7.5% body 
mass, 4-6 x 30sec sprints 15-20min recovery against 75g per kg body mass), 
has previously demonstrated a change in dominance in muscle fibre recruitment 
during exercise (Allemeier et al., 1994; Esbjörnsson et al., 1993; Jacobs et al., 
1987; Jansson et al., 1990). Alterations have shown to decrease the recruitment 
of faster type muscle fibres (type IIX) and increase the recruitment of 
intermediate fast twitch muscle fibres (type IIA (Allemeier et al., 1994; 
Esbjörnsson et al., 1993; Jacobs et al., 1987; Jansson et al., 1990; Pette., 1998; 
Pette & Staron., 1997; Ross & Leveritt., 2001)). This also leads to a decrease in 
type I muscle fibre recruitment and in some cases shows no alteration in the 
recruitment of type I (Allemeier et al., 1994; Jacobs et al., 1987; Jansson et al., 
1990; Pette., 1997; Ross & Leveritt., 2001). Neural impulse responses are 
responsible for these alterations, due to the progression/ loading of HIT, which 
alters metabolic homeostasis (Pette., 1985). Further neural adaptations, 
following 4 weeks HIT (4-10 x 30sec sprints with 4min recovery, twice a week), 
increased motor unit activation in the vastus lateralis (Creer et al., 2004). Which 
is in keeping with producing greater amounts of PPO, MPO and total work 
(Creer et al., 2004). It is also thought that following 5 weeks of HIT (20 x 10sec 
sprint with 50sec recovery, 3 times a week, against 8-8.5% body mass) leads to 
an increase in sarcoplasmic reticulum, due to an increase in Ca2+ release of 
~5.5% (Ørtenblad et al., 2000). Who also found greater maintenance of MPO 
 67 
during 10 sprints in pre to post and compared to the control group (Ørtenblad et 
al., 2000). 
 
It is unclear how important manipulating the work to rest ratio of multiple sprint 
bouts is for manipulating the training induced improvements in power (Hazell et 
al., 2010; Kavaliasukas, Aspe, Babraj., 2015; Yamagishi and Babraj., 2017). 
Kavaliasukas, Aspe, Babraj., (2015) found significant improvements in MPO, 
with a 1:8 (6 x 10sec sprint 80sec recovery, against 7.5% body mass), 1:12 (6 x 
10sec sprint 120sec recovery, against 7.5% body mass) work to rest ratio, and 
PPO with the 1:8 work to rest ratio, following 6 sessions of HIT. Hazell et al., 
(2010) also show a significant increase in MPO, with a 1:8 (4-6 x 30sec sprint 
with 4min recovery against 7.5% body mass) and a 1:24 (4-6 x 10sec sprint with 
4min recovery, against 7.5% body mass) work to rest ratio. They also found a 
significant increase in PPO with a 1:8, 1:24 and 1:12 (4-6 x 10sec sprint with 
2min recovery against 7.5% body mass) work to rest ratio, following 6 sessions 
of HIT. Kavaliasukas, Aspe, Babraj., (2015) state that maintaining PPO in 
training, with higher work to rest ratios, leads to neuromuscular adaptations to 
create a larger training effect of power production. However, Hazell et al., 
(2010) found that the 1:8 work ratio group PPO, MPO and minimum power 
output during training was significantly lower when compared to the 1:24 and 
1:12 work ratio groups. All three of their training groups found significant 
improvements in PPO regardless of work to rest ratio, with the 1:12 group been 
the only group not to improve MPO significantly. Causing debate whether 
maintaining power output during training is vital or not. 
 
It has been found that sprint duration between 6-30 sec sees a shift from a 
dominance in anaerobic metabolism (glycolysis and PCr) to a dominance in 
aerobic metabolism as the duration of the sprint increases (Bogdanis et al., 
1996; Bogdanis et al., 1998; Gaitanos et al., 1993; Parolin et al., 1999). 
Protocols using sprint bout durations of 6-30 sec have seen significant 
improvements in PPO and MPO (Hazell et al., 2010; Jakeman, Adamson, 
Babraj., 2012; Kavaliasukas, Aspe, Babraj., 2015; Yamagishi and Babraj., 
2017). Fuel consumption during HIT has been previously documented, and 
potentially explains how participants improve in endurance testing (Gaitanos et 
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al., 1993; Bogdanis et al., 1996). Gaitanos used 10 x 6 sec sprints with a 30 sec 
recovery and found a decrease in MPO after each sprint. When comparing 
muscle biopsies, from sprint 1 and sprint 10, glycolysis and ATP utilisation had 
dropped from 44.1% - 16.1% and 6.3% - 3.8% respectively. Whereas, PCr 
increased from 49.6% - 80.1%, suggesting that the power output in the latter 
sprints were fuelled by an increase in oxidative metabolism (Gaitanos et al., 
1993). However, the oxidative metabolism was not directly measured. Bogdanis 
et al., (1996) performed a similar study but identified changes in two 30 sec 
sprints separated by 4 min rest, measuring glycolysis, ATP + PCr, and aerobic 
contribution during the sprint. The findings of Bogdanis et al., (1996) supports 
the suggestion from Gaitanos et al., (1993) that a larger aerobic contribution 
occurs even after one sprint. They found that ATP turnover in glycolysis 
decreased from 48% - 36%, PCr + ATP also decreased from 23% - 20%, and 
aerobic contribution increased from 29% - 43%. This increase in aerobic 
contribution during HIT is thought to be a factor for improving aerobic capacity 
(Gaitanos et al., 1993; Gosselin et al., 2012). This shift to a dominance in 
aerobic metabolism is in keeping with a reduced force development (Russ et al., 
2005). 
 
3.1.3 Improving endurance 
It is well documented that aerobic metabolism can be enhanced by repeated 
bouts of intense exercise (Hazell et al., 2010; Jakeman, Adamson, Babraj., 
2010; Kavaliasukas, Aspe, Babraj., 2015; Rodas et al., 2000; Yamagishi and 
Babraj., 2017). More specifically HIT has found to increase the sarcolemmal 
lactate transport capacity, with an enhanced content of MCT1 and MCT4 
(Pilegaard et al., 1999). Following 10 x 6 sec sprints there is a rightward shift in 
the blood lactate curve during an incremental time to exhaustion test (Jakeman 
Adamson, Babraj., 2012). Suggesting either altered lactate production or altered 
lactate utilisation. Increasing lactate transporter activity is known to improve 
recovery during moderate and high intensity exercise (Juel & Halestrap., 1999). 
Increased lactate transporter activity is suggested to be a key factor for 
improvements in time trial, time to exhaustion and critical power following HIT 
(Hazell et al., 2010; Jakeman, Adamson, Babraj., 2012; Kavaliauskas, Aspe, 
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Babraj., 2016; Yamagishi, Babraj., 2017). This enables a greater movement 
through the lactate shuttle, which maintains lower blood lactate concentration at 
the same absolute workload (Jacobs et al., 2011) and reflects increased lactate 
utilisation (Rodas et al., 2000). During HIT, skeletal muscle produces high 
volumes of lactate and pH levels drop by ~ 0.5 units (MacLaren & Morton., 
2012); however, the type 1 fibres use lactate as a respiratory fuel (Juel & 
Halestrap., 1999). This is reflected in the findings in Juel et al., (2003) who 
found an increase in lactate and H+ release in trained (8 weeks of maximal 
intensity leg extensor activity) vs. untrained participants, during a 30 W test. 
Along with increases in lactate and H+ release, Juel et al., (2003) also found an 
increase in monocarboxylate transport protein 1 (MTC1), Na+/H+ exchanger 
protein (NHE1) and an increased blood flow of ~16% within trained participants. 
Blood volume increases by an increase in lactate concentration and lactate 
uptake in skeletal muscle tissue (Gladden., 2000). As lactate increases 75-80% 
of the lactate is oxidised with the remaining 25-20% been converted into 
glucose and glycogen (Brooks., 2000). Therefore, allowing a greater ATP 
turnover to allow higher muscular contraction rates (Bogdanis et al., 1996; 
Gaitanos et al., 1993). Pilegaard et al., (1999), found similar results to Juel et 
al., (2003) but also found an increase in MCT4 activity when comparing trained 
against untrailed participants. MCT4 has similar purposes to MCT1 but works 
directly with the removal of lactate within type II muscle fibres, so MTC4 aids 
with oxidative and glycolic metabolism (Pilegaard et al., 1999). Therefore, 
fatiguing metabolites that become present with an increase in lactate (Pi and 
predominately within type II muscle fibres) are transported to the TCA cycle, via 
lactate transporter proteins MCT1, MCT4 and, at an increased rate in trained 
athlete’s vs non-trained (Juel & Halestrap., 1999; Pilegaard et al., 1999). This 
would suggest that athletes would see an improvement in endurance tests that 
involve an increase in intensity with time, e.g. time to exhaustion test, due to an 
increase in MTC4 leading to greater substrate provision to the TCA cycle. 
Following HIT there is an increase in enzymatic activity related to mitochondrial 
aerobic metabolism, citrate synthase and 3-hydroxyacyl-CoA dehydrogenase 
(HAD) (Rodas et al., 2000). These are oxidative mitochondrial proteins, with 
citrate synthase and HAD been responsible for the first and third step within the 
Kreb cycle respectively (MacLaren & Morton., 2012). Burgomaster et al., (2005) 
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and Shepley et al., (1992) found an increase in CS of ~ 38% and ~ 18% 
respectively in association with improved endurance performance (~ 100% 
increase in time to exhaustion Burgomaster et al., 2005; and +22% increase in 
time to exhaustion Shepley et al., (1992) activity post HIT. 
 
3.1.3.1 Variables for adaptation 
Similar to improving power, manipulating the intensity of the bout and the work 
to rest ratio of multiple sprint bouts can stimulate certain aerobic metabolic 
responses that improve endurance performance (Laursen & Jenkins., 2002). 
Even short sprint cycle bouts of 10 x 6 sec, (1:10), and 6 x 10 sec sprints, (1:3 
(7.5% body mass resistance)) for 6 sessions over a 2 week period have found 
improvements in time trial and time to exhaustion tests in triathletes and runners 
(Jakeman, Adamson, Babraj., 2012; Kavaliauskas, Aspe, Babraj., 2015). 
Indeed, Hazell et al., (2010) have shown that sprint duration does not appear to 
be important for endurance adaptations, with similar improvements in VO2 max 
and 5km run time with 30sec (1:8 ratio) and 10sec (1:24 and 1:12 ratios) sprints 
(Hazell et al., 2010). In addition, Yamagashi & Babraj., (2017) found similar 
improvements in VO2 peak, time trial, time to exhaustion, and critical power 
when using 15sec and 30sec sprints but still using a 1:8 work to rest ratio. The 
reason for this could be the similar metabolic demand of both sprint protocols, 
resulting in a reduction of PCr and glycogen across the repeated sprints 
resulting in a shift to aerobic metabolism in later sprints (Hazell et al., 2010; 
Bogdanis et al., 1995). Lloyd Jones, Morris, Jakeman., (2017) also found similar 
improvements in self-paced 10km time trial testing (5.1%, 6.2%) after 
completing 6 HIT sessions when comparing a 6sec sprint and 30sec sprint 
(both using a 1:8 ratio against 7.5% body mass) when matched for overall 
sprinting time of 2min. They speculate that both groups may have improved 
time trial testing due to an increase in citrate synthase activity. The similar 
increase in citrate synthase in both groups could be due to the shorter rest in 
the 6sec group and the maintained PPO which may have caused a greater 
stress on the working skeletal muscles (Lloyd Jones, Morris, Jakeman., 2017). 
It has also been demonstrated that when matching training groups for work (4 x 
30sec sprint 4min rest vs. 2min continuous maximal sprint) there is no 
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difference in the regulation of cellular energy homeostasis (AMPK 
phosphorylation (Taylor et al., 2016)). Indicating that short duration exercise 
(6sec sprint) can have similar endurance adaptations to longer duration 
exercise (30sec sprint (Lloyd Jones, Morris, Jakeman., 2017; Taylor et al., 
2016)). 
 
Another variable that may affect endurance outcomes to HIT is work to rest 
ratio. Hazell et al., (2010) found a significant improvement in endurance 
performance regardless of work to rest ratio, with 5km time trial performance 
improved for all groups and VO2max for 1:24 and 1:8 work to rest ratio groups 
only. In contrast, Kavaliauskas, Aspe, Babraj., (2015) found that a lower work to 
rest ratio leads to greater endurance adaptations, with 3km time trial improved 
only in 1:3 work to ratio group and time to exhaustion improved in the 1:3 and 
1:8 but not the 1:12 work to rest ratio group (Kavaliauskas, Aspe, Babraj., 
2015). 
 
3.1.4 Self-regulated recovery 
It has been shown that young adult participants (18-35 years) can SR their 
recovery time effectively to maintain sprint speed performance (12 x 30m 
(Glaister et al., 2010)) and MPO (10 x 6 seconds, 7.5% body mass resistance 
(Phillips, Thompson, Oliver., 2014) to maintain maximal performance 
(coefficient of variation (CV (≤ 5.2%)). Both Glaister et al., (2010) and Phillips 
Thompson, Oliver., (2014) have shown that young adults can self-regulate 
recovery between sprints. However, in Study 1 we found that not all participants 
managed to do so with 20% of participants failing to do so. Glaister et al., 
(2010) have suggested that participants with a lower level of aerobic capacity 
would choose longer rest periods, suggesting the longer the rest period would 
indicate an increase in fatigue, and this could be used as a surrogate indicator 
for fatigue. However, Phillips Thompson, Oliver., (2014) suggests that 
participants could be using pacing strategies during SR rest to prevent any 
homeostatic disturbances that could lead to early exercise termination (Tucker 
et al., 2006). It is believed that participants pace their efforts to prioritise energy 
expenditure (Edwards & Polman., 2013). Pre planning will identify what the task 
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is, the importance of the task, the person’s capabilities and willingness to do the 
task (Edwards & Polman 2013). Therefore, during a sprint protocol participants 
will select a longer rest duration if there is no willingness to complete the next 
sprint, due to the factors above, and select a shorter rest duration if there is a 
willingness to complete the next sprint. 
 
During self-paced cycling exercise, there is evidence to suggest that the 
exercise is regulated through sensory feedback to the central nervous system 
(CNS) through central fatigue (Davis., 1995; Froyd et al 2016; Kay et al 2001; 
Meeusen et al., 2006; Noakes et al 2001; St Clair Gibson et al 2001; Swart et al 
2009; Swart et al 2012; Tucker et al 2006). Central fatigue is defined as a 
reduction in maximal capacity of the CNS to optimally recruit motor units to 
produce force (Gandevia., 2001). Central and peripheral fatigue, through 
afferent feedback (from peripheral organs: lungs, heart and skeletal muscle), 
work together to ensure that the participant’s peripheral critical threshold is 
never exceeded (Amann., 2011; Amann., 2012; Froyd et al 2016). The 
peripheral critical threshold is defined as the reduction in the muscle capacity 
and the reduction in the neuromuscular junction to prevent maximal force 
(Froyd et al 2016). It is thought that peripheral fatigue is a regulator for self-
paced cycling exercise by reducing the amount of muscle recruitment through 
afferent feedback (Amann., 2011; Amann., 2012; Froyd et al 2016). Afferent 
feedback comes from sensory nerves located within muscle spindles and Golgi 
tendon organs (Marcora., 2008; Proske., 2005). These sensory nerves sense 
tension, position and movement, and then send signals through the CNS to give 
the sense of effort (Proske., 2005). Both central and peripheral fatigue are 
believed to contribute to neuromuscular fatigue during exercise (Froyd et al 
2016). It has been demonstrated that when intensity during exercise bouts 
increase there is also an increase in neuromuscular and peripheral fatigue 
(Amann & Dempsey., 2008). However, these studies have used self-paced time 
trial cycling and not looked at central or peripheral fatigue during rest periods. 
What can be highlighted from these studies is that peripheral fatigue occurs 
20% into the time trial and steadily increases as the time trial continues (Froyd, 
Millet, Noakes., 2013). Whereas central fatigue is thought to occur only after 
peripheral fatigue had already developed (Decorte et al., 2012) and further 
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develops depending on the exercise duration (Place et al., 2010). Giving the 
lack of research in central and peripheral fatigue during HIT specifically in 
recovery periods, it would suggest from the above that peripheral fatigue plays 
a larger role during exercise and therefore would control duration of SR rest. 
Therefore, SR rest could be regulated by afferent feedback. 
 
Phillips Thompson, Oliver., (2014) and Study 1 identified that male and female 
participants over-estimated their SR rest period by at least 10%. There is a 
potential that pacing tactics may have occurred in both sexes when SR rest is 
reduced by 15%, due to the significant drop in MPO when compared to the 
criterion sprint (~ -5.1%) and trial 3 (~ -4.1% (Study 1)). This could potentially 
explain how the participants were able to keep their CV% to ≤ 5.2%. Pacing 
tactics may have occurred to prevent homeostatic disturbance that would have 
led to early exercise failure (Tucker et al., 2006). Using SR rest to repeatedly 
reproduce similar or greater MPOs of a criterion sprint during training could lead 
to improvements in endurance and power output. 
 
3.1.5 Aims and hypothesis 
Therefore, the aim to this study is to determine whether training adaptations are 
similar between SR and set work to rest ratios. It is hypothesised that SR rest 
training will lead to greater improvements in power output vs fixed rest (30 sec) 
training. Given that participants are able to maintain MPO (Phillips Thompson, 
Oliver., 2014; Study 1). With this maintenance of power, it would suggest that 
participants would increase their anaerobic pathway stores (PCr and glycogen) 
and see an improvement in neural responses (Rodas et al., 2000; Creer et al., 
2004), therefore improve MPO and PPO. It is also hypothesised that the fixed 
rest training will lead to greater endurance adaptations. Due to the decrement in 
performance between sprints, which in turn will allow a greater aerobic 
presence during and between sprints. 
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3.2 Methods 
3.2.1 Participants 
Twenty-four physically active young males, took part in more than the American 
College of Sports Medicine and American Heart Association recommended 2.5 
hours of moderate physical activity (Haskell., 2007) volunteered for this study. 
Participants completed 6 ± 2 h structured activity per week consisting of training 
and playing team sports. All participants were required to be either competitive 
or recreational athletes, aged 18-35 years and trained > 3 hours per week. 
Before taking part, participants were given written and verbal instructions about 
the study prior to giving informed consent. Participants also completed a 
physical activity readiness questionnaire to ensure there was no known health 
issues that would put the participants in harm by taking part this study. 
Participants were stratified into three group based on VO2 peak: SR group (n = 
8, 178 ± 7 cm, 78 ± 7 kg, 48 ± 8 ml.min-1.kg-1), fixed rest (FR) group (n = 8, 178 
± 4 cm, 81 ± 8 kg, 48 ± 7 ml.min-1.kg-1), and control (C) group (n = 8, 180 ± 6 
cm, 80 ± 13 kg, 51 ± 9 ml.min-1.kg-1). Abertay University ethics committee 
granted ethical approval for the study and the study was carried out in line with 
the declaration of Helsinki.  
 
3.2.2 Procedures 
3.2.2.1 Pre and post testing 
At the beginning of the study, participants’ body mass (BM, kg) and height (cm) 
were recorded using a digital scale (Tanita SA 165A-0950U-3) and digital 
stadiometer (Seca 264), respectively. Participants underwent 3 separate testing 
sessions, 24 hours apart, pre and post intervention, which involved : VO2 peak, 
time to exhaustion (TTE), and haemoglobin blood test (test day 1), a single 30 
second Wingate test (test day 2), and 10km time trial test (test day 3). 
 
3.2.2.2 Haemoglobin, VO2 peak and time to exhaustion 
Haemoglobin concentration, haematocrit % and haemoglobin ratio were 
measured in pre and post testing (same testing day as VO2 peak test), by using 
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a haemoglobin photometer (EKF Diagnostics). Haemoglobin ratio was 
calculated by using the formula as shown in equation 3.1. 
 
Haemoglobin ratio = hen % / hemo. 
Equation 3.1: Where hen % is haematocrit percentage, and hemo is 
haemoglobin concentration. 
 
A single blood sample was taken from the participant’s index finger prior to the 
VO2 peak test, the skin was punctured using an Accu-check single use lancet 
(Roche Diagnostics, UK). Pressure was applied to the finger to draw blood, the 
first blood sample was wiped away with a sterile cotton wipe, and pressure to 
the finger was applied again for a second blood sample and placed within a 
haemoglobin microcuvette (EKF Diagnostic), to collect ~ 8μl of blood. Blood 
measures were taken from the right hand as this has shown to be more reliable 
than using the left hand (CV = 6.3%, r = 0.69), and continued to be more 
reliable after four days of consecutive testing (CV = 7%, r = 0.5) when using a 
photometer (Morris et al., 1999). After the photometer had analysed the blood 
sample, haemoglobin concentration was presented as mmol.L-1 and haematocrit 
was presented as a percentage. Using a portable photometer to calculate 
haemoglobin and haematocrit percentage from capillary blood has been proven 
to be a reliable measure (Morris et al., 1999). When comparing laboratory 
measures and using a portable photometer data appears to be very similar (CV 
= 1%, r = 0.99). Indicating that using a portable photometer for haemoglobin 
measures is a reliable measure with similar readings to laboratory methods 
(Morris et al., 1999).  
 
Participants then underwent a cycle VO2 peak test. Participants were fitted with 
a mask connected to an online expired gas analyser (Cortex Metalyzer 3B). 
Participants then mounted the cycle ergometer (Monark Ergomedic 894), which 
was adjusted to ensure full leg extension, and cycled for 4 minutes at 60 W. 
Immediately following this warm up, power output increased by 30 W·min–1 until 
volitional exhaustion or participants could no longer maintain 60 RPM 
(Jakeman, Adamson, Babraj., 2012). Participants were instructed to maintain a 
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cadence of 60 RPM and were verbally encouraged throughout. VO2 peak was 
determined as the highest 30 sec average across the test (See section 3.2.2.2). 
 
The duration of the VO2 peak test was recorded (sec) and was defined as a 
participant’s TTE (Jakeman, Adamson, Babraj., 2012; Stevens & Dascombe., 
2015), which is another measure of endurance capacity (Stevens & Dascombe., 
2015). This will allow a measure of how long a participant can perform at a 
specific speed (60 RPM) whilst cycling at a steady state increasing intensity (30 
watt increase each minute), and allows a comparison of physiological markers 
(VO2 peak for the purpose of this thesis) between testing periods (Laursen et 
al., 2007). An increase in TTE is a reflection of an increase in power output 
(Hopkins, Schabort, Hawley., 2001), which is suggested to be an indicator of 
improving endurance performance (Bulbulian, Wilcox, Darbos., 1986; Noakes., 
1988). 
 
3.2.2.3 Wingate (30 sec sprint) test 
Seat height was adjusted on the ergometer (Monark Ergomedic 894E, Sweden) 
to ensure the participant had a full leg extension, prior to the test. The 
participants then cycled for 60 seconds at 60rpm against a resistance of 1kg. 
Participants then completed a 30 second all out Wingate sprint. Once the 
participant reached 110rpm the resistance was added and the sprint began. 
Strong verbal encouragement was given throughout. After the sprint PPO was 
recorded as the highest W.kg-1 value, and MPO was recorded as the overall 
W.kg-1 mean average of the sprint. 
 
Within study 2 a single 30 sec Wingate test was used to measure maximal 
anaerobic power and anaerobic capacity (Vandewalle, Pérès, Monod., 1987) 
before and after the intervention. Similar to using multiple Wingate sprints for 
HIT (Burgomaster et al., 2005, 2006, 2008; Hazell et al., 2010; Lloyd Jones, 
Morris, Jakeman., 2017; Yamagishi & Babraj., 2017), 7.5% of the participant’s 
body mass is typically used for a Wingate test (Vandewalle, Pérès, Monod., 
1987). The purpose of the Wingate test within study 2 was to measure the 
maximal watt value (maximal anaerobic power) known as PPO (typically 
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achieved within the first 5-10 sec of the sprint) and measure the total amount of 
work (overall average watt value) known as MPO which is an index of anaerobic 
capacity (Vandewalle, Pérès, Monod., 1987). PPO will be a reflection of the 
predominate use of PCr (48%) and glycolysis (43%). MPO is then therefore a 
reflection of ATP turnover from 10-30 sec, which is predominately oxidative 
phosphorylation (> 50%), with glycolysis (~35%) and PCr (~15%) making up for 
the rest of ATP turnover (Parolin et al., 1999). Using a Wingate test to measure 
anaerobic capacity has proven to be a reliable measure, it is highly correlated 
between test-retest by r = 0.91 (Ayalon, Inbar, Bar-or., 1974) and r = 0.93 
(Patton, Murphy, Fredrick., 1985). 
 
3.2.2.4 Time trial and time trial rational 
Again, the seat height was adjusted on the ergometer to ensure the participant 
had a full leg extension, prior to the test. The participants then cycled for 4 min 
at 60 revolutions per minute (RPM) against 1kg of resistance. Participants then 
completed a 10km cycle on the ergometer, as fast as possible. The rpm was 
self-selected by the participant as they cycled against a fixed resistance of 2kg 
(60W) (Jakeman, Adamson, Babraj., 2012). Participants were not informed of 
time during the time trial until post testing was complete. Distance completed 
was the only visible feedback participants received. 
 
To assess endurance performance time trial (TT) tests are commonly used by 
using self-selected pace with the objective to cover a specific distance as 
quickly as possible (Burgomaster et al., 2005, 2006, 2008; Hazell et al., 2010; 
Kavaliauskas, Aspe, Babraj., 2015; Lloyd Jones, Morris, Jakeman., 2017; 
Stevens & Dascombe., 2015; Yamagishi & Babraj., 2017). HIT research has 
found improvements in TT performance by 5-10% (Burgomaster et al., 2005, 
2006, 2008; Hazell et al., 2010; Kavaliauskas, Aspe, Babraj., 2015; Lloyd 
Jones, Morris, Jakeman., 2017; Stevens & Dascombe., 2015; Yamagishi & 
Babraj., 2017). TT testing has been shown to be a reliable test-retest measure 
(CV = 3.4%, r = > 0.95) for predicting competitive endurance performance 
(Dantas, Pereira, Nakamura., 2015; Jeukendrug et al., 1996).  
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In studies 2 and 3, a 10km cycle (Monark peak bike 894) TT was used to asses 
endurance performance. Prior to this participants completed a warm up 
consisted of 4 min cycling at 60 rpm against 1kg as resistance on a cycle 
ergometer. Participants were then instructed to complete a self-paced 10km 
cycle time trial as quickly as possible with a fixed resistance (males – 2kg, 
females – 1.5kg). Only distance covered was reported to the participants. In 
study 3 females used a lighter resistance than males due to morphological 
differences in muscle and fat mass between sexes, which results in a greater 
power output in males compared to females (Perez-Gomez et al., 2008). Using 
a fixed resistance would replicate a realistic time trial performance in the sense 
that if participants were to perform a 10km time trial cycle on a track/course they 
would all have to cycle against the same gradient. However, with the overall aim 
of a time trial to maintain a high speed for a long period of time, participants that 
can produce greater amounts of force will cycle faster (Bulbulian, Wilcox, 
Darbos., 1986; Noakes., 1988). Therefore, morphological differences between 
participants would give a greater advantage to participants that have a greater 
muscle mass and or greater body mass (Perez-Gomez., 2008). Using 
percentage of body mass as a resistance for a time trial may allow the test to be 
fairer and allow participants to produce similar power outputs (Billaut & Bishop., 
2009). However, using a fixed resistance during a time trial (males: 2kg, 
females: 1.5kg) is commonly used (Jakeman, Adamson, Babraj., 2012; 
Kavaliauskas, Aspe, Babraj., 2016; Yamagishi & Babraj., 2017). 
 
3.2.2.5 Sprint training warm up 
In all training sessions, participants were required to complete a warm up that 
consisted of 4 min cycling at 60 RPM against 1kg of resistance on a cycle 
ergometer. Once completed a sprint specific warm up was carried out; 
consisting of 3 x 3 second sprints against 7.5% body mass with an active 45s 
recovery consisting of cycling at 50-60 RPM (with no resistance) between 
sprints. Participants then rested for 4 minutes prior to completing the sprint trials 
(Phillips Thompson, Oliver., 2014). After resting, participants could perform any 
light stretches that they wished. 
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3.2.2.6 Criterion sprint 
In trial 1 participants underwent the sprint training warm up procedure before 
completing the criterion sprint (CS) test. The CS test consisted of a single 6 sec 
cycle sprint against a resistance equal to 7.5% body mass to familiarise them 
with the procedure and to provide criterion sprint data (MPO W.kg-1) for 
comparison with repeated sprint performance. Once the 6 sec sprint was 
completed, participants cycled at 60rpm for 1 minute against a resistance of 
1kg. Participants then came off the ergometer and rested for 5 minutes before 
repeating another single 6 sec sprint. If participants achieve a lower MPO in test 
2, the result of test 1 was taken as the participants MPO (Phillips Thompson, 
Oliver., 2014). If participants achieved a MPO in test 2 that is ≥ 5% greater than 
test 1, a third test was undertaken (Phillips Thompson, Oliver., 2014). This was 
repeated as necessary until MPO no longer increases (Phillips Thompson, 
Oliver., 2014; see section 3.2.3.3 for further details on the CS). 
 
3.2.2.7 Sprint training 
10 x 6 second sprints (see section 2.2.3.2 for sprint duration rational) were 
completed in each training session with either a FR or SR rest between sprints, 
against 7.5% body mass resistance (see section 2.2.3.1 for body mass 
resistance rational). Resistance was applied to the flywheel once participants 
reached 110 RPM. The aim for the SR group was to take as much time as 
required during the active recovery (cycling against no resistance at 50-60 
RPM) to enable them to perform a maximal effort in all sprints (instructions were 
adapted from Glaister et al 2010; and Phillips Thompson, Oliver., 2014; see 
section 2.2.3.4 for SR instructions). The aim for the FR group was to perform 
maximally across all 10 sprints after 30 seconds of active/passive recovery. 
Participants were informed to remain seated during each sprint and no external 
feedback was given to the participants apart from cadence. During each sprint 
participants were verbally encouraged to cycle to a maximal effort. The rest 
period was defined as the moment from the bike cradle weight being lifted until 
it dropped again to start the next sprint. Participants were not informed on the 
duration of their rest period. During training sessions 1 and 6 participants had 
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heart rate recorded throughout (Bioharness; see section 2.2.5.2 for further 
details on recording heart rate). 
 
3.2.3 Statistical analysis 
Statistical analysis for the study was analysed on IBM SPSS Version 22.0 
software. Two-way (group x test) repeated mixed linear measures analysis of 
variance (ANOVA) compared magnitude of change for haemoglobin and 
haematocrit %, VO2peak, time to exhaustion, PPO, MPO, and time trial. A further 
two-way repeated mixed linear (group x trial) ANOVA compared mean 
normalised heart rate in training sessions 1 and 6, for rests 1 vs. 9 and sprints 1 
vs. 10. Bonferroni post hoc analysis explored significant main effects. 
Significant main effects between groups were further explored by using an 
independent samples T test. If sphericity was violated then Greenhouse-
Geisser corrections were used. Cohen’s D was used to measure effect size 
between the SR rest group and the fixed rest group. Effect size was defined as 
trivial (0.0-0.2), small (0.2-0.5), moderate (0.6-1.1), and large (1.2-1.9 (Cohen., 
1992)). Negative effect size values indicate a greater change in the fixed rest 
group and positive effect size values indicate a greater change in the SR group. 
Magnitude of change between pre and post testing was calculated as post 
value – pre value / pre value *100. Statistical significance was as accepted at p 
≤ 0.05, data are mean with ± standard deviation (SD), and figures 2.1-2.3 data 
are magnitude of change with ± standard error measurement (SEM). SEM was 
employed instead of standard deviation in magnitude of change measurements, 
due to the larger variability. Using standard error of measurement allowed a true 
reflection of the magnitude in change error by considering group size. A 
Pearson’s correlation was used to identify a link between maintenance of MPO 
data, haemoglobin measures, sprint HR, and resting HR between percentage 
change of performance measures. A Pearson’s correlation was also used to 
identify a link between the percentage change of performance measures from 
pre to post against other performance measures (example: correlation between 
TTE and TT). 
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3.3 Results 
3.3.1 Self-regulated recovery duration 
Mean results for self-regulated recovery duration is shown in Table 3.1. In the 
SR group there was no significant main effect between trials for rest duration (F 
1,5 = 1.037, p > 0.05). 
 
3.3.2 Mean power output 
A main effect was present between trials for MPO (F 2.933,1 = 8.639, p < 0.05), 
post hoc indicates that the CS is significantly greater than trial 1 (Table 3.1). A 
main effect was also present between groups for MPO (F 1,14 = 9.668, p < 0.05), 
post hoc indicates that MPO is significantly higher in trials 1-6 for the SR group 
compared to FR group (p < 0.05). No significant interaction was present (F 
2.933,1 = 2.38, p > 0.05). 
 
3.3.3 Mean power output percentage change 
A significant main effect was found in MPO % change between the CS and 
trials 1-6 (F 2.443,1 = 3.436, p < 0.05), post hoc is unable to identify where 
significance lies (Table 3.1). A significant main effect between groups is also 
present (F 1,13 = 5.366, p < 0.05), post hoc indicates that FR MPO % change is 
significantly greater than the SR group in when comparing trial 1 and 4 to the 
CS. No significant interaction was present (F 2.443,1 = 0.426, p > 0.05). 
 
3.3.4 Fatigue index 
FI% found no main effect between trials (F 1,5 = 0.624, p > 0.05; Table 3.1), and 
no interaction (F 1,5 = 0.688, p > 0.05). However, a main effect between groups 
for FI% data was present (F 1,14 = 69.274, p < 0.05), post hoc indicates that FR 
group FI% data is significantly higher across all trials compared to SR group 
data (p < 0.05). 
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3.3.5 Coefficient variation  
A significant main effect was found between trials for CV % (F 5,1 = 4.519, p < 
0.05; Table 3.1), post hoc indicates that CV % in trial 1 is significantly higher vs. 
trials 2/3/6 (p < 0.05). A significant main effect was also found between groups 
(F 1,14 = 8.412, p < 0.05), FR group CV % is significantly greater than SR group 
in all trials (p < 0.05). No significant interaction was present for CV % data (F 5,1 
= 0.896, p < 0.05).
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Table 3.1: Performance variables across the 6 trials of self-regulated and fixed rest (30sec) repeated sprint exercise for both groups. 
Measures Criterion Sprint Trial 1 Trial 2 Trial 3 Trial 4 Trial 5 Trial 6 
Recovery time 
(sec) 
       
SR - 84 ± 30 114 ± 63 108 ± 35 113 ± 46 101 ± 39 105 ± 44 
MPO (W.kg -1)        
SR 11.29 ± 1.6a 10.48 ± 1.52* 10.98 ± 1.63* 10.76 ± 1.54* 11.03 ± 1.7* 11.09 ± 1.44* 11.10 ± 1.54* 
FR 10.57 ± 1.06a 8.86 ± 0.84 9.14 ± 0.78 9.34 ± 0.69 9.27 ± 0.75 9.24 ± 1.06 9.44 ± 0.98 
MPO (W.kg -1) % 
change (CS vs. 
trial) 
       
SR - -7.1 ± 3.3 -2.8 ± 3.4 -4.5 ± 4.6 -2.2 ± 4.9 -1.7 ± 4.3 -1.4 ± 5.4 
FR - -15.9 ± 7.8b -12.7 ± 12.2 -10.9 ± 11.6 -11.6 ± 10.2b -11.9 ± 13.5 -10 ± 11.9 
Fatigue index (%)         
SR - 7.29 ± 3.06 3.57 ± 1.6 4.52 ± 2.36 6.26 ± 4.58 5.88 ± 2.34 6.64 ± 2.97 
FR - 12.31 ± 3.48‡ 11.92 ± 3.93‡ 12.45 ± 3.82‡ 11.28 ± 4.47‡ 11.77 ± 4.46‡ 12.08 ± 4.58‡ 
CV %        
SR - 5.74 ± 3.22 2.81 ± 0.91† 3.42 ± 2.22† 4.48 ± 2.78 3.99 ± 2.24 3.87 ± 1.16† 
FR - 10.85 ± 5.56‡ 9.03 ± 4.16‡† 9.56 ± 5.69‡† 9.2 ± 5.28‡ 9.38 ± 6.08‡ 8.17 ± 3.41‡† 
Data shown as mean average ± standard deviation. * Significantly greater than corresponding FR data. ‡ Significant greater than corresponding 
SR data. † Significantly lower than trial 1. a Significantly greater than trial 1. b Significantly greater than corresponding SR data.
8
3
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3.3.6 Percentage change for endurance measures 
3.3.6.1 VO2 peak 
Percentage change for VO2 peak (ml.kg-1.min-1), time to exhaustion (TTE) 
(seconds), and 10km TT (seconds) for pre to post percentage change testing 
results for all groups are shown in figure 3.1. In VO2 peak, no significant 
difference was present between groups in pre testing (F 2, 23 = 0.411, p > 0.05; 
SR: 47.8 ± 7.5; FR: 48 ± 7.1; C: 50.1 ± 8.6 ml.kg-1.min-1). No significant main 
effect was present in percentage change post testing between all groups but 
there was a medium effect between groups (F 2, 23 = 0.995, p > 0.05; SR vs. FR: 
d = -0.7). 
 
3.3.6.2 Time to exhaustion 
In TTE, no significant difference was present between groups in pre testing (F 2, 
23 = 1.275, p > 0.05; SR: 544 ± 75; FR: 601 ± 42; C: 586 ± 96sec). No 
significant main effect was present in percentage change post testing between 
all groups but there was a large effect between groups (F 2, 23 = 0.27, p > 0.05; 
SR vs. FR: d = 0.8). 
 
3.3.6.3 Time trial 
In TT, no significant difference was present between groups in pre testing (F 2, 
22 = 1.427, p > 0.05; SR: 1013 ± 175; FR: 895 ± 50; C: 992 ± 185sec). No 
significant main effect was present in percentage change post testing between 
all groups but there was a large effect between groups (F 2, 22 = 1.51, p > 0.05; 
SR vs. FR: d = -1.1). 
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Figure 3.1: VO2 peak, TTE and TT percentage change in SR, FR and C groups 
from pre to post testing. 
 
3.3.7 Percentage change for power measures 
3.3.7.1 Wingate peak power output 
Power measures during a 30 sec Wingate test for PPO (W.kg-1), and MPO 
(W.kg-1) for pre to post percentage change testing results for all groups are 
shown in figure 3.2. In PPO, no significant main effect was present between 
groups in pre testing (F 2, 22 = 0.151, p > 0.05; SR: 11.9 ± 2.1; FR: 12.4 ± 2.4; C: 
11.8 ± 2.1 W.kg-1). No significant main effect was present in percentage change 
post testing between all groups but there was a medium effect between groups 
(F 2, 22 = 0.342, p > 0.05; SR vs. FR: d = 0.5). 
 
3.3.7.2 Wingate mean power output 
In MPO, no significant difference was present between groups in pre testing (F 
2, 22 = 0.37, p > 0.05; SR: 8 ± 1.1; FR: 8.1 ± 0.6; C: 8.1 ± 1.1 W.kg-1). No 
significant main effect was present in percentage change post testing between 
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all groups, with a small effect between groups (F 2, 22 = 0.441, p > 0.05; SR vs. 
FR: d = 0.3). 
 
 
Figure 3.2: Wingate PPO and MPO percentage change in SR, FR and C groups 
from pre to post testing. 
 
3.3.8 Performance measures correlations 
Table 3.2 shows correlation values (r) comparing between the percentage 
change of in session MPO and the CS (MPO% of CS), in session CV% and FI% 
for the overall percentage changes of performance tests whilst combining both 
training groups’ data. No significant correlations occurred in MPO% of CS and: 
VO2 peak (r = -0.44, p > 0.05) TTE (r = 0.09, p > 0.05), TT (r = -0.14, p > 0.05), 
PPO (r = -0.2, p > 0.05), MPO (r = -0.01, p > 0.05). No significant correlations 
occurred in CV% and: VO2 peak (r = 0.38, p > 0.05) TTE (r = 0.02, p > 0.05), TT 
(r = 0.17, p > 0.05), PPO (r = 0.27, p > 0.05), MPO (r = -0.09, p > 0.05). No 
significant correlations occurred in FI% and: VO2 peak (r = 0.29, p > 0.05) TTE 
(r = 0.04, p > 0.05), TT (r = 0.32, p > 0.05), PPO (r = -0.18, p > 0.05), MPO (r = -
0.28, p > 0.05). 
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Table 3.2: correlations values between percentage change of in session MPO 
against the CS, in session CV and FI for performance measures percentage 
changes. 
Measure VO2 peak TTE TT PPO MPO 
MPO% of CS r = -0.44 r = 0.09 r = -0.14 r = -0.2 r = -0.01 
CV% r = 0.38 r = 0.02 r = 0.17 r = 0.27 r = -0.09 
FI% r = 0.29 r = -0.04 r = 0.32 r = -0.18 r = -0.28 
 
Correlation values comparing MPO% of CS, CV% and FI% between percentage 
change in performance tests. 
 
Table 3.3 shows correlation values (r) for the overall percentage changes of 
performance tests whilst combining both training groups’ data. A significant 
correlation occurred within Wingate PPO and MPO (r = 0.61, p < 0.05). 
 
Table 3.3: correlations values between percentage change between 
performance measures. 
Test VO2 peak TTE TT PPO MPO 
VO2 peak - r = -0.13 r = 0.18 r = 0.23 r = 0.26 
TTE r = -0.13 - r = -0.41 r = 0.05 r = 0.03 
TT r = 0.18 r = -0.41 - r = -0.26 r = -0.31 
PPO r = 0.23 r = 0.05 r = -0.26 - r = 0.61* 
MPO r = 0.26 r = 0.03 r = -0.31 r = 0.61* - 
 
Correlations of combined training groups and sexes percentage change in 
performance tests. * Significant positive correlation (p < 0.05). 
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3.3.9 Haemoglobin measures 
3.3.9.1 Haemoglobin 
Haemoglobin (mmo/l), haematocrit % and haemoglobin ratio measures for pre 
to post percentage change testing results for all groups are shown in figure 3.3. 
In haemoglobin, no significant main effect was present between groups in pre 
testing (F 2, 23 = 0.764, p > 0.05; SR: 8.8 ± 0.8; FR: 8.8 ± 0.8; C: 9.2 ± 0.5 
mmo/l). No significant main effect was present pre vs. post testing between all 
groups but there was a medium effect between groups (F 2, 23 = 0.404, p > 0.05; 
SR vs. FR d = 0.5). 
 
3.3.9.2 Haematocrit 
In haematocrit % no significant main effect was present between groups in pre 
testing (F 2, 22 = 0.689, p > 0.05; SR: 41.9 ± 3.8; FR: 42.6 ± 3.4; C: 43.8 ± 2.4 
%). No significant main effect was present in percentage change post testing 
between all groups and there was a small effect between groups (F 2, 22 = 0.721, 
p > 0.05) SR vs. FR: d = 0.3). 
 
3.3.9.3 Haemoglobin ratio 
In haemoglobin ratio no significant main effect was present between groups in 
pre testing (F 2, 22 = 0.948, p > 0.05; SR: 4.7 ± 0.04; FR: 4.7 ± 0.03; C: 4.7 ± 
0.03). No significant main effect was present in percentage change post testing 
between all groups but there was a medium effect between groups (F 2, 22 = 
2.143, p > 0.05; SR vs. FR: d = -0.5). 
 89 
 
Figure 3.3: Haemoglobin, haemoglobin haematocrit % and haemoglobin ratio 
percentage change in SR, FR and C groups from pre to post testing. 
 
Table 3.4 shows correlation of haemoglobin measures between percentage 
changes of performance measures. A significant correlation occurred within 
haemoglobin and TTE (r = 0.73, p < 0.05), haematocrit% and TTE (r = 0.69, p < 
0.05), and ratio and TTE (r = -0.58, p < 0.05). 
 
Table 3.4: correlation between haemoglobin measures and performance 
measures. 
Test VO2 peak TTE TT PPO MPO 
Haemoglobin r = -0.37 r = 0.73* r = -0.29 r = 0.35 r = 0.07 
Haematocrit% r = -0.35 r = 0.69* r = -0.26 r = 0.38 r = 0.02 
Ratio r = -0.12 r = -0.58** r = 0.14 r = -0.02 r = 0.01 
 
Correlation values comparing percentage change of haemoglobin, haematocrit 
and ratio between percentage change in performance tests. * Significant 
positive correlation (p < 0.05). ** Significant negative correlation (p < 0.05). 
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3.3.10 Normalised sprint heart rate data 
Figure 3.4 shows heart rate (HR) for sprint 1 (S1) and sprint 10 (S10) for trials 1 
and 6 for SR and FR groups, A: shows normalised sprinting HR between the 
two groups, B: shows normalised trial 1 S1 and S10 HR curve, C: shows 
normalised trial 6 sprint S1 and sprint S10 HR curve. In normalised sprinting 
HR, a significant main effect was present between trials and sprint periods (F 3, 
38.845 = 23.259, p < 0.05), and between groups (F 1, 13.867 = 3.273, p < 0.05). Post 
hoc indicates that all sprint 10 data is significantly greater than all sprint 1 data 
(p < 0.05). No significant main effect was present between groups (F 1, 13.867 = 
3.273, p < 0.05). No significant interaction effect was present (F 3, 38.845 = 1.921, 
p > 0.05).  
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Figure 3.4: A: Normalised average sprinting HR sprint 1 and sprint 10 between 
trials 1 and 6 for SR and FR groups. * Significantly greater than all sprint 1 data. 
B: Normalised sprinting HR curve data showing sprints 1 and 9 in trial 1. C: 
Normalised sprinting HR curve data showing sprints 1 and 9 in trial 6 for SR and 
FR groups. 
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3.3.11 Normalised resting heart rate data 
Figure 3.5 shows heart rate (HR) for rest 1 (R1) and rest 9 (R9) for trials 1 and 6 
for SR and FR groups, A: shows normalised resting HR between the two 
groups, B: shows normalised trial 1 R1 and R9 HR curve, C: shows normalised 
trial 6 R1 and R9 HR curve. In normalised resting HR, a significant main effect 
was present between trials and rest periods (F 3, 39.591 = 5.239, p < 0.05), and 
between groups (F 1, 15.156 = 10.545, p < 0.05). Post hoc indicates that trial 1 R9 
is significantly greater than trial 1 R1 (p < 0.05). Post hoc between groups 
indicates that SR group HR is significantly greater than FR group in trial 1 R1, 
R9 and trial 6 R9 (p < 0.05). No significant interaction effect was present (F 1, 
39.591 = 1.017, p > 0.05).  
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Figure 3.5: A: Normalised average resting HR rest 1 and rest 9 between trials 1 
and 6 for SR and FR groups. * Significantly greater than trial 1 rest 1. + 
Significantly greater than FR group data. B: Normalised resting HR curve data 
showing rests 1 and 9 in trial 1. C: Normalised resting HR curve data showing 
rests 1 and 9 in trial 6 for SR and FR groups. 
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3.3.12 Haemoglobin correlations 
Table 3.5 shows correlation of normalised sprint and resting HR between 
percentage changes of performance measures. Normalised sprint and resting 
HR measures are overall total of trials 1 and 6 rests 1 and 9 data (TOTAL). 
 
Table 3.5: correlation between sprint and resting HR, and percentage change of 
performance measures. 
Measure VO2 peak TTE TT PPO MPO 
HR:      
Sprint 
TOTAL 
r = -0.62† r = 0.23 r = -0.18 r = 0.05 r = -0.56 
Rest TOTAL r = -0.51 r = 0.22 r = -0.21 r = 0.03 r = -0.47 
 
Correlation values comparing TOTAL in sprint and resting normalised HR 
between percentage change in performance tests. Data is from trials 1 and 6 
rests 1 and 9. † Approaching significant negative correlation (p = 0.056). 
 
3.4 Discussion 
The aim to this study was to determine whether training adaptations were 
similar between SR and fixed work to rest ratios. It was hypothesised that SR 
rest training would lead to greater improvements in power output vs. FR group, 
and that the FR group would lead to greater endurance adaptations vs. SR 
group. Interestingly there is no significant difference in either group in VO2 peak, 
TTE, TT, PPO, MPO, haemoglobin, haematocrit %, and haemoglobin ratio pre 
vs post testing (p > 0.05). Percentage change within the performance tests and 
effect size (Cohen’s D) does show small, moderate and large effect sizes 
between the two training groups. With the SR group experiencing a larger 
percentage increase in TTE, TT, PPO and MPO compared to the FR group. 
The FR group shows a greater percentage change in VO2 peak compared to 
the SR group. It was also hypothesised that maintaining MPO would lead to 
improvements in PPO and MPO during a 30 sec Wingate test. However, 
correlation data (Table 3.2) indicates that maintenance of MPO, CV% and 
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lowered FI% is not essential for increasing power output or any of the 
endurance tests. 
 
3.4.1 Trial data 
Table 3.1 data suggests that the SR group were able to maintain CV% of MPO 
in trials 2-6 (trial 1 CV% is > 5.2%) and did so significantly greater than FR 
group in all trials (p < 0.05). Trials 2, 3 and 6 CV% data was also significantly 
less than trial 1 for both groups (p < 0.05). FI% was also significantly less in the 
SR group when compared to the FR group across all trials (p < 0.05). 
Therefore, the CV% and FI% data would suggest that the SR group were 
successful in maintaining MPO across trials 2-6, and that the 30 sec FR 
between sprints was effective in creating a decrement in MPO performance. 
However, the percentage change from the CS vs. MPO within trials 1-6 
suggests that the SR group may have adopted pacing tactics, similar to the 
findings of female MPO data in Study 1. It has previously been demonstrated 
that pacing occurs during a single bout of exercise (Wittekind, Micklewright, 
Beneke., 2011). Wittekind, Micklewright, Beneke., (2011) found that PPO was 
significantly greater in a 5 sec sprint compared to a 15, 30 and 45 sec sprint 
despite PPO usually been achieved between 0-5 seconds (Vandewalle, Pérès, 
Monod., 1987). SR participants may have identified that seeking to maintain 
their CS MPO over 10 x 6 sec sprints was too challenging and adapted their 
efforts (Wittekind, Micklewright, Beneke., 2011). Further explaining why CV% 
and FI% is unaffected and similar between trials 2-6. Therefore, SR participants 
did not keep within the aim of the study and did not maintain their maximal effort 
repeatedly. As expected, due to a shorter work:rest ratio, the FR group 
experience a greater percentage change in MPO from the CS and trials when 
compared to the FR group, with a significance appearing in trials 1 and 4 (FR 
trial 1: ~ -15.9%, SR trial ~  -7.1%, FR trial 4: ~ -11.6%, SR trial 4: ~ -2.2%, p < 
0.05). A significant main effect between trials is present for both groups, with 
the CS sprint MPO been significantly greater than trial 1 MPO. Both groups 
appear to have increased their average MPO as the number of trials increased 
but did not do so significantly. It is thought that FR group experienced a greater 
aerobic demand due to the shorter work to rest ratio compared to the SR group 
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(FR: 1:5. SR: ~1:17 (Gaitanos et al., 1993; Kavaliauskas, Aspe, Babraj., 2015)). 
The greater aerobic demand during the sprints and rest periods could indicate 
that that there isn’t sufficient time to fully recover PCr with a shortened fixed rest 
would lead to a decrement in MPO (Gaitanos et al., 1993; Kavaliauskas, Aspe, 
Babraj., 2015). This is evident from Table 3.1 power, CV% and FI% data. 
 
Correlation data that compares Table 3.1 measures against percentage 
increase in performance testing (Table 3.2) indicates that maintenance of power 
during HIT is not related to improving performance in endurance or power 
output. Data in Table 3.2 is not significant; however, correlation values (r) 
suggest that improving VO2 peak is related to varying MPO (seeking a 
decrement in MPO) within trials for both training groups. This is suggested by 
the negative correlation (r = -0.44) of percentage change between the CS and 
trial 1-6 MPO and VO2 peak. A greater CV% and FI% percentage also seems to 
have a link in improving VO2 peak (CV% r = 0.38, FI% r = 0.29). Suggesting 
that varying MPO during HIT with a shorter work to rest ratio increases aerobic 
activity during HIT (Gaitanos et al., 1993; Gosselin et al., 2012), which is 
consistent to an improvement in VO2 peak (Kavaliauskas, Aspe, Babraj., 2015). 
There is also the possibility that decreasing FI% (maintaining MPO) is a factor 
for improving 10km TT performance (r = 0.32) and MPO (r = -0.28). HIT 
research is consistent with finding improvements in a greater sustained work 
rate or PPO and MPO (Creer et al., 2004; Forbes, Slade, Meyer., 2008; Hazell 
et al., 2010; Jakeman, Adamson, Babraj., 2012; Kavaliauskas, Aspe, Babraj., 
2015; Kavaliauskas, Steer, Babraj., 2016; Lloyd Jones, Morris, Jakeman., 2017; 
Ørtenblad et al., 2000; Rodas et al., 2000). Participants that improved their TT 
performance may have done so by greater motor unit activation, increase Ca2+ 
release from the sarcoplasmic reticulum, improved MTC1,4 activity, increased 
glycogen availability, and lactate metabolism, which are all linked to improving 
TT performance post HIT (Burgomaster et al., 2006; Creer et al 2004; Jakeman, 
Adamson, Babraj., 2012; Juel et al., 2003; Ørtenblad et al., 2000). Increasing 
glycogen availability and increasing Ca2+ release and uptake within the 
sarcoplasmic reticulum would decrease the amount of Pi, which is in keeping 
with maintaining power output (Ørtenblad et al., 2000; Westerblad, Allen, 
Lannergren., 2002). Given that the TT in the present study was against a fixed 
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resistance, an increase in power output would allow participants to pedal faster 
and therefore decrease their TT. These potential adaptations post HIT may 
explain why the SR group improved their TT performance despite a negative 
change in VO2 peak. Why the FR group saw a negative response to TTE and 
TT despite an increase in VO2 peak is surprising given that increasing VO2 max 
is correlated to increase TTE, due to an increase in PPO (r = 0.86), and 
increasing MPO is correlated to increasing TT performance (r = 0.93 (Driller., 
2012)). This could indicate that increasing TTE and TT performance is greatly 
associated with anaerobic measures (as discussed above), potentially 
explaining why HIT research has found increases in TTE and TT despite no 
change in VO2 peak or max (Burgomaster et al., 2005, 2006; Kavaliauskas, 
Aspe, Babraj., 2015; Kavaliauskas, Steer, Babraj., 2016; Lloyd Jones, Morris, 
Jakeman., 2017). 
 
3.4.2 Performance measures 
3.4.2.1 VO2 peak 
VO2 peak (SR: -1 ± 4.2%, d = -0.2. FR: 5 ± 3.2%, d = 1.5. C: -3 ± 4.9%, d = -0.7 
(Figure: 3.1)) saw no significant changes between pre and post testing in all 
groups (p > 0.05). It was hypothesised that the FR group would improve greater 
than the SR group due to a shorter work to rest ratio (FR: 1:5, SR: ~1:17) that 
would create a greater aerobic response during HIT (Gaitanos et al., 1993; 
Gosselin et al., 2012; Kavaliauskas, Aspe, Babraj., 2015). However, HIT 
research is not consistent with increasing VO2 peak or VO2 max (Burgomaster 
et al., 2005; Kavaliasukas, Steer, Babraj., 2016; Linossier et al., 1993; Lloyd 
Jones, Morris, Jakeman., 2017), possibly explaining the no change in VO2 peak 
for the SR group. Kavaliasukas, Steer, Babraj., (2016) discuss that the no 
change in VO2 peak for their participants could be due to the short duration of 
the study (2 weeks). Astorino & Schubert., (2014) found a greater response in 
participants increasing VO2 max (78% of participants) when using a long term 
HIT protocol (12 weeks) when compared to participants (65%) using a short 
term protocol (2 weeks). Therefore, literature would suggest that the SR group 
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within the present study may experience an increase in VO2 peak if the duration 
of the present HIT protocol increased by > 2 weeks. 
 
Hazell et al., (2010) speculates that the reproducibility of power output may be a 
key factor for improving endurance power measures. However, in the present 
study non-significant correlation data in Table 3.2 indicates that not maintaining 
CS MPO (r = -0.44), varying power output by a decrement in force (CV r = 
0.38), and causing greater fatigue (FI r = 0.29) is linked with increasing VO2 
peak. The decrement in force in relation to the CS and during the trial indicates 
a dominant shift in energy metabolism from PCr and glycolysis to aerobic 
metabolism (Bogdanis et al., 1996; Gaitanos et al., 1993; Kavaliasukas, Aspe, 
Babraj., 2015). Kavaliasukas, Aspe, Babraj., (2015) speculate that increasing 
aerobic demand and decreasing power output during HIT may be a key factor 
for improving endurance measures. Therefore, within the present study 
participants may have increased their VO2 peak by using a rest duration that 
reduces ATP turnover due to a depletion in PCr and inhibition of anaerobic 
glycolysis (Bogdanis et al., 1996; Gaitanos et al., 1993). 
 
Increasing haemoglobin (r = -0.37), haematocrit (r = -0.35) and haemoglobin 
ratio (r = -0.12) is not significantly correlated to increasing VO2 peak (Table 3.4). 
The SR group experience the greatest increase in haemoglobin (SR: 5 ± 5.2%, 
d = 1, p > 0.05. FR: 1 ± 3.6%, d = 0.2, p > 0.05. C: 1 ± 2.9%, d = 0.5, p > 0.05) 
and haematocrit (SR: 5 ± 4.9%, d = 1.1, p > 0.05. FR: 2 ± 3.9%, d = 0.5, p > 
0.05. C: 1 ± 3%, d = 0.3, p > 0.05 (Figure 3.3)) yet experienced a negative 
magnitude in change in VO2 peak. Given that haemoglobin is a contributing 
factor in the delivery of oxygen (Pottgiesser, Schumacher., 2013; Warburton et 
al., 2000), it would suggest that an increase in oxygen kinetics increased, which 
would explain why there is no change in VO2 peak for the SR group but 
increases in all other performance measures (Kavaliasukas, Steer, Babraj., 
2016; Marsh & Martin., 1997).  Menz et al., (2015) found no significant increase 
in VO2 max and haemoglobin mass after 11 HIT sessions with trained athletes. 
Menz et al., (2015) explains that several studies using trained athletes 
experience no link between VO2 max and haemoglobin after HIT. The increase 
in VO2 peak for the FR group could due to an increase in citrate synthase 
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activity, which is linked to an increase in VO2 max following HIT (Vigelso, 
Andersen, Dela., 2014). Citrate synthase activity may have increased due to a 
greater aerobic demand in the FR group due to the shorter work:rest ratio, given 
its adaptability following aerobic training (Vigelso, Andersen, Dela., 2014). 
 
Reducing sprint and recovery TOTAL normalised HR (Table 3.5) is potentially 
linked to increasing VO2 peak respectively (r = -0.62, p < 0.075; r = -0.51). Both 
training groups sprint and recovery HR significantly increase from sprint 1/ rest 
1 vs. sprint 10/ rest 9 within trials 1 and 6 (Figure 3.4, 3.5). However, rest 9 HR 
data is significantly greater in the SR group vs. the FR group in trials 1 and 6. 
This suggest that increasing the aerobic demand during HIT or a decrement in 
trial MPO leads to a decreased HR due to a steady decline in power output. 
Yamagishi & Babraj., (2017) found similar normalised HR measures along with 
similar lactate measures despite using 15 and 30 sec sprints. They also found 
similar reproducibility of PPO during the HIT sessions, indicating that the SR 
group experienced a greater use of anaerobic glycolysis during the present 
study HIT due to a higher normalised HR during sprints and rests. The potential 
greater use in glycolysis for the SR group and greater aerobic demand for the 
FR group may explain why a decrease in HR led to an increase in VO2 peak for 
the FR group and no change for the SR group (Gaitanos et al., 1993). This is in 
contrast with the work of Kavaliasukas, Aspe, Babraj., (2015) who found a 
greater HR during HIT with a shorter recovery period. However, Kavaliasukas, 
Aspe, Babraj., (2015) did not normalise their HR data, which may explain the 
contrast in findings within the present study. 
 
3.4.2.2 Time to exhaustion 
The SR group experienced larger improvements in TTE (3 ± 3.4%, d = 1) when 
compared to the FR (TTE: 0.2 ± 1.3%, d = 0.2) and a moderate effect size (SR 
vs. FR d = 0.8). It was hypothesised that the SR group would experience a 
smaller improvement for endurance based testing when compared to the FR 
group. Due to longer recovery period, which leads to a smaller aerobic demand 
during HIT (Gosselin et al., 2012; Kavaliasukas, Aspe, Babraj., 2015). In 
contrast to this study, Kavaliauskas, Aspe, Babraj., (2015) found significant 
 100 
increases in TTE with 30 sec (1:3) rest (~ 6.4%, d = 0.8, p = 0.003) and 80 sec 
(1:8) rest (~ 4.4%, d = 0.6, p = 0.03) whereas 120 sec (1:12) rest saw no 
significant improvement (~ 1.9%). Using a work:rest ratio of 1:8 appears to be 
consistent with increasing TTE by 100% (Burgomaster et al., 2005), 12% 
(Kavaliauskas, Steer, Babraj., 2016), 6.2% and 12.8% (Yamagishi, Babraj., 
2017). Further studies have found an increase in TTE (4%) using a work:rest 
ratio of 1:10 (Jakeman, Adamson, Babraj., 2012), and by 3.5% and 3% when 
using a work:rest ratio of 1:24 and 1:12 respectively (Hazell et al., 2010). 
Indicating that shorter rest durations or smaller work:rest ratios are not essential 
for increasing endurance capacity. This potentially explains why the SR group 
increased their TTE despite using an average work:rest ratio of ~1:17. 
 
Hazell et al., (2010) speculates that the maintenance of power output may be a 
key factor for improving performance measures given that using a 30 and 10 
sec sprint had similar magnitude in change from pre to post testing and due to a 
greater maintenance of power using a 10 sec sprint. However, in the present 
study maintaining CS power output, reducing CV% and FI% of MPO during the 
trials was not strongly correlated to increasing TTE (r = 0.09; r = 0.02; r = -0.04 
respectively). TOTAL HR during sprints (r = 0.23, p < 0.05) and rest periods (r = 
0.22, p < 0.05) also appears to not be strongly linked to increasing TTE. It is 
thought that the increasing haemoglobin (SR: ~5%. FR: ~1%) and haematocrit 
(SR: ~5%. FR: ~2%), and no change in haemoglobin ratio (SR: ~-0.1%. FR: 
~0.4%) is linked with improving TTE. This is suggested by the significant 
correlation between TTE and haemoglobin (r = 0.73, p < 0.05), haematocrit (r = 
0.69, p < 0.05), and haemoglobin ratio (r = -0.58, p < 0.05). Increasing 
haemoglobin concentration would increase the delivery of oxygen to the 
working muscles during the TTE (Pottgiesser, Schumacher., 2013; Warburton 
et al., 2000) and has been found to increase aerobic power output (Kanstrup & 
Ekblom., 1984), which may explain the greater increase in TTE for the SR 
group compared to the FR group. Haemoglobin concentration may have 
increased more in the SR group than the FR group due to a greater work:rest 
ratio, using a shorter work:rest ratio is thought to increase the aerobic demand 
during HIT (Gosselin et al., 2012; Kavaliasukas, Aspe, Babraj., 2015). It is 
unsure why the SR group had a greater increase in haemoglobin compared to 
 101 
the FR group, the differences in recovery duration and or greater maintenance 
of CS MPO may have caused a greater lowering in the amount of O2 within the 
blood, which would stimulate erythropoiesis (Mairbaurl., 2013). This releases 
stem cells from bone marrow that have the ability to self-duplicate and after a 
maturation process haemoglobin is synthesised with developing erythroblasts 
(Adamson & Finch., 1975). 
 
Improving TTE could be due to increased muscle citrate synthase activity after 
HIT, which would increase mitochondrial activity (Burgomaster et al., 2005), and 
increased resting PCr stores (Burgomaster et al., 2005). Increasing resting PCr 
stores decreases an onset of fatiguing mechanisms such as lowering pH (~ 0.5 
units), build up in Pi and a reduction in impeded Ca2+ dynamics (Balsom et al., 
1992; MacLaren & Morton., 2012; Westerblad, Allen, Lannergren., 2002). 
However, increasing PCr and citrate synthase activity is strongly linked (Kent-
Braun & Alexander., 2000) and positively linked (Vigelso, Andersen, Dela., 
2014) to an increase in VO2 max respectively. Indicating that SR group 
participants did not increase their TTE due to an increase in PCr or increased 
citrate synthase activity, given that the SR group saw no increase in VO2 peak. 
SR group participants may have increased their TTE due to an increase in 
power output, which would allow a higher sustainability of work rate (Vanhatalo, 
Doust, Burnley., 2008). This higher sustainability of work rate could be due to 
an increase in glycogen stores and glycogen availability, due to an increase in 
the glycolytic flux mechanism, which has been found to increase power output 
following HIT (7 x 15-30 sec sprints (Rodas et al., 2000)). This is suggested by 
the ~10% increase in TTE observed in Rodas et al., (2000) following HIT. 
Research from Jakeman, Adamson, Babraj., (2012) found a significant 
rightward shift in the lactate curve which resulted in an increase of power 
(~30W) following 6 sessions of 10 x 6 sec cycle sprints. The SR group may 
have increased their TTE by changes in lactate metabolism, which would lead 
to a greater power output during the test. Post HIT has also shown to increase 
lactate transporter activity MTC1 and MTC4 (Bishop et al., 2008; Burgomaster et 
al., 2005; Perry et al., 2008). It is thought that MTC1 and MTC4 activity may 
have increased in the current study due to the substantial rest duration, which 
would allow time for lactate removal after each sprint (Bishop et al., 2008; 
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Sahlin et al., 1976). Indicating that the SR group may have increased their TTE 
by an increase in lactate metabolism, via increased MTC1 and or MTC4 activity, 
which would lead to a greater power maintenance during the test. 
 
3.4.2.3 Time trial 
Similar to the TTE test, the SR group saw a greater improvement in 10km TT 
testing by decreasing their time by ~-3% whereas the FR increased their time 
by ~3%. These changes were not significant, however, there was a large effect 
size when comparing between the SR and FR groups (d = -1.1). Kavaliauskas, 
Aspe, Babraj., (2015) also found a significant improvement in 3km TT, only in 
the 30 sec rest group (30 sec rest ~ -3.1% p < 0.05; 80 sec rest ~ -2.4% p > 
0.05; 120 sec rest ~ 2.4% p > 0.05). Burgomaster et al., (2005 (~-10%)) Hazell 
et al., (2010 (1:8: ~-5.2%, 1:24: ~-3.5%, 1:12: ~-3%)), Jakeman, Adamson, 
Babraj., (2012 (~-10%)), Lloyd Jones, Morris, Jakeman., (2017 (6 sec sprint: ~-
5.1%, 30 sec sprint: ~-6.2%)), and Yamagishi, Babraj., (2017 (15 sec sprint: ~-
8.6%, 30 sec sprint: ~-17.2%)) also saw significant decreases in TT testing. The 
present study data appears to be inconsistent with the findings of Kavaliauskas, 
Aspe, Babraj., (2015), who found greater improvements in 3km TT performance 
with the shortest work:rest ratio (1:3) when compared to greater work:rest ratios 
(1:8 and 1:12). They speculate that reducing the work:rest ratio will increase the 
aerobic demand of the HIT and lead to greater improvements in endurance 
testing (Gaitanos et al., 1993; Gosselin et al., 2012). In contrast with Jakeman, 
Adamson, Babraj., (2012), they used double the amount of rest (60 sec) 
between sprints compared to the FR group in this study and both studies used 
10 x 6 sec sprints, yet Jakeman, Adamson, Babraj., (2012) found a decrease of 
~10% whereas the FR group increased their time by ~3% . This could be due to 
a larger maintenance in power across each trial, made possible by 60 sec rest 
period in comparison to the 30 sec rest period used for this study (Hazell et al., 
2010). 
 
Similar to the TTE test, TT performance may have improved due to an increase 
in lactate metabolism, which is potentially linked to an increased work rate of 
30W (Jakeman, Adamson, Babraj., 2012), and or an increase in power output 
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which potentially increased TTE by ~10% (Rodas et al., 2000). This is 
potentially indicated by a small correlation link between reducing FI% and TT (r 
= 0.32 (Table 3.2)). As FI% increases a decrement in power also increases 
(Bogdanis., 2012), when this occurs glycogen stores decrease and the aerobic 
metabolism becomes the dominant fuel source for the sprints (Pette., 1985). 
Suggesting that the SR group were able to continue using glycogen as an 
energy source for their sprints more than the FR group (Pette., 1985). Small 
and moderate correlations between TT, increasing Wingate PPO (r = -0.26), 
increasing Wingate MPO (r = -0.31), and increasing TTE (r = -0.41) could 
suggest that the increases in all these tests for the SR group are linked (Table 
3.3). Jakeman, Adamson, Babraj., (2012) explain a decrease in blood lactate 
could be due to an increase in skeletal muscle uptake of lactate, due to an 
increase in MTC1,4 activity (Burgomaster et al., 2007). There is also the 
possibility that that the SR group improved their TT performance due to an 
increase in greater glycogen stores (Rodas et al., 2000), which would increase 
power output and allow participants to sustain a higher work rate (Vanhatalo, 
Doust, Burnley., 2008). Therefore, SR participants may have improved their TT 
performance by been able to pedal faster against the same fixed resistance 
from the pre TT test. 
 
3.4.2.4 Wingate power output testing 
No significant difference between testing and groups was found in PPO (SR: 1 
± 4.5%, p > 0.05. FR: -4 ± 6%, p > 0.05. C: 1 ± 3.5%, p > 0.05) and MPO (SR: 
0.4 ± 2.9%, p > 0.05. FR: -2 ± 1.7%, p > 0.05. C: 0.3 ± 1.2%, p > 0.05 (Figure 
3.2)). When comparing effect size between the SR and FR groups, there is a 
moderate effect size in PPO (d = 0.5) and small effect size in MPO (d = 0.3). 
Further indicating a greater increase in PPO and MPO in the SR group. This is 
consistent with the work of Kavaliauskas, Aspe, Babraj., (2015) who found that 
longer work:rest ratios (1:8 and 1:12) found greater improvements in Wingate 
PPO (~8.5% and ~7.1%) and MPO (~4.6% and ~5.3%) following HIT compared 
to a shorter work:rest ratio (1:3, ~4.3% and ~0.3%). From their study it was 
hypothesised that the SR group would see larger improvements in PPO and 
MPO due to a higher training power output average. Previous HIT research has 
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shown to increase power output due to an improvement in neurological 
responses (firing rate), remodelling of muscle fibres, increased PCr stores or 
recovery, glycogen stores, and improved Ca2+ dynamics (Burgomaster et al., 
2005; Creer et al., 2004; Ørtenblad et al., 2000; Pette., 1985; Rodas et al., 
2000). The repetition of producing multiple maximal efforts would lead to a 
dominant recruitment of type II fibres and use in glycolytic enzyme activity 
(Roepstorff et al 2006; Russ et al., 2005). In comparison, the FR group saw a 
drop in both PPO and MPO, which may explain the lack of positive change in 
the TTE and TT tests despite an increase in VO2 peak.  Hazell et al (2010) 
found a significant increase in PPO and MPO when using 10 and 30 sec sprints 
with 4min recovery, however, they only found a significant increase in PPO 
when using 10 sec sprints with 2min recovery (MPO p = 0.06). Further 
suggesting that a longer recovery during HIT is a factor for improving PPO and 
MPO. 
 
A moderate correlation was present in TOTAL normalised sprinting HR and 
increasing MPO (r = -0.56 (Table 3.5)). A similar correlation occurred in TOTAL 
normalised resting HR and increasing MPO (r = -0.47). Potentially suggesting 
that increasing HR during sprints and during rest periods is important for 
improving MPO. Given that normalised HR was higher in the SR group than the 
FR group in sprints but also significantly higher during trial 1 rest 1 and rest 9, 
and trial 6 rest 9. There is also a significant correlation between MPO and PPO 
(r = 0.61, p < 0.05 (Table 3.3)). These correlations suggest that seeking to 
increase HR during HIT leads to an improvement to PPO and MPO (Table 3.5). 
PPO and MPO may not have increased as much as recent research (Hazell et 
al., 2010; Kavaliauskas, Aspe, Babraj., 2016) due to the known 10% over-
estimation in required SR recovery (Phillips Thompson, Oliver., 2014; Study 
1).Phillips Thompson, Oliver., (2014) discusses that this 10% over-estimation in 
SR may not stimulate the correct physiological responses to improve 
performance testing. Further research should identify if PPO and MPO are 
increased when SR is reduced by > 10%. 
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3.4.3 Limitations 
The current study did not take into account what sport, activity or competition 
phases the participants take part in. This may have caused tiredness or 
lethargic states for some of the participants who were midway through their 
competition calendar. The potential tiredness or lethargic states could have 
affected TTE, TT, Wingate PPO and MPO in post testing for the FR group, 
given that previous similar research (10 x 6 sec cycle sprints, 60 sec rest 
between sprints) has found a ~10% improvement in TT and ~4% improvement 
in TTE (Jakeman, Adamson, Babraj., 2012). The difference of 30 sec in rest 
between the FR group in the current study and Jakeman, Adamson, Babraj., 
(2012) would previously indicated towards a greater improvement in TTE and 
TT due to a potentially greater aerobic demand during the HIT because of the 
shorter rest period (Kavaliauskas, Aspe, Babraj., 2015).  
 
In the current study it is thought that the SR group experienced a greater 
normalised aerobic demand during the HIT trials compared to FR group. Given 
that normalised HR was greater in the SR group, Study 1 shows a significant 
increase in VO2 and VCO2 measures from rest 1 to rest 9, and Study 1 also 
shows an association between greater sum of trial MPO, VO2 and VCO2. 
However, this is speculative and gas masks within trials, to measure VO2 and 
VCO2, were not used due to potential discomfort factors discussed in Study 1 
(see section 3.5). Using gas masks to measure and normalise VO2 and VCO2 
between the two training groups could further indicate that seeking to maintain 
CS MPO ten times in a single trial leads to a greater aerobic demand compared 
to using a shorter work:rest ratio, as used by the FR group.  
 
3.4.4 Conclusion 
This study demonstrates that maintaining power through SR rest leads to 
greater improvements in TTE, TT, Wingate PPO and MPO when compared to 
varying power output. Increasing haemoglobin concentration, haematocrit, and 
HR measures during HIT appear to be key factors for improving TTE, TT, 
Wingate PPO and MPO, which was achieved more greatly when using SR rest 
compared to a 30 sec FR period. Seeking to maintain CS MPO during HIT is 
 106 
not strongly correlated to increasing any of the performance measures. 
However, seeking to cause a decrement in MPO during HIT appears to be 
moderately correlated to increasing VO2 peak, possibly due to an increasing 
aerobic demand during HIT (Kavaliauskas, Aspe, Babraj., 2015). This present 
study is also consistent with previous literature that found smaller work to rest 
ratios lead to greater increase in VO2 peak and greater work to rest ratios lead 
to greater power outputs (Kavaliauskas, Aspe, Babraj., 2015). Data from the SR 
group may not be significant due to the established 10% overestimated SR rest 
(Phillips Thompson, Oliver., 2014; Study 1). Further research should 
demonstrate the effects of HIT and SR rest but aim to remove the 10% 
overestimated rest during HIT. 
 
3.4.5 Practical implications 
The present study has identified four major findings. 1) Created further evidence 
that HIT over a two-week period (6 sessions) using short duration sprints (10 x 
6 sec sprints against 7.5% body mass resistance) leads to increased 
performance in endurance and power measures. 2) The use of SR rest leads to 
greater improvements in TTE, TT and Wingate power output measures 
compared to a FR, which may create tailored rest periods for each participant. 
3) Using a FR between sprints and perhaps creating a greater aerobic demand 
during the HIT creates greater improvements in VO2 peak. 4) A participant’s 
ability to maintain their CS MPO during HIT whilst using SR rest may be 
affected by the instructions or their interpretation of the instructions given by the 
researcher. Males been able to maintain their CS MPO during HIT more greatly 
in Study 1 (Table 2.1) compared to Study 2 (Table 3.1) suggests this. 
Practitioners should consider what performance outcomes they desire from their 
athletes when contemplating using SR recovery, and consider their word choice 
when explaining what they want their athletes to achieve when using SR 
recovery. Practitioners should also treat the current data as populations specific 
until further research has been conducted with elite athletes.  
 
 107 
3.4.6 Proceeding research 
The present study found that the SR group experience greater improvements in 
TTE, TT, Wingate power output and haemoglobin measures compared to the 
FR group. Whereas the FR experience greater improvements in VO2 peak 
compared to the SR group. However, this study has not identified if the over-
estimation in SR rest (Phillips, Thompson, Oliver., 2014; Study 1) has a 
negative impact on magnitude in change for the endurance and power output 
measures. There is also an uncertainty as to what endurance adaptations would 
occur in female participants, given that they cannot maintain their MPO as 
greatly as males when using SR rest (Study 1). Therefore, the proceeding 
research will seek to remove this over-estimation in SR rest during a HIT 
intervention, and compare HIT effects between males and females. 
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4 Chapter 4 – Study 3 (Sex differences and changes in 
endurance measures using reduced self-regulated recovery 
during high intensity training) 
4.1 Introduction 
4.1.1 Adaptations to high intensity training 
A number of different High intensity training (HIT) protocols have been utilised 
with differences in work to rest ratio, sprint duration and number of sprints 
(Burgomaster et al., 2005, 2006, 2008; Hazell et al., 2010; Kavaliauskas, Steer, 
Babraj., 2015; Kavaliauskas, Steer, Babraj., 2016; Lloyd Jones, Morris, 
Jakeman., 2017; Rodas et al., 2000; Yamagishi & Babraj., 2017). When total 
sprint work is balanced (20 x 6 sec sprints 4 x 30 sec sprints) or total number of 
sprints is the same (4-6 x 15 sec sprints compared to 4-6 x 30 sec sprints) and 
work to rest ratio is the same then the reported endurance adaptations (time to 
exhaustion, time trial, critical power and VO2 peak) are similar regardless of 
sprint duration (Lloyd Jones, Morris, Jakeman., 2017; Yamagishi & Babraj., 
2017). This may reflect that glycogen depletion is a major regulator of 
endurance adaptation (Bogdanis et al., 1996, 1998; Parolin et al 1999) to HIT 
and if enough sprints are performed then the extent of glycogen depletion is 
identical regardless of sprint duration (Bogdanis et al., 1998). The majority of 
phosphocreatine (PCr) and glycogen degradation occurs within the first 15 sec 
of a 30 sec sprint (Bogdanis et al., 1996, 1998; Parolin et al 1999), suggesting 
that the last 15 sec of a 30 sec sprint is not vital for improving endurance. When 
Yamagishi & Babraj., (2017) compared two HIT duration protocols, they found 
using half the amount of time during HIT led to similar training adaptations in 
VO2 peak, time to exhaustion (TTE), time trial (TT) and critical power (CP). 
Research also indicates that as long as there are multiple sprint bouts during 
HIT there will be a decrease in anaerobic dominance and an increase in aerobic 
dominance during HIT when using 6-30 sec long sprints and separated by 30 
sec to 4 min recovery (Bogdanis et al., 1996, 1998; Parolin et al 1999; Gaitanos 
et al., 1993). There is an increase in research that is showing that 
improvements in endurance (VO2 max, VO2 peak, TT and TTE) are able to 
occur when using HIT protocols that use 6-10 sec long sprints (Hazell et al., 
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2010; Jakeman, Adamson, Babraj., 2012; Kavaliauskas, Aspe, Babraj., 2015; 
Lloyd Jones, Morris, Jakeman., 2017). Shorter sprint periods (5-10sec) have 
found muscle metabolite, such as PCr and glycogen, increases compared to 
using a 30sec sprint (Burgomaster et al., 2005 and 2006; Forbes, Slade, 
Meyer., 2008; Linnosier et al 1993; Ørtenblad et al., 2000; Rodas et al., 2000). 
Protocols using 30sec sprints saw increases in glycogen by ~26%, ~50%, 
32.3% (Burgomaster et al., 2005, 2006; Rodas et al., 2000), and PCr has 
previously increased by ~31%, ~3.7% and ~1% (Burgomaster et al., 2005, 
2006; Rodas et al., 2000). Glycogen and PCr stores have also recorded an 
increase after performing a 30sec sprint by ~57.9% and ~48% respectively 
(Rodas et al., 2000). During exercise (60% and 90% of VO2 peak) has seen 
increases in glycogen and PCr following HIT by > 50% and ~13%, > 100% and 
~33% respectively (Burgomaster et al., 2006). Duration of PCr recovery, 
following high intensity leg extension exercise, has also been found to decrease 
(~14%) following six sessions of HIT (4-6 x 30sec sprints 4min rest against 
7.5% for males and 6.5% for females body mass (Forbes, Slade, Meyer., 
2008)). Protocols using 5-10sec sprints have also seen increases in glycogen 
by ~11.5% (Ørtenblad et al., 2011), glucose 6 phosphate by ~59.1% and PCr by 
~5.3% (Linnosier et al., 1993). However, increasing PCr after HIT is not 
consisted as Ørtenblad et al., (2000) found a decrease in resting PCr (~ 10%) 
following five weeks of HIT (10sec sprints). After repeat running sprint training 
(over 8 weeks: 2 x 30sec sprints 10min rest twice a week, 6-10 x 6sec sprints 
54sec rest once a week, 5 x 2min run 5min rest once a week) PCr also saw a 
decrease at rest (~ 1%) and after a 30sec sprint (~ 8.9% (Nevill et al., 1988)). 
 
The use of 30 sec sprint protocols increasing endurance capacity is linked to 
increasing VO2 peak, citrate synthase activity, glycogen stores and 
phosphocreatine (PCr) stores (Burgomaster et al., 2005; Burgomaster et al., 
2006; Burgomaster et al., 2008; Kent-Braun & Alexander., 2000; Rodas et al., 
2000). Increasing citrate synthase activity is a reflection of an increase in 
mitochondrial activity, which is an important adaptation in endurance training to 
improve capacity and performance (Holloszy & Coyle., 1984). Increased 
glycogen and PCr stores following HIT (Burgomaster et al., 2005; Burgomaster 
et al., 2006; Burgomaster et al., 2008; Ørtenblad et al., 2011; Rodas et al., 
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2000) also increase sarcoplasmic reticulum calcium (Ca2+) release, which is in 
keeping with a greater force development (Ørtenblad et al., 2011; Westerblad, 
Allen, Lannergren., 2002). Increasing glycogen (through an increase glycolytic 
enzyme activity phosphofructokinase, lactate dehydrogenase (Rodas et al., 
2000)) and PCr stores is advantageous for seeking to maintain a high rate of 
muscular contraction for a sustained period of time (Gaitanos et al., 1993; 
Ørtenblad et al., 2011; Rodas et al., 2000; Westerblad, Allen, Lannergren., 
2002). 
 
During multiple sprint bouts, using 10 x 6sec sprints with 30sec recovery (1:5 
work:rest ratio), degradation of PCr is accounted for 49.6% of ATP resynthesis 
in sprint 1, whereas in sprint 10 PCr accounts to 80.1% of ATP resynthesis 
(Gaitanos et al., 1993). Therefore, sprint 10 power output was supported by PCr 
degradation and an increase in aerobic metabolism (Gaitanos et al., 1993). The 
hydrolysis of ATP produces ADP and inorganic phosphates (Pi) when producing 
maximal bursts of muscular contraction (Glaister., 2005). During PCr hydrolysis, 
lactic acid is ionized and produces lactate and H+ (Glaister., 2005). 
Accumulation of Pi are thought to be causes for peripheral fatigue, which 
prevents PCr resynthesis and affects calcium (Ca2+) dynamics (Glaister., 2005; 
Ørtenblad et al., 2011; Westerblad, Allen, Lannergren., 2002). This release in Pi 
leads to an impairment in Ca2+ release (muscular contraction) and absorption 
(muscular relaxation) within the sarcoplasmic reticulum (Ørtenblad et al., 2011; 
Pilegaard et al., 1999; Westerblad, Allen, Lannergren., 2002). This impairment 
in Ca2+ kinetics directly impacts force production in the myofibrils and reduces 
sarcoplasmic reticulum Ca2+ ATPase (SERCA) concentration (Periasamy & 
Kalyanasundaram., 2007). A reduction in SERCA leads to a decrement in Ca2+ 
been pumped back (absorbed) to the sarcoplasmic reticulum (Periasamy & 
Kalyanasundaram., 2007). 
 
Anaerobic capacity and skeletal muscle power is regarded as a contributing 
factor for improving endurance performance (Bulbulian et al., 1986; Noakes., 
1988). Increasing activity in factors such as lactate monocarboxylate 
transporters (MTC), specifically MTC1 and MTC4, are strongly linked with 
increasing endurance testing, mean and peak power output testing (Pilegaard 
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et al., 1999). Increased MTC activity leads to a larger blood flow (~16%) due to 
an increase in lactate concentration and lactate uptake in skeletal muscle tissue 
(Gladden., 2000). As lactate increases 75-80% of the lactate is oxidised with the 
remaining 25-20% been converted into glucose and glycogen (Brooks., 2000). 
Therefore, allowing a greater ATP turnover to allow higher muscular contraction 
rates (Bogdanis et al., 1996; Gaitanos et al., 1993). Increasing resting muscle 
glycogen content, post HIT, has previously been demonstrated (Burgomaster et 
al., 2005, 2006, 2008). It is possible that an increase in glycogen is responsible 
for cellular Ca2+ homeostasis driving the sarcoplasmic reticulum Ca2+ pump, 
which will cause functional coupling of ATP caused by sarcoplasmic reticulum 
glycolytic enzymes, allowing a sustaining high rate of muscular contraction 
(Ørtenblad et al., 2011; Pilegaard et al., 1999; Westerblad, Allen, Lannergren., 
2002). Increasing muscular power is regarded as an important factor for 
improving endurance performance such as a 1.5-10km time trial (Bulbulian et 
al., 1986; Noakes., 1988). A greater resynthesis of ATP through glycolysis will 
allow participants to maintain a higher speed during important stages of the time 
trial such as the start and finish (Bulbulian et al., 1986; Joyner & Coyle., 2008). 
 
Increasing muscular power is due to a greater neuromuscular function, 
increased Ca2+ dynamics and muscle fibre distribution (Allemeier et al., 1994; 
Bell et al., 2015; Creer et al., 2004; Esbjörnsson et al., 1993; Jacobs et al., 
1987; Jansson et al., 1990; Ørtenblad et al., 2000; Yu, Carlsson, Thornell., 
2004). HIT (4-6 30sec sprints 4min recovery against 7.5% body mass,15 x 
10sec sprints with 50sec recovery against 7% body mass, 2-6 x 15 and 30sec 
sprints against 7.5% body mass, 4-6 x 30sec sprints 15-20min recovery against 
75g per kg body mass), has previously demonstrated a change in dominance in 
muscle fibre recruitment during exercise (Allemeier et al., 1994; Esbjörnsson et 
al., 1993; Jacobs et al., 1987; Jansson et al., 1990). Alterations have shown to 
decrease the recruitment of faster type muscle fibres (type IIX) and increase the 
recruitment of intermediate fast twitch muscle fibres (type IIA (Allemeier et al., 
1994; Esbjörnsson et al., 1993; Jacobs et al., 1987; Jansson et al., 1990; Pette., 
1998; Pette & Staron., 1997; Ross & Leveritt., 2001)). This also leads to a 
decrease in type I muscle fibre recruitment and in some cases shows no 
alteration in the recruitment of type I (Allemeier et al., 1994; Jacobs et al., 1987; 
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Jansson et al., 1990; Pette., 1997; Ross & Leveritt., 2001). Neural impulse 
responses are responsible for these alterations, due to the progression/ loading 
of HIT, which alters metabolic homeostasis (Pette., 1985). Further neural 
adaptations, following 4 weeks of HIT (4-10 x 30sec sprints with 4min recovery, 
twice a week), are an increased motor unit activation in the vastus lateralis 
(Creer et al., 2004). Which is in keeping with producing greater amounts of peak 
power output (PPO), mean power output (MPO) and total work (Creer et al., 
2004). It is also thought that following 5 weeks of HIT (20 x 10sec sprint with 
50sec recovery, 3 times a week, against 8-8.5% body mass) leads to an 
increase in sarcoplasmic reticulum, due to an increase in Ca2+ release of ~5.5% 
(Ørtenblad et al., 2000). Who also found greater maintenance of MPO during 10 
sprints in pre to post and compared to the control group (Ørtenblad et al., 2000). 
 
4.1.2 Maintenance of power 
HIT involves a series of repeated sprints of between 6 seconds and 4 minutes 
duration and rest durations that are longer than the sprint duration. Previous 
literature has demonstrated that improvements in endurance capacity, 
endurance performance and power output is tailored around the specific work to 
rest ratio during HIT (Kavaliauskas, Aspe, Babraj., 2016). For example, 
Kavaliauskas, Aspe, Babraj., (2016) speculate that their HIT group with the 
shortest work to rest ratio (1:3) increased in VO2 peak, TTE and TT due to a 
larger aerobic demand from a shorter rest. However, research is starting to 
indicate that maintaining power output during HIT leads to similar training 
adaptations to HIT protocols that use shorter rest and work or reduced work to 
rest ratios (Hazell et al., 2010; Study 2; Yamagashi & Babraj 2017). Typically, 
an increase in PCr degradation and fall in peak power during HIT (4-6 x 30sec 
sprint 4 min recovery) is a key factor for improving endurance, as this creates a 
greater aerobic metabolism demand during training (Bogdanis et al., 1995; 
Bogdanis et al., 1996; Gaitanos et al., 1993; Sloth et al., 2013). However, the 
majority of PCr degradation and glycogen uptake during HIT occurs within the 
first 15 sec of a 30 sec sprint (Bogdanis et al., 1985; Bogdanis et al., 1998; 
Parolin et al., 1999). Therefore, similar training adaptations that occur using a 
30sec sprint can also occur when reducing the sprint duration by half 
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(Yamagashi & Babraj., 2017). Maintaining to ~ 60% of maximal power output 
during HIT (4 x 30sec sprint 4min recovery) causes a continued decrease in 
PCr and glycogen (McCartney et al., 1986), and as long as there are multiple 
bouts there will be an increasing demand on oxidative phosphorylation (Hazell 
et al., 2010; McCartney et al., 1986; Spriet et al., 1989). Potentially explaining 
the similar endurance adaptations between using longer vs. shorter work to rest 
ratios and shorter sprints vs. longer sprints (1:8, 1:12, 1:24, 4-6 x 30 and 10sec 
sprints Hazell et al., 2010; 1:8, 15 and 30sec sprints Yamagashi & Babraj., 
2017). With Hazell et al., (2010) finding a decrease in 5km TT (1:8: ~ 5.2%, 
1:12: ~ 3%, 1:24: ~ 3.5%) and increase in VO2 max (1:8: ~ 9.3%, 1:12: ~ 3.8%, 
1:24: ~ 9.2%), and Yamagashi & Babraj., (2017) finding an increase in VO2 
peak (15sec: ~ 12.1%, 30sec: ~ 12.8%), TTE (15sec: ~ 16.2%, 30sec: ~ 
12.8%), CP (15sec: ~ 7.8%, 30sec: ~ 7.4%) and decrease in 10km TT (15sec: ~ 
8.6%, 30sec: ~ 7.2%). 
 
4.1.3 Variables for adaptations 
Hazell et al., (2010) used 4-6 cycle sprints (7.5% body mass resistance), with 
either a 30sec (4 min rest) or 10sec (4 min and 2min rest) sprint duration. 
Manipulating the work:rest ratio (1:12, 1:24) to maintain peak power output 
(PPO (1:12 = 95%. 1:24 = 96%)), MPO (1:12 = 82%. 1:24 = 84%) and minimum 
power output (1:12 = 69%. 1:24 = 73%) could explain the similar pre vs. post 
testing results in VO2 max (1:8 = 9.3%. 1:12 = 3.8%. 1:24 = 9.2%) and 5km TT 
run (1:8 = 5.2%. 1:12 = 3%. 1:24 = 3.5%) when using a work:rest ratio (1:8) that 
saw a diminished PPO (89%), MPO (58%) and minimum power output (40% 
(Hazell et al., 2010)). The 1:12 group no significant change in VO2 max (p = 
0.06) despite similar power output data to the 1:24 group. The 1:8 group also 
saw a greater significant change and percentage change in the 5km TT run test 
compared to the other training groups (1:8 p < 0.001, 1:12 and 1:24 p < 0.03). 
Suggesting that seeking to diminish power output during HIT and create a larger 
amount of work may have a slight advantage over maintaining power output 
during HIT. However, similar to Hazell et al., (2010) Yamagashi & Babraj., 
(2017) compared sprint duration, 15sec (2min rest) and 30sec (4min rest), using 
4 cycle sprints before progressing to 6 sprints (7.5% and 6.5% body mass 
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resistance for males and females respectively) over 18 HIT sessions. 
Yamagishi & Babraj., (2017) found that using a 15sec and 30sec sprint but with 
the same work:rest ratio (1:8) found similar training session average PPO 
percentage change from session 1 (15sec: 1 vs. 6 = 7%, 1 vs. 12 = 7.4%, 1 vs. 
18 = 7.9%. 30sec: 1 vs. 6 = 4.6%, 1 vs. 12 = 5.4%, 1 vs. 18 = 5.4%). In addition, 
the 30sec group had a significant larger average amount of total work (KJ) 
across all the measured sessions (15sec: < 40 KJ. 30sec: > 55 KJ), with 
session 12 total work been significantly greater in the 30sec group (~ 57.8 KJ) 
vs. 15sec group (~ 38.6 KJ). Both training groups experienced similar 
improvements in VO2 peak (15sec: ~ 12.1%, 30sec: ~ 12.8%), TTE (15sec: ~ 
16.2%, 30sec: ~ 12.8%), 10km cycle TT (15sec: ~ 8.6%, 30sec: ~ 7.2%) and 
CP (15sec: ~ 7.8%, 30sec: ~ 7.4%). Lloyd Jones, Morris, Jakeman., (2017) 
compared 6sec sprints vs. 30sec sprints both using a work:rest ratio of 1:8 but 
matched for overall sprint time of 2min (20 x 6sec sprints 48sec recovery, 4 x 
30sec sprints 4min recovery, both against 7.5% body mass) for 6 sessions. 
Both groups produced similar amounts of average PPO across the 6 sessions, 
with both groups significantly improving PPO in session 6 vs. 1 (6sec = 9%, 
30sec = 20%). Across the 6 HIT sessions the 6 sec group produced more total 
work (~ > 110KJ) compared to the 30sec group (~ < 90KJ), with session 6 total 
work been significantly greater. In addition to this both groups improved their 
10km TT cycle time by a similar amount (6sec = 5.1%, 30sec = 6.2%). 
Indicating that the reproducibility of power output and not overall total work 
completed is an important factor for improving endurance using HIT (Lloyd 
Jones, Morris, Jakeman., 2017). This may explain why Hazell et al., (2010) saw 
an increase in endurance in all three groups despite the 20sec difference in 
sprint duration between 1:8 vs. 1:12 and 1:24 work:rest ratio. As the greater 
work:rest ratio allows a greater maintenance of power output during HIT (Hazell 
et al., 2010), due a greater recovery of PCr from a longer rest duration 
(Bogdanis et al., 1985; Bogdanis et al., 1998; Parolin et al., 1999). The intensity 
of the rest (passive vs. set recovery intensity) during HIT may also play a role 
on the recovery of PCr (Yamagishi & Babraj., 2016). Yamagishi & Babraj., 
(2016) found a greater decline in PPO in sprint 2 of 4 x 30sec sprints (4min 
recovery) when recovering at 30% (~12.7%) and 40% (~12.7%) vs. passive 
(~7.4%) and 20% (~5.8%) of VO2 peak. Therefore, greater work:rest ratios and 
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lower intensity of recovery leads to a greater maintenance of power during HIT, 
perhaps due to a greater recovery in PCr (Bogdanis et al., 1985; Bogdanis et 
al., 1998; Parolin et al., 1999; Yamagishi & Babraj., 2016). 
 
An explanation for these similar improvements in endurance performance in 
Yamagishi & Babraj., (2017) could be that the majority of PCr and glycogen 
uptake occurs within the first 15sec of a 30sec sprint (Bogdanis et al., 1985; 
Bogdanis et al., 1998; Parolin et al., 1999). Despite the greatest aerobic 
contribution been present in the final 15sec of a 30sec sprint (Parolin et al., 
1999). Further potentially indicating that the aerobic contribution during the 
sprint may not an important factor for improving endurance after HIT. It is 
thought that the aerobic demand during the rest periods between sprints may 
be crucial for improving endurance post HIT (Kavaliauskas, Aspe, Babraj., 
2016). Kavaliauskas, Aspe, Babraj., (2016) speculate that creating a shorter 
work:rest ratio and therefore creating a greater aerobic demand during rest 
periods could be a factor for causing an increase in endurance adaptations. 
Suggesting that the duration of the sprint and rest duration is not as great a 
factor as the work:rest ratio, with a work:rest ratio of 1:8 been consistent in 
improving endurance adaptations post HIT (Burgomaster et al., 2005, 2006, 
2008; Hazell et al., 2010; Kavaliasuskas, Steer, Babraj., 2016; Lloyd Jones, 
Morris, Jakeman., 2017; Yamagashi & Babraj., 2017). 
 
Manipulating the rest duration between sprints might be another factor to allow 
the maintenance of MPO (Phillips Thompson, Oliver., 2014; Study 1; Study 2). 
Phillips., Thompson, Oliver., (2014) speculates that improvements in endurance 
performance may not be achieved when using self-regulated (SR) rest between 
10 x 6 sec cycle sprints (7.5% body mass resistance) due to an over-estimation 
in rest by 10% which may not stimulate the required aerobic response. 
However, Study 2 demonstrates a greater percentage change in TTE and 10km 
TT testing for the SR group vs. fixed rest (30 sec, 1:5 work:rest ratio) group. In 
addition, although the SR group improved in these endurance tests, there was 
no increase in VO2 peak, whereas the 30 sec group saw a positive (~ 5%) 
percentage increase in VO2 peak. This would suggest that the short work to rest 
ratios in the 30sec group meant that they experienced a larger aerobic demand 
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than the SR group (Gosselin et al., 2012). The improvement in TTE (~ 3%) and 
TT (~ 3%) for the SR group could be due to an improvement in anaerobic 
capacity (Bulbulian et al., 1986; Noakes., 1988). The greater percentage 
change for the SR group vs. the 30 sec group in PPO (~ 1% vs. ~ -4%) and 
MPO (~ 0.4% vs. ~ -2%) testing could suggest this is possible. In contrast to the 
findings of Study 2, Kavaliauskas, Aspe, Babraj., (2016) found that manipulating 
the rest period between sprints would lead to specific adaptations. Such as 
shorter rest periods would only lead to improvements in endurance performance 
and longer rest periods would only lead to improvements in power output. 
Therefore, it is still uncertain if increasing rest duration between sprints to 
maintain MPO will lead to any performance adaptation. 
 
4.1.4 Sex fatiguing differences 
There is consistent research that indicates that females are more fatigue 
resistant when compared against males (Billaut & Bishop., 2012; Laurent et al., 
2010; and Smith & Billaut., 2012). This is reflected by females recruiting a larger 
amount of type I muscle fibres during HIT whereas males have a larger 
recruitment in type II muscle fibres (Glenmark et al., 1992; Hicks et al., 2001). 
This difference in fibre use is strongly correlated to females oxidising more fat 
during exercise than males (Knechtle et al., 2004). With males demonstrating a 
higher glycolytic enzyme activity and lower oxidative capacity (Roepstorff et al., 
2006; Russ et al 2005) which is in keeping with a greater force development 
(Russ et al 2005). However, with this greater force development comes a 
greater disturbance in Ca2+ kinetics possibly from an increase in Pi (Glaister., 
2005; Gaitanos et al., 1993; Ørtenblad et al., 2011; Westerblad, Allen, 
Lannergren., 2002). In relation to repeat sprint cycle activity (20 x 5sec sprints 
25sec rest against 0.9 N kg-1 of body mass), Billaut & Bishop., (2012) found that 
males had a significant greater power output than females but also saw a 
greater decrement in power output compared to female participants. They also 
identify no significant difference between sexes in power output in the final 4 
sprints, and identify that females were able to maintain closer to the maximal 
power output. Indicating that during HIT males experience a greater drop in 
their performance compared to females. Suggesting that males experience an 
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impairment in muscular contraction due to diminished Ca2+ kinetics (Ørtenblad 
et al., 2011; Westerblad, Allen, Lannergren., 2002). 
 
4.1.5 Possible sex differences in performance adaptation 
Due to the female ability to recruit more type I muscle fibres, oxidise more fat 
and reduce an accumulation in Pi, it would suggest that females would require a 
shorter self-regulated (SR) rest period. However, Study 1 found no significant 
difference in SR rest duration between sexes, with males having a shorter mean 
SR rest period than females. Study 1 also identified that both male and female 
participants over-estimate their recovery duration by 10% but not 15%. 
Normalised resting VO2 data from Study 1 shows that male rest 1 and rest 9 
data is significantly greater than female data. Curve data from study 1 is similar 
in rest 1 and 9 in females across all trials. The curve of VO2 in rest 9 in males is 
higher than rest 1 when SR rest is reduced by 15%. Indicates that females do 
not experience the same aerobic demand compared to males during SR HIT. It 
has also been speculated that creating a greater aerobic demand during HIT 
will lead to an increase in endurance measures (Gaitanos et al 1993; 
Kavaliauskas, Aspe, Babraj., 2016; Sloth et al., 2013). Therefore, it is unsure if 
SR HIT, even with a reduction of ≥ 15% will stimulate a response increase in 
VO2 peak for females. Given that Study 2 found no percentage change in VO2 
peak following 6 sessions of SR HIT when using male participants, females may 
require a larger reduction in SR rest to stimulate a larger aerobic response 
(Gaitanos et al., 1993). 
 
4.1.6 Self-regulated rest 
It has been shown that young adult participants (18-35 years) can SR their 
recovery time effectively to maintain sprint speed performance (12 x 30m 
(Glaister et al., 2010)) and MPO (10 x 6 seconds, 7.5% body mass resistance 
(Phillips Thompson, Oliver., 2014; Study 1; Study 2)) to maintain maximal 
performance (coefficient of variation (CV) ≤ 5.2%)). Both Glaister et al., (2010) 
and Phillips Thompson, Oliver., (2014) have shown that young adults can self-
regulate recovery between sprints. However, in studies 1 and 2 we found that 
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not all participants managed to do so with a combined failing of 18% in both 
studies. Glaister et al., (2010) have suggested that participants with a lower 
level of aerobic capacity would choose longer rest periods, suggesting the 
longer the rest period would indicate an increase in fatigue, and this could be 
used as a surrogate indicator for fatigue. However, Phillips Thompson, Oliver., 
(2014) suggests that participants could be using pacing strategies during SR 
rest to prevent any homeostatic disturbances that could lead to early exercise 
termination (Tucker et al., 2006). It is believed that participants pace their efforts 
to prioritise energy expenditure (Edwards & Polman., 2012). Pre planning will 
identify what the task is, the importance of the task, the person’s capabilities 
and willingness to do the task (Edwards & Polman 2013). 
 
During self-paced cycling exercise, there is evidence to suggest that the 
exercise is regulated through sensory feedback to the central nervous system 
(CNS) through central fatigue (Davis., 1995; Froyd et al 2016; Meeusen et al., 
2006; Swart et al 2012; Kay et al 2001; Noakes et al 2001; St Clair Gibson et al 
2001; Swart et al 2009; Tucker et al 2006). Central fatigue is defined as a 
reduction in maximal capacity of the CNS to optimally recruit motor units to 
produce force (Gandevia., 2001). This is to ensure that within peripheral fatigue 
the participant’s peripheral critical threshold is never exceeded (Amann., 2011; 
Amann., 2012). The peripheral critical threshold is defined as the reduction in 
the muscle capacity to beyond the neuromuscular junction to produce maximal 
force (Froyd et al 2016). It is also thought that peripheral fatigue is a regulator 
for self-paced cycling exercise by reducing the amount of muscle recruitment 
through afferent feedback (from peripheral organs: lungs, heart and skeletal 
muscle (Amann., 2011; Amann., 2012; Froyd et al 2016)). Afferent feedback 
comes from sensory nerves located within muscle spindles and Golgi tendon 
organs (Marcora., 2008; Proske., 2005). These sensory nerves sense tension, 
position and movement, and then send signals through the CNS to give the 
sense of effort (Proske., 2005). Both central and peripheral fatigue are believed 
to contribute to neuromuscular fatigue (Froyd et al 2016). It has been 
demonstrated that when intensity during exercise bouts increase there is also 
an increase in neuromuscular and peripheral fatigue (Amann & Dempsey., 
2008). However, these studies have used self-paced time trial cycling and not 
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looked at central or peripheral fatigue during rest periods. What can be 
highlighted from these studies is that peripheral fatigue occurs 20% into the 
time trial and steadily increases as the time trial continues (Froyd, Millet, 
Noakes., 2013). Whereas central fatigue is thought to occur when after 
peripheral fatigue had already developed (Decorte et al., 2012) and only further 
develops depending on the exercise duration (Place et al., 2010). Giving the 
lack of research in central and peripheral fatigue during HIT specifically in 
recovery periods, it would suggest from the above that peripheral fatigue plays 
a larger role during SR rest. Therefore, SR rest could be regulated by afferent 
feedback. 
 
Phillips Thompson, Oliver., (2014) and study 1 identified that male and female 
participants over-estimated their SR rest period by at least 10%. There is a 
potential that pacing tactics may have occurred in both sexes when SR rest is 
reduced by 15%, due to the significant drop in MPO when compared to the 
criterion sprint (~ -5.1%) and trial 3 (~ -4.1% (Study 1)). This could potentially 
explain how the participants were able to keep their CV% to ≤ 5.2%. There is a 
possibility that females are using pacing tactics in Study 1 as the criterion MPO 
data is significantly greater than trials 1-6 (T1: ~ -6.5%. T2: ~ -8.6%. T3: ~ -
8.4%. T4: ~ -6.5%. T5: ~ -4.3%. T6: ~ -7.5%). Pacing tactics may have occurred 
to prevent homeostatic disturbance that would have led to early exercise failure 
(Tucker et al., 2006). As an observation from studies 1 and 2, participants with 
an above within group average VO2 peak (Study 1: males = 43 ± 5, females = 
33 ± 6 ml.kg-1.min-1. Study 2: 48 ± 7 ml.kg-1.min-1) and longer TTE (Study 1: 
males = 718 ± 80, females 511 ± 45secs. Study 2: 544 ± 75secs) times and did 
not consistently have a shorter rest period than participants who had a below 
group average VO2 peak (Study 1 sex combined: high VO2 peak = 95 ± 32 
secs, low VO2 peak = 106 ± 31 secs. Study 2: high VO2 peak = 103 ± 44 secs, 
low VO2 peak = 106 ± 43 secs) and TTE (Study 1 sex combined: high TTE = 93 
± 32, low TTE = 108 ± 30secs. Study 2: high TTE = 111 ± 38, low TTE = 98 ± 
47secs). This suggests that SR rest duration is a personal choice and argues 
against Glaister et al., (2010) hypothesis that participants with a greater 
endurance capacity will select shorter rest periods. Using SR rest could have 
the potential to create specific rest times for each individual during HIT. 
 120 
4.1.7 Aims and hypothesis 
Given that male and female participants over-estimate their required SR rest by 
10% (Phillips Thompson, Oliver., 2014; Study 1), this study aimed to determine 
the impact of removing over recovery on endurance adaptations to 4 weeks of 
HIT. The second aim was to identify if any post HIT endurance adaptation 
should be present when reducing each participant’s most reliable SR rest time 
by 15% or 20% between 10 x 6 sec cycle sprints. It was hypothesised that both 
groups and sexes would see positive performance adaptations in TTE, TT and 
CP testing by either maintaining close to maximal performance or by 
experiencing a larger aerobic demand due to the reduction in SR rest. It was 
also hypothesised that females would not experience a greater increase in VO2 
peak compared to males due to their significantly less aerobic activity compared 
to males when SR rest is reduced by 15% (Study 1). 
 
4.2 Methods 
4.2.1 Participants 
Physically active young adult males (n = 24, 180 ± 7 cm, 82 ± 14 kg, and 48 ± 8 
VO2peak ml.kg-1.min-1) and females (n = 24, 166 ± 7 cm, 64 ± 10 kg, and 39 ± 8 
VO2peak ml.kg-1.min-1) volunteered for this study. Participants took part in more 
than the American College of Sports Medicine and American Heart Association 
recommended 2.5 hours of moderate physical activity (Haskell., 2007). 
Participants completed 6 ± 3 h (males = 8 ± 3h, females = 5 ± 3h) of structured 
physical activity (competitive and recreational), and aged between 18-35. 
Before taking part participants were given written and verbal instructions about 
the study prior to giving informed consent. Participants also completed a 
physical activity readiness questionnaire to ensure there was no known health 
issues that would put the participants in harm by taking part in this study. Ethical 
approval was received from Abertay University ethics committee and the study 
was carried out in line with the declaration of Helsinki.  
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4.2.2 Procedures 
4.2.2.1 Sprint warm-up 
Participants reported to the laboratory, their body mass (kg) and height (cm) 
were recoreded using a digital scale (Tanita SA 165A-0950U-3) and digital 
stadiometer (Seca 264) respectively. In all trials subjects were required to 
complete a warm up that consisted of 4 min cycling at 60 rpm against 1kg as 
resistance on a cycle ergometer (Monark peak bike). Once completed a sprint 
specific warm up was carried out; consisting of 3 x 3 second sprints against 
7.5% body mass with an active 45s recovery, cycling at 50-60 rpm (with no 
resistance), between sprints. Subjects then rested for 4 minutes prior to 
completing the sprint trials (Phillips Thompson, Oliver., 2014). 
 
4.2.2.2 Trial 1 
Participants undertook a MPO test (the criterion sprint) consisting of a single 6 
sec cycle sprint against a resistance equal to 7.5% body mass to familiarise 
them with the procedure and to provide criterion sprint data for comparison with 
repeated sprint performance (see section 2.2.3.3 for further details on the 
criterion sprint). Participants then cycled against 1kg for 60 sec at 60rpm before 
sitting quietly for 5 minutes. After this, the 6 sec sprint was then repeated to 
identify whether a representative maximal effort was achieved in the first test. If 
participants achieve a lower MPO in test 2, the result of test 1 will be taken as 
the participants MPO (Phillips Thompson, Oliver., 2014). If participants 
achieved a MPO in test 2 that is ≥ 5% greater than test 1, a third test was 
undertaken (Phillips Thompson, Oliver., 2014). This will be repeated as 
necessary until MPO no longer increases (Phillips Thompson, Oliver., 2014).  In 
this situation, the best performance by the participant was taken as their MPO. 
 
During each trial participants wore a heart rate monitor (Bioharness 2, Zephyr 
Technology, MD, USA) and gas mask connected to a gas analyser (Metalyzer 
3B gas analyser, Cortex, Leipzig, Germany) throughout the protocol (see 
section 2.2.5.2 for further details on cardiorespiratory measures). Once 
participants had completed their criterion sprint (CS) test and rested for 8 
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minutes, they completed the warm up procedure and prepared for their 
familiarization trial (trial 1). Prior to beginning exercise, participants were 
reminded that the aim of the trial is to complete 10 x 6 sec maximal effort sprints 
(see section 2.2.3.2 for sprint duration rational), with a self-regulated recovery 
between each sprint that enables the participant to replicate in all ten sprints the 
performance that they achieved in their CS (see section 2.2.3.4 for self-
regulated instructions). Participants then completed 10 x 6 sec cycle sprints 
against a resistance equal to 7.5% of pre-exercise body mass (see section 
2.2.3.1 for body mass resistance rational); participants were blind to any timing 
apparatus. 
 
4.2.2.3 Trials 2-4 
In trials 2-4, the protocol was identical to that completed in trial 1, without the 
use of CS test. Previous research has indicated that two familiarisation trials are 
required for reliable self-regulation of repeated sprint exercise to be achieved 
(Glaister et al 2010). The CS test allows participants to familiarise with the bike 
and identify how to produce their maximal effort over ≥ 2 sprints. Successful 
self-regulation was measured by taking the MPO scores across all ten sprints 
and using a within-trial CV measurement. If CV is ≥ 5.2% it was deemed that 
participants were unable to self-regulate (Glaister et al 2010; Phillips 
Thompson, Oliver., 2014; see section 2.2.3.3 for further details on CV 
measures). 
 
4.2.2.4 Pre testing measures 
Testing was performed over 3 days with 48 hours between each test. 
Consisting of a VO2 peak/ time to exhaustion (TTE), leg and lower back 
dynamometry, critical power (CP), and 10km time trial (TT) test. 
 
4.2.2.5 Day 1, VO2 peak and time to exhaustion test 
VO2 peak and TTE test – Participants were fitted with a mask connected to an 
online expired gas analyser (Cortex Metamax3B). Participants then mounted 
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the cycle ergometer (Monark peak bike) and cycled for 4 minutes at 60 W. 
Immediately following this warm up, power output increased by 30 W·min–1 until 
volitional exhaustion (Jakeman Adamson, Babraj., 2012). Participants were 
instructed to maintain a cadence of 60 RPM and were verbally encouraged 
throughout.  The test was terminated if a participant dropped below a cadence 
of 60 RPM for more than 5 sec or if the participant chose to stop. VO2 peak was 
determined as the highest 30 sec average of VO2 across the test (see section 
3.2.2.2 for rational on VO2 peak). The duration of the VO2 peak test was 
recorded (sec) and was defined as a participant’s time to exhaustion (Jakeman, 
Adamson, Babraj., 2012; Stevens & Dascombe., 2015; see section 3.2.2.2 for 
TTE testing rational). 
 
4.2.2.6 Day 2, Critical power test 
CP test – Participants underwent a warm up consisting of 1 minute cycling at 60 
RPM against 1kg. Participants were reminded of what the test involves and had 
the opportunity to ask any questions. Participants completed a maximal effort 
for 3 min on a cycle ergometer (Monark peak bike 894) against a fixed 
resistance of 4.5% of their body mass. Participants were strongly verbally 
encouraged throughout the test and were blind to any timing apparatus, 
distance covered, and speed/ RPM in an attempt to prevent pacing. The power 
output from the last 30 sec of the test was determined as a participant’s CP and 
was measured from the cycle ergometer software (Monark Anaerobic Test 
Software version 2.24.2, Monark Exercise AB).  
 
CP is a reflection of maximal aerobic capabilities, which estimates the 
relationship between power output and TTE, and is presented as the highest 
power output value (Watts) over an extended period of time (Bergstrom et al., 
2012). In study 3 a CP test was used to determine maximum aerobic power 
output (Bergstrom et al., 2012; Jones et al., 2010). The CP test involves a 
maximum all out effort that is typically 3 min long (Bergstrom et al., 2012; 
Burnley, Doust, Vanhatalo., 2006; Francis et al., 2010; Vanhatalo, Doust, 
Burnley., 2008) against a resistance of 4.5% of the participant’s body mass 
(Bergstrom et al., 2012). The purpose of this 3 min duration is to allow depletion 
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of PCr, inhibited glycolysis, increase an accumulation of fatiguing metabolites 
(such as Pi), and lead to oxidative phosphorylation for ATP turnover (Jones et 
al., 2010). To calculate CP, a mean average of the power output from the last 
30 sec of the 3 min sprint is used (Bergstrom et al., 2012; Jones et al., 2010). 
This method for measuring CP has been strongly correlated (r = 0.91-0.97) with 
the power output from the end of a TTE test, but achieved over a shorter 
distance of time (Jones et al., 2010). Therefore, the CP is indicated to be a 
reliable measure for determining maximum aerobic power output (Jones et al., 
2010).  
 
4.2.2.7 Day 3, Time trial test 
TT test – Participants were fitted with a heart rate monitor and mask connected 
to an online expired gas analyser. Participants then mounted the cycle 
ergometer to begin a warm up consisted of 4 min cycling at 60 rpm against 1kg 
as resistance on a cycle ergometer. Participants were then instructed to 
complete a self-paced 10km cycle time trial as quickly as possible with a fixed 
resistance (males – 2kg, females – 1.5kg; see section x for greater description 
of TT test). Only distance covered was reported to the participants (see section 
3.2.2.4 for TT testing rational).  
 
VO2, VCO2 and HR was recorded at each km (Baden et al., 2005; St Clair 
Gibson, Schabort, Noakes., 2001) using 2 sec averages, due to the uncertainty 
of when a participant would complete a km, and measures were averaged 6 sec 
around the time of the completed km (St Clair Gibson, Schabort, Noakes., 
2001). These measures were then compared between groups and sexes. Due 
to the sex differences in VO2 peak, percentage of VO2 peak at each km was 
also calculated (equation 4.1). 
 
% of VO2 peak = (VO2 km / VO2 peak) * 100 
Equation 4.1: Percentage of VO2 peak at each km. Where VO2 km is the VO2 
value at a specific km. 
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Percentage of predicted HR max was also calculated for each km between 
groups and sexes (equation 4.2). 
 
PHR-M = (208 – 0.7) * age (years) 
% of PHR-M = (HR km / PHR-M) * 100 
Equation 4.2: Shows formula for predicted HR max and percentage of predicted 
HR max at each km. Where PHR-M is predicted heart rate max, and HR km is 
the heart rate value at a specific km. 
 
This equation for predicting HR max is strongly correlated with actual HR max (r 
= 0.9) and is not effected by sex or physical activity status (Tanaka, Monahan, 
Seals., 2001). Percentage change of VO2, VOC2 and HR at each km for pre and 
post time trial testing (change / pre testing value) *100)). 
 
4.2.2.8 Intervention training and training groups 
Participants were stratified into two training groups (15% and 20% reduced rest) 
based on VO2 peak to ensure similar aerobic capacity between groups, and a 
control group. Both training groups performed 10 x 6 sec sprints with an altered 
self-regulated rest period. A mean average rest time was calculated from each 
participant’s most reliable trial (the trial with the lowest CV) from trials 1-4. The 
two training groups consisted of reducing participant’s mean self-regulated rest 
time between sprints by 15% (Males: n = 8, 181 ± 8 cm, 81 ± 14 kg, and 50 ± 11 
VO2 peak ml.kg-1.min-1, 98 ± 42 sec rest. Females: n = 8, 171 ± 7 cm, 63 ± 7 kg, 
and 41 ± 11 VO2 peak ml.kg-1.min-1, 73 ± 18 sec rest) and 20% (Males: n = 8, 
180 ± 5 cm, 83 ± 11 kg, and 48 ± 7 VO2 peak ml.kg-1.min-1, 72 ± 34 sec rest. 
Females: n = 8, 164 ± 7 cm, 62 ± 6 kg, and 41 ± 7 VO2peak ml.kg-1.min-1, 77 ± 29 
sec rest). Participants who were unsuccessful in maintaining MPO in at least 2 
of the 4 trials within trials 1-4 joined the control group and adhered to their 
normal training schedule (Males: n = 8, 178 ± 8 cm, 83 ± 17 kg, and 47 ± 5 VO2 
peak ml.kg-1.min-1. Females: n = 8, 165 ± 6 cm, 69 ± 14 kg, and 34 ± 4 VO2 
peak ml.kg-1.min-1). Other participants joined the control group when the two 
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training groups reached 16 participants (8 males and females) within each 
group. 
 
4.2.2.9 Session 1 
The same process that occurred in trial 1 was repeated for session 1. 
Participants performed another MPO test (criterion sprint number 2). After the 8-
minute rest the participants performed the sprint trials warm up before 
beginning their intervention of 10 x 6 sec cycle sprints with either a reduction in 
self-regulated mean rest by 15% or 20%. Participants wore a heart rate monitor 
(bioharness) and gas mask. 
 
4.2.2.10 Session 2-8 
Similar to session 1, participants completed the sprint trials warm up procedure 
and then completed 10 x 6 sec cycle sprints with their own specific rest time, 
(reduced by15% or 20% depending on group) based off their most reliable 
mean average self-regulated rest time. In sessions 2-7 participants did not wear 
a heart rate monitor or wear a gas mask. Participants were only required to 
wear a heart rate monitor and also wear a gas mask that is connected to a gas 
analyser in session 8. The purpose of this was to create a comparison between 
each participant’s most reliable trial (from trials 1-4), session 1 and 8, thus 
identifying any potential training adaptations. 
 
4.2.2.11 Post testing measures 
Once all 8 sessions were complete, participants recompleted the same three-
day testing process used in the pre testing measures with at least 48h after 
session 8. Once completed participants were thanked for the contribution and 
given an explanation of the study based on their results. 
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4.2.3 Fatigue index calculations 
MPO was recorded for each sprint throughout the trials and Fatigue index (FI; 
see section 2.2.3.2 for FI rational) for each trial was calculated using the 
formula (Fitzsommons et al., 1993):  
FI = (100 x [total sprint performance / ideal sprint performance]) – 100. 
Where total sprint performance = sum of MPO from all sprints, and ideal sprint 
performance = number of sprints x greatest MPO. 
 
4.2.4 Statistical analysis 
Statistical analysis for the study was analysed on IBM SPSS Version 22.0 
software. Two-way (sex * trial) repeated measures (mixed linear model) 
analysis of variance (ANOVA) compared the following: mean SR recovery time, 
MPO, and FI; the CS, subjects’ reliable trial (based on within-trial CV for MPO) 
based on the first four trials and best trial (table 4.1). Two x two way 
(sex*group*time) ANOVA compared magnitude of change for VO2peak, TTE, 
10km TT and CP. A further two-way repeated mixed linear (group*sex*time) 
ANOVA compared mean normalised heart rate, VO2 and VCO2 in best trial, 
training sessions 1 and 8 for rests 1 vs. 9 and sprints 1 vs. 10. Bonferroni post 
hoc analysis explored significant main effects. Significant main effects between 
sexes and groups were further explored by using an independent samples T 
test. In the case of a significant interaction, the data was split by group and or 
sex, the ANOVA test was performed again and significant main effects were 
explored as previously described. If sphericity was violated then Greenhouse-
Geisser corrections were used. Magnitude of change between pre and post 
testing was calculated as post value – pre value / pre value *100. Statistical 
significance was set up as p ≤ 0.05, and data are mean with ± standard 
deviation (SD). Standard error of measurement was employed instead of 
standard deviation in magnitude of change measurements, due to the larger 
variability. Using standard error of measurement allowed a true reflection of the 
magnitude in change error by considering group size. Cohen’s D was used to 
measure effect size between the two training groups. Effect size was defined as 
trivial (0.0-0.2), small (0.2-0.5), moderate (0.6-1.1), and large (1.2-1.9 (Cohen., 
1992)). A Pearson’s correlation was used to identify an association between 
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trial/ session data, magnitude in change testing data, and trial/ session 
cardiorespiratory response data. 
 
4.3 Results 
4.3.1 Trials 1-4 data 
4.3.1.1 Self-regulated recovery time 
Table 5.1 shows sex comparison (male n = 24, female n = 24) for SR recovery 
duration, MPO, FI% and CV% within trials 1-4 and best SR trial from each 
participant. No significant main effect of SR rest was present between trials 
(F3.18, 1 = 0.562, p > 0.05), between sexes (F1, 45 = 2.781, p > 0.05) or interaction 
was present (F3.18, 1 = 0.187, p > 0.05). 
 
4.3.1.2 Self-regulated rest 1 vs. rest 9 
A significant main effect was present between trials and rest number (F 9, 413.132 
= 4.785, p < 0.05), post hoc indicates that trial 3 rest 9 is > than trial 1-3/best 
SR rest 1 (p < 0.05), best SR trial rest 9 is > than trial 2-3/best SR rest 1 (p < 
0.05). No significant main effect of sex (F 1, 48.112 = 2.476, p < 0.05) or significant 
interaction of trial and rest number*sex (F 9, 413.132 = 0.751, p < 0.05) was 
present. 
 
4.3.1.3 Mean power output 
A significant main effect was present for MPO between trials (F2.018, 1 = 4.674, p 
< 0.05), post hoc indicates that the CS is significantly greater than trials 1-4 (p < 
0.05). A significant main effect between sex was also present in MPO (F1, 45 = 
83.514, p < 0.05), post hoc indicates that male MPO data is significantly greater 
than female MPO data in the CS and in all trials. No significant interaction was 
present in MPO (F2.018, 1 = 0.712, p > 0.05). 
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4.3.1.4 Fatigue index 
A significant main effect between trials was present in FI% (F2.178, 1, = 6.662, p < 
0.05), post hoc in indicates that trial 1 FI% is significantly greater than trial 4 and 
best SR trial (p < 0.05). No significant main effect between sexes (F1, 45 = 0.096, 
p > 0.05) or interaction (F2.178, 1 = 1.566, p > 0.05) was present for FI%. 
 
4.3.1.5 Coefficient variation 
A significant main effect was present between trials in CV% (F2.466, 1 = 9.078, p 
< 0.05), post hoc indicates that trial 1 CV% is significantly greater than trial 3, 
trial 4 and best SR trial CV% (p < 0.05) also trial 2 CV% is significantly greater 
than best SR trial CV% (p < 0.05). A significant main effect was also present 
between sex (F1, 45 = 4.019, p < 0.05), post hoc cannot indicate where 
significance lies, however, trial 1 is closest to significance (p = 0.067), indicating 
that male CV% is lower than female CV% in trial 1. No significant interaction 
was present in CV% (F2.466, 1 = 1.148, p > 0.05). 
 130 
Table 4.1: Performance variables across the 4 trials of SR rest repeated sprint exercise for both sexes. 
 CS1 Trial 1 Trial 2 Trial 3 Trial 4 Best SR Trial 
SR rest time (secs)       
Male - 94 ± 43 101 ± 44 100 ± 43 102 ± 44 100 ± 40 
Female - 82 ± 40 86 ± 37 94 ± 40 92 ± 42 91 ± 30 
       
SR rest time (secs)  Rest 1 Rest 9 Rest 1 Rest 9 Rest 1 Rest 9 Rest 1 Rest 9 Rest 1 Rest 9 
Male - 83 ± 28 99 ± 45 81 ± 29 95 ± 50 76 ± 25 98 ± 55a 89 ± 42 95 ± 38 83 ± 33 98 ± 49b 
Female - 68 ± 18 79 ± 34 71 ± 27 86 ± 44 75 ± 24 94 ± 38a 71 ± 27 92 ± 29 69 ± 20 91 ± 32b 
       
MPO (W.kg-1)       
Male 11.14 ± 1.1*+ 10.67 ± 1.39* 10.79 ± 1.36* 10.73 ± 1.2* 10.83 ± 1.22* 10.93 ± 1.23* 
Female 9.21 ± 1+ 8.23 ± 1.27 8.33 ± 0.98 8.29 ± 1.08 8.42 ± 0.99 8.53 ± 1.03 
       
Fatigue index (%)       
Male - 15.2 ± 17.3** 7.7 ± 8.1 6.3 ± 4.8 5.6 ± 3.3 3.9 ± 1.8 
Female - 9.8 ± 7.1** 8.4 ± 5.3 6.9 ± 3.8 7.1 ± 4.8 6.6 ± 4.6 
       
CV %       
Male - 4.7 ± 2.6† 4.5 ± 2.8‡ 3.7 ± 2.1 3.8 ± 1.6 2.6 ± 1.2 
Female - 6.8 ± 4.9† 5.2 ± 2.6‡ 4.3 ± 1.9 4 ± 2.3 3.5 ± 2.3 
 
* Significantly greater than corresponding female data. + Significantly greater than trials 1-4 data. ** Significantly greater than trial 4 and best SR 
trial. † Significantly greater than trials 3, 4 and best SR trial. ‡ Significantly greater than best SR trial. a Significantly greater than trial 1-3/best SR 
trial rest 1. b Significantly greater than 2-3/best SR trial rest 1.
1
3
0
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4.3.2 Sessions 1-8 data 
4.3.2.1 Best self-regulated recovery and reduced rest duration 
Table 4.2 shows sex and group comparison (15% group: male n = 8, female n = 
8. 20% group: male n = 8, female n = 8) for rest duration, MPO, FI% and CV% 
within sessions 1-8 and best SR trial from each participant used within the two 
training groups. A significant main effect between best SR trial and sessions 
(time1) for rest duration was present (F1, 1 = 202.798, p < 0.05), post hoc 
indicates that the best SR trial rest duration is significantly greater than the 15% 
and 20% training groups rest duration (p < 0.05). No significant main effect 
between sexes (F1, 28 = 0.742, p > 0.05) or group (F1, 28 = 0.742, p > 0.05) was 
present for rest duration. No significant interaction was present for time1*sex 
(F1, 1 = 0.408, p > 0.05), time1*group (F1, 1 = 1.044, p > 0.05), sex*group (F1, 28 = 
1.784, p > 0.05) and time1*sex*group (F1, 1 = 1.472, p > 0.05) for rest duration. 
 
4.3.2.2 Mean power output 
No significant main effect between CS, best SR trial and sessions 1-8 (time2) for 
MPO was present (F1.845, 1 = 2.021, p > 0.05), and no significant main effect 
between groups was present (F1, 28 = 0.042, p > 0.05). However, a significant 
main effect of MPO between sexes was present (F1, 28 = 46.036, p < 0.05), post 
hoc indicates that male MPO is significantly greater than female MPO in CS, 
best SR trial and sessions 1-8 (p < 0.05). No significant interaction was present 
in time2*group (F1.845, 1 = 0.391, p > 0.05), time2*sex (F1.845, 1 = 0.147, p > 0.05), 
time2*group*sex (F1.845, 1 = 0.349, p > 0.05) and group*sex (F1, 28 = 0.368, p > 
0.05). 
 
4.3.2.3 Fatigue index 
A significant main effect of FI% between best SR trial and sessions 1-8 (time3) 
was present (F5.065, 1 = 2.475, p < 0.05), post hoc is unable to identify where 
significance lies. No significant main effect of FI% between groups (F1, 28 = 
1.301, p > 0.05) and sexes (F1, 28 = 0.004, p > 0.05) was not present. No 
significant interaction for group*sex (F1, 28 = 0.906, p > 0.05), time3*group (F5.065, 
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1 = 1.813, p > 0.05), time3*sex (F5.065, 1 = 1.099, p > 0.05) and time3*group*sex 
(F5.065, 1 = 0.539, p > 0.05) was present. 
 
4.3.2.4 Coefficient variation 
A significant main effect of CV% between time3 was present (F5.037, 1 = 4.857, p 
< 0.05), post hoc indicates that the best SR trial CV% is significantly less that 
sessions 1-2 and sessions 4-7 (p < 0.05). No significant main effect of group 
(F1, 28 = 0.892, p > 0.05) or sex (F1, 28 = 0.014, p > 0.05) was present in CV%. 
No significant interaction of group*sex (F1, 28 = 0.509, p > 0.05), time3*group 
(F5.037, 1 = 0.501, p > 0.05), time3*sex (F5.037, 1 = 0.558, p > 0.05) and 
time3*group*sex (F5.037, 1 = 1.201, p > 0.05). 
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Table 4.2: Performance variables across the 8 sessions of reduced SR rest and best SR trial repeated sprint exercise for both sexes and groups. 
 Best SR 
Trial 
CS2 Session 1 Session 2 Session 3 Session 4 Session 5 Session 6 Session 7 Session 8 
Rest 
(secs) 
15% 20% 15% 20% 15% 20% 15% 20% 15% 20% 15% 20% 15% 20% 15% 20% 15% 20% 15% 20% 
Male 113 ± 
49ɸ 
86 ± 
40ɸ 
- - 98 ± 
42 
72 ± 
33 
98 ± 
42 
72 ± 
33 
98 ± 
42 
72 ± 
33 
98 ± 
42 
72 ± 
33 
98 ± 
42 
72 ± 
33 
98 ± 
42 
72 ± 
33 
98 ± 
42 
72 ± 
33 
98 ± 
42 
72 ± 
33 
Female 84 ± 
21ɸ 
92 ± 
34ɸ 
- - 73 ± 
18 
77 ± 
29 
73 ± 
18 
77 ± 
29 
73 ± 
18 
77 ± 
29 
73 ± 
18 
77 ± 
29 
73 ± 
18 
77 ± 
29 
73 ± 
18 
77 ± 
29 
73 ± 
18 
77 ± 
29 
73 ± 
18 
77 ± 
29 
           
MPO 
(W.kg-
1) 
          
Male 11.4 ± 
1.46* 
10.73 
± 
0.96* 
11.33 
± 
1.15* 
11.49 
± 
1.19* 
10.96 
± 1.5* 
10.6 ± 
0.9* 
10.87 
± 
1.43* 
10.74 
± 
1.09* 
10.93 
± 
1.49* 
10.64 
± 
0.73* 
11.11 
± 
1.51* 
10.69 
± 
1.21* 
11.19 
± 
1.43* 
10.78 
± 1* 
10.78 
± 
1.83* 
10.86 
± 0.9* 
11.33 
± 
1.69* 
10.94 
± 
0.81* 
11.26 
± 
1.69* 
10.96 
± 
0.86* 
Female 8.8 ± 
0.94 
8.75 ± 
1.29 
9.18 ± 
1.15 
9.1 ± 
1.04 
8.4 ± 
0.79 
8.39 ± 
1.19 
8.63 ± 
0.87 
8.51 ± 
1.48 
8.33 ± 
1.24 
8.7 ± 
1.22 
8.5 ± 
1 
8.79 ± 
1.33 
8.44 ± 
0.67 
8.87 ± 
1.19 
8.58 ± 
0.76 
9.07 ± 
1.08 
8.77 ± 
0.92 
8.77 ± 
1.48 
8.82 ± 
1.02 
8.85 ± 
1.37 
           
Fatigue 
Index 
(%) 
          
Male 3.1 ± 
0.9 
3.6 ± 
1.3 
- - 4.8 ± 
2.3 
6.4 ± 
4.7 
6.2 ± 
4.5 
7.5 ± 
3.8 
5.4 ± 
3.6 
7.3 ± 
3.7 
4.3 ± 
2.8 
8 ± 
4.6 
5.3 ± 
3.5 
8.6 ± 
5.2 
8.4 ± 
8 
7.4 ± 
4.1 
5.5 ± 
2.8 
9 ± 
4.3 
4.5 ± 
3.5 
7.8 ± 
4.7 
Female 4.7 ± 
3.2 
6.4 ± 
5.3 
- - 5.4 ± 
2.1 
6.1 ± 
3.9 
7 ± 
2.6 
6.2 ± 
3.7 
7.8 ± 
5.9 
7.8 ± 
5.4 
6 ± 
3.4 
6.4 ± 
2.5 
6.4 ± 
3.2 
6.2 ± 
3.5 
8.3 ± 
3.7 
4.9 ± 
3.3 
6.1 ± 
2.2 
6.2 ± 
4.3 
4.8 ± 
1.2 
7.8 ± 
6 
           
CV%           
Male 2.1 ± 
0.4† 
2.3 ± 
0.8† 
- - 3.7 ± 
1.8 
4.2 ± 
2.7 
3.9 ± 
1.5 
4.9 ± 
3 
3.5 ± 
2.3 
4.9 ± 
2.4 
3.7 ± 
2 
5 ± 
2.8 
3.8 ± 
2.7 
5.6 ± 
3 
3.4 ± 
2.2 
4.8 ± 
2.1 
4.5 ± 
2.2 
5.3 ± 
2 
3.7 ± 
3.2 
4.6 ± 
2 
Female 2.5 ± 
0.6† 
2.8 ± 
1.2† 
- - 3.7 ± 
1.2 
4.8 ± 
3 
5 ± 
2.4 
4.3 ± 
2.4 
5.1 ± 
5.2 
4.9 ± 
3 
3.8 ± 
1.8 
4.4 ± 
1.6 
4.8 ± 
2.4 
4.2 ± 
2.6 
5 ± 
2.4 
3.5 ± 
1.9 
4 ± 
1.4 
4.4 ± 
3.2 
3 ± 
0.9 
5 ± 
4.2 
 
ɸ Significantly greater than all sessions rest times in both groups and sexes. * Significantly greater than corresponding female data. † 
Significantly less than sessions 1-2 and sessions 4-7.  
 
1
3
3
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4.3.3 Percentage change measures 
4.3.3.1 Critical power 
Figure 4.1 shows percentage change measures for all groups (15% group: male 
n = 8, female n = 8. 20% group: male n = 8, female n = 8. Control group: male n 
= 8, female n = 8) in critical power, VO2 peak, TTE and 10km TT testing. No 
significant main effect of pre vs. post testing (test1) for critical power was 
present (F1, 1 = 2.309, p > 0.05) and no significant main effect was found 
between sexes (F1, 41 = 0.014, p > 0.05). However, a significant main effect 
between groups was present (F2, 41 = 3.786, p < 0.05), post hoc indicates that in 
post testing the 20% group critical power is significantly greater than the control 
group’s (p < 0.05). No significant interaction of group*sex (F2, 41 = 0.165, p > 
0.05), test1*sex (F1, 1 = 0.014, p > 0.05) and test1*group*sex (F2, 2 = 0.165, p > 
0.05) was present in critical power data. However, a significant interaction of 
test1*group was present (F2, 2 = 3.786, p < 0.05), post hoc indicates that the 
20% group post testing data is significantly greater than pre testing data (p < 
0.05), the 15% group is also approaching significance (p = 0.062).  
 
 
Figure 4.1: Percentage change ± SEM in CP testing for males and females in 
the 15% RR, 20% RR and control groups. * Significantly greater than control 
group data (p < 0.05). 
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Table 4.3: Effect sizes between groups for critical power 
Group M15% F15% M20% F20% MC FC 
M15% - d = -0.2 d = -1.4 d = -1.2 d = 2.1 d = 2.3 
F15% d = 0.2 - d = -0.7 d = -0.7 d = 1.5 d = 1.8 
M20% d = 1.4 d = 0.7 - d = -0.3 d = 2.7 d = 2.7 
F20% d = 1.2 d = 0.7 d = -2.7 - d = 2.2 d = 2.3 
MC d = -2.1 d = -1.5 d = -2.7 d = -2.2 - d = 0.7 
FC d = -2.3 d = -1.8 d = -2.7 d = -2.3 d = -0.7 - 
Table 4.3: M15%, male 15% reduced rest group; F15%, female 15% reduced 
rest group; M20%, male 20% reduced rest group; F20%, female 20% reduced 
rest group; MC, male control group; and FC, female control group. 
 
4.3.3.2 VO2 peak 
No significant main effect was present in test1 for VO2 peak (F1, 1 = 1.73, p > 
0.05) and between groups (F2, 42 = 2.743, p > 0.05). However, a significant main 
effect between sex for VO2 peak was present (F1, 42 = 9.739, p < 0.05); post hoc 
indicates that within all groups, male VO2 peak is significantly greater than 
females’ in post testing (p < 0.05). No significant interaction of group*sex (F2, 42 
= 0.181, p > 0.05), test1*group (F2, 2 = 2.743, p > 0.05) and test1*group*sex (F2, 2 
= 0.181, p > 0.05) was present in VO2 peak testing. However, a significant 
interaction in test1*sex was present (F1, 1 = 9.739, p < 0.05), post hoc indicates 
that males significantly improved VO2 peak greater compared to females in pre 
to post testing (p < 0.05).  
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Figure 4.2: Percentage change ± SEM in VO2 peak testing for males and 
females in the 15% RR, 20% RR and control groups. * Significantly greater than 
corresponding female data (p < 0.05). 
Table 4.4: Effect sizes between groups for VO2 peak 
Group M15% F15% M20% F20% MC FC 
M15% - d = 2.9 d = 0.9 d = 2.7 d = 2.1 d = 4 
F15% d = -2.9 - d = -2.6 d = -0.1 d = -0.8 d = 2.2 
M20% d = -0.9 d = 2.6 - d = 2.4 d = 1.6 d = 4.1 
F20% d = -2.7 d = 0.1 d = -2.4 - d = -0.6 d = 2.2 
MC d = -2.1 d = 0.8 d = -1.6 d = 0.6 - d = 2.6 
FC d = -4 d = -2.2 d = -4.1 d = -2.2 d = -2.6 - 
 
4.3.3.3 Time to exhaustion 
A significant main effect of test1 was present in TTE (F1, 1 = 4.063, p < 0.05), 
post hoc indicates that TTE increased significantly in post testing (p < 0.05). No 
significant main effect between groups (F2, 42 = 0.779, p > 0.05) or sexes (F1, 42 
= 0.442, p > 0.05) was present. No significant interaction was present in 
group*sex (F2, 42 = 0.886, p > 0.05), test1*group (F2, 2 = 0.779, p > 0.05), 
test1*sex (F1, 1 = 0.442, p > 0.05) and test1*group*sex (F2, 2 = 0.886, p > 0.05). 
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Figure 4.3: Percentage change ± SEM in TTE testing for males and females in 
the 15% RR, 20% RR and control groups. * Significant percentage change 
increase from pre to post testing (p < 0.05). 
Table 4.5: Effect sizes between groups for TTE 
Group M15% F15% M20% F20% MC FC 
M15% - d = -0.3 d = 0.8 d = 0.5 d = 0.1 d = 1.8 
F15% d = 0.3 - d = 1 d = 0.8 d = 0.3 d = 1.8 
M20% d = -0.8 d = -1 - d = -0.3 d = -0.5 d = 1.4 
F20% d = -0.5 d = -0.8 d = 0.3 - d = -0.3 d = 1.6 
MC d = -0.1 d = -0.3 d = 0.5 d = 0.3 - d = 1.5 
FC d = -1.8 d = -1.8 d = -1.4 d = -1.6 d = -1.5 - 
 
4.3.3.4 Time trial 
A significant main effect of test1 was present in 10km TT (F1, 1 = 24.697, p < 
0.05) post hoc indicates that 10km TT decreased significantly in post testing (p 
< 0.05). No significant main effect between groups (F2, 41 = 2.739, p > 0.05) or 
sexes (F1, 41 = 0, p > 0.05) was present. No significant interaction was present in 
group*sex (F2, 41 = 0.991, p > 0.05), test1*group (F2, 2 = 2.739, p > 0.05), 
test1*sex (F1, 1 = 0, p > 0.05) and test1*group*sex (F2, 2 = 0.991, p > 0.05). 
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Figure 4.4: Percentage change ± SEM in TT testing for males and females in 
the 15% RR, 20% RR and control groups. * Significant percentage change 
increase from pre to post testing (p < 0.05). 
Table 4.6: Effect sizes between groups for TT 
Group M15% F15% M20% F20% MC FC 
M15% - d = -0.5 d = -0.7 d = -1.8 d = 0.5 d = 2.9 
F15% d = 0.5 - d = 0.1 d = -0.3 d = 0.7 d = 1.5 
M20% d = 0.7 d = -0.3 - d = -0.7 d = 1 d = 2.8 
F20% d = 1.8 d = -0.3 d = 0.7 - d = 2 d = 3.9 
MC d = -0.5 d = -0.7 d = -1 d = -2 - d = 2 
FC d = -2.9 d = -1.5 d = -2.8 d = -3.9 d = -2 - 
 
4.3.3.5 Correlation 
Table 4.7 shows correlation values (r) comparing between the percentage 
change of in session MPO and the CS (MPO% of CS), in session CV% and FI% 
for the overall percentage changes of performance tests whilst combining males 
and females and both training groups’ data. No significant correlations occurred 
in MPO% of CS and: TTE (r = 0.24, p > 0.05), CP (r = -0.1, p > 0.05), VO2 peak 
(r = 0.21, p > 0.05), and TT (r = -0.23, p > 0.05). No significant correlations 
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occurred in CV% and: TTE (r = -0.03, p > 0.05), CP (r = 0.3, p > 0.05), VO2 
peak (r = 0.00, p > 0.05), and TT (r = -0.06, p > 0.05). No significant correlations 
occurred in FI% and: TTE (r = -0.02, p > 0.05), CP (r = 0.3, p > 0.05), VO2 peak 
(r = -0.03, p > 0.05), and TT (r = -0.08, p > 0.05). 
 
Table 4.7: Correlation values comparing between percentage change of in 
session MPO to the CS and in session CV, and FI. 
Measure CP VO2 peak TTE TT 
MPO% of CS r = -0.1 r = 0.21 r = 0.24 r = -0.23 
CV% r = 0.3 r = 0.00 r = -0.03 r = -0.06 
FI% r = 0.3 r = -0.03 r = -0.02 r = -0.08 
 
Table 4.8 shows correlation values for the overall percentage changes of 
performance tests whilst combining males and females and both training 
groups’ data. Significant correlations lie in: CP vs. TT (r = -0.47, p < 0.05), TT 
vs. TTE (r = -0.43, p < 0.05), and TTE vs. VO2 peak (r = 0.4, p < 0.05). Tests 
that did not correlate include: TTE vs. CP (r = 0.07, p > 0.05), VO2 peak vs. CP 
(r = 0.03, p > 0.05), and TT vs. VO2 peak (r = -0.24, p > 0.05). 
 
Table 4.8: Correlation values between percentage change of performance tests. 
Test CP VO2 peak TTE TT 
CP - r = 0.03 r = 0.07 r = -0.47* 
VO2 peak r = 0.03 - r = 0.4* r = -0.24 
TTE r = 0.07 r = 0.4* - r = -0.43** 
TT r = -0.47* r = -0.24 r = -0.43** - 
 
* Significant positive correlation (p < 0.05). ** Significant negative correlation (p 
< 0.05). 
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4.3.4 Time trial heart rate and gas measures 
4.3.4.1 Heart rate 
Figure 4.5 shows change of HR in pre and post 10km TT. A significant main 
effect of HR between km number was present (F19. 817.015 = 41.205, p < 0.05). 
Post hoc indicates that HR is significantly greater in pre 2km vs. pre 1km (p < 
0.05), pre 3/4km vs. pre 1km and post 1/2km (p < 0.05), pre 5km vs. pre 1/2km 
and post 1/2km (p < 0.05), pre 6/7km vs. pre 1/2km and post 1-3km (p < 0.05), 
pre 8km vs. pre 1-4km and post 1-3km (p < 0.05), pre 9km vs. pre 1-5km and 
post 1-4 (p < 0.05), pre 10km vs. pre 1-9km and post 1-7km (p < 0.05), post 
3km vs. pre and post 1km (p < 0.05), post 4/5km vs. pre and post 1/2km (p < 
0.05), post 6km vs. pre 1/2km and post 1-3km, post 7km vs. pre 1-4 and post 1-
3km (p < 0.05), post 8km vs. pre 1-5km and post 1-4km (p < 0.05), post 9km vs. 
pre 1-6km and post 1-6km (p < 0.05), post 10km vs. pre 1-9km and post 1-8km 
(p < 0.05). No significant main effect of group (F2, 44.868 = 0.319, p > 0.05) was 
present. However, a main effect of sex was present (F1, 44.868 = 4.231, p < 0.05). 
Post hoc indicates that female HR data is significantly greater than male HR 
data in pre 1-3km and post 1/4/7km (p < 0.05). No significant interaction of 
sex*group (F2, 44.868 = 1.671, p > 0.05), sex*km number (F19, 817.015 = 1.184, p > 
0.05) and sex*group*km number (F38, 817.013 = 0.976, p > 0.05) was present. 
However, a significant interaction of group*km number was present (F38, 817.013 = 
1.715, p < 0.05). Post hoc indicates that the 15% group HR is significantly 
greater in pre 3/4km vs. pre and post 1km (p < 0.05), pre 5/6km vs. pre 1km 
and post 1/2km (p < 0.05), pre 7km vs. pre 1km and post 1-3km (p < 0.05), pre 
8/9km vs. pre 1-2km and post 1-3km (p < 0.05), pre 10km vs. pre 1-4km and 
post 1-4km (p < 0.05), post 4-6km vs. pre 1/2km and post 1/2km (p < 0.05), 
post 7km vs. pre 1km and post 1-3km (p < 0.05), post 8/9km vs. pre 1/2km and 
post 1-3km (p < 0.05), post 10km vs. pre 1-6km and post 1-6km (p < 0.05); 20% 
group HR is significantly greater in pre 3/4km vs. pre 1km (p < 0.05), pre 5-7km 
vs. pre 1/2km and post 1km (p < 0.05), pre 8/9km vs. pre 1-4km and post 1/2km 
(p < 0.05), pre 10km vs. pre 1-7 and post 1-6km (p < 0.05), post 1km vs. pre 
1/2km (p < 0.05), post 3-5km vs. 1/2km and post 1km (p < 0.05), post 6km vs. 
pre 1/2/4km and post 1km (p < 0.05), post 7/8km vs. pre 1-4km and post 1-2km 
(p < 0.05), post 9km vs. pre 1-5km and post 1-3km (p < 0.05), post 10km vs. 
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pre 1-8km and post 1-7km (p < 0.05); control group HR is significantly higher in 
pre 3km vs. post 1km (p < 0.05), pre 4-7km vs. post 1/2km (p < 0.05), pre 8km 
vs. pre 1km and post 1/2km (p < 0.05), pre 9km vs. pre 1km and post 1-3km (p 
< 0.05), pre 10km vs. pre 1-2km and post 1-4km (p < 0.05), post 4km vs. post 
1km (p < 0.05), post 5/6km vs. post 1/2km (p < 0.05), post 7km vs. pre 1km and 
post 1/2km (p < 0.05), post 8 vs. pre 1km and post 1-3km (p < 0.05), post 9km 
vs. pre 1/2km and post 1-3km (p < 0.05), post 10km vs. pre 1-5km and post 1-
5km (p < 0.05).  
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Figure 4.5: Heart rate during 10km TT in pre vs. post testing at each km for 15% 
males (A), 15% females (B), 20% males (C), 20% females (D), control males 
(E) and control females (F). * Significantly greater in pre 2km vs. pre 1km, pre 
3/4km vs. pre 1km and post 1/2km, pre 5km vs. pre 1/2km and post 1/2km, pre 
6/7km vs. pre 1/2km and post 1-3km, pre 8km vs. pre 1-4km and post 1-3km, 
pre 9km vs. pre 1-5km and post 1-4, pre 10km vs. pre 1-9km and post 1-7km (p 
< 0.05). + Significantly greater in post 3km vs. pre and post 1km, post 4/5km vs. 
pre and post 1/2km, post 6km vs. pre 1/2km and post 1-3km, post 7km vs. pre 
1-4 and post 1-3km, post 8km vs. pre 1-5km and post 1-4km, post 9km vs. pre 
1-6km and post 1-6km, post 10km vs. pre 1-9km and post 1-8km. † Significantly 
greater than pre male data (p < 0.05). ‡ Significantly greater than post male 
data (p < 0.05). 1 Interaction, 15% RR group data is significantly greater in pre 
3/4km vs. pre and post 1km, pre 5/6km vs. pre 1km and post 1/2km, pre 7km 
vs. pre 1km and post 1-3km, pre 8/9km vs. pre 1-2km and post 1-3km, pre 
10km vs. pre 1-4km and post 1-4km (p < 0.05). 11 Interaction, 15% RR group 
data is significantly greater in post 4-6km vs. pre 1/2km and post 1/2km, post 
7km vs. pre 1km and post 1-3km, post 8/9km vs. pre 1/2km and post 1-3km, 
post 10km vs. pre 1-6km and post 1-6km (p < 0.05). 2 Interaction, 20% RR 
group data is significantly greater in pre 3/4km vs. pre 1km,pre 5-7km vs. pre 
1/2km and post 1km, pre 8/9km vs. pre 1-4km and post 1/2km, pre 10km vs. 
pre 1-7 and post 1-6km. 22 Interaction, 20% RR group data is significantly 
greater in post 1km vs. pre 1/2km, post 3-5km vs. 1/2km and post 1km, post 
6km vs. pre 1/2/4km and post 1km, post 7/8km vs. pre 1-4km and post 1-2km, 
post 9km vs. pre 1-5km and post 1-3km, post 10km vs. pre 1-8km and post 1-
7km. 3 Interaction, control group data is significantly greater in pre 3km vs. post 
1km, pre 4-7km vs. post 1/2km, pre 8km vs. pre 1km and post 1/2km, pre 9km 
vs. pre 1km and post 1-3km, pre 10km vs. pre 1-2km and post 1-4km(p < 0.05). 
33 Interaction, control group data is significantly greater in post 4km vs. post 
1km, post 5/6km vs. post 1/2km, post 7km vs. pre 1km and post 1/2km, post 8 
vs. pre 1km and post 1-3km, post 9km vs. pre 1/2km and post 1-3km, post 
10km vs. pre 1-5km and post 1-5km (p < 0.05). 
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Figure 4.6 shows percentage of HR max in pre and post 10km TT. A main effect 
of km number was present (F 19, 817.047 = 40.416, p < 0.05). Post hoc indicates 
that percentage of HR max is greater in pre 2km vs. pre and post 1 km (p < 
0.05), pre 3/4km vs. pre 1km and post 1/2km (p < 0.05), pre 5/6km vs. pre 
1/2km and post 1/2km (p < 0.05), pre 7km vs. pre 1/2km and post 1-3km (p < 
0.05), pre 8km vs. pre 1-4km and post 1-3km (p < 0.05), pre 9km vs. pre 1-5km 
and post 1-4km (p < 0.05), pre 10km vs. pre 1-8km and post 1-7km (p < 0.05), 
post 3km vs. pre and post 1km (p < 0.05), post 4/5km vs. pre and post 1-2km (p 
< 0.05), post 6km vs. pre 1/2km and post 1-3km (p < 0.05), post 7km vs. pre 1-
4km and post 1-3km (p < 0.05), post 8km vs. pre 1-5km and post 1-4km (p < 
0.05), post 9km vs. pre 1-6km and post 1-6km (p < 0.05), post 10km vs. pre 1-
9km and post 1-8km (p < 0.05). Also, a significant main effect of sex was 
present (F 1, 44.875 = 4.255, p < 0.05). Post hoc indicates that female percentage 
of HR max data is significantly greater than male data in pre 1-3km and post 
1/4/7km (p < 0.05). No significant main effect of group was present (F 2, 44.875 = 
0.335, p > 0.05). No significant interaction of sex*group (F 2, 44.875 = 1.805, p > 
0.05), sex*km (F 19, 817.047 = 1.169, p > 0.05) and sex*group*km (F 38, 817.044 = 
0.986, p > 0.05) was present. However, a significant interaction of group*km 
was present (F 38, 817.044 = 1.671, p < 0.05). Post hoc indicates that 15% group 
percentage of HR max data is significantly greater in pre 3/4km vs. pre and post 
1km (p < 0.05), pre 5-7km vs. pre 1km and post 1/2km (p < 0.05), pre 8/9km vs. 
pre 1/2km and post 1-3km (p < 0.05), pre 10km vs. pre 1-4km and post 1-3km 
(p < 0.05), post 4km vs. pre and post 1km (p < 0.05), post 5-7km vs. pre 1km 
and post 1/2km (p < 0.05), post 8/9km vs. pre 1/2km and post 1-3km (p < 0.05), 
post 10km vs. pre 1-6km and post 1-5km (p < 0.05); 20% group percentage of 
HR max data is significantly greater in pre 3/4km vs. pre 1km (p < 0.05), pre 5-
7km vs. pre 1/2km and post 1km (p < 0.05), pre 8km vs. pre 1/2/4km and post 
1km (p < 0.05), pre 9km vs. pre 1-4km and post 1/2km (p < 0.05), pre 10km vs. 
pre 1-7km and post 1-4km (p < 0.05), post 2km vs. pre 1km (p < 0.05), post 3-
6km vs. pre1/2km and post 1km (p < 0.05), post 7km vs. pre 1/2/4km and post 
1km (p < 0.05), post 8km vs. pre 1-4km and post 1/2km (p < 0.05), post 9km vs. 
pre 1-4km and post 1/2km (p < 0.05), post 10km vs. pre 1-8 and post 1-7km (p 
< 0.05); control group percentage of HR max data is significantly greater in pre 
3km vs. post 1km (p < 0.05), pre 4-7km vs. post 1/2km (p < 0.05), pre 8km vs. 
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pre 1km and post 1/2km (p < 0.05), pre 9km vs. pre 1km and post 1-3km (p < 
0.05), pre 10km vs. pre 1/2km and post 1-4km (p < 0.05), post 3/4km vs. post 
1km (p < 0.05), post 5/6km vs. post 1/2km (p < 0.05), post 7km vs. pre 1km and 
post 1/2km (p < 0.05), post 8km vs. pre 1km and post 1-3km (p < 0.05), post 
9km vs. pre 1/2km and post 1-3km (p < 0.05), post 10km vs. pre 1-5km and 
post 1-5km (p < 0.05). 
Figure 4.6: Percentage of heart rate max during 10km TT in pre vs. post testing 
at each km for 15% males (A), 15% females (B), 20% males (C), 20% females 
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(D), control males (E) and control females (F). * Significantly greater in pre 2km 
vs. pre and post 1 km, pre 3/4km vs. pre 1km and post 1/2km, pre 5/6km vs. pre 
1/2km and post 1/2km, pre 7km vs. pre 1/2km and post 1-3km, pre 8km vs. pre 
1-4km and post 1-3km, pre 9km vs. pre 1-5km and post 1-4km, pre 10km vs. 
pre 1-8km and post 1-7km (p < 0.05). + Significantly greater in post 3km vs. pre 
and post 1km, post 4/5km vs. pre and post 1-2km, post 6km vs. pre 1/2km and 
post 1-3km, post 7km vs. pre 1-4km and post 1-3km, post 8km vs. pre 1-5km 
and post 1-4km, post 9km vs. pre 1-6km and post 1-6km, post 10km vs. pre 1-
9km and post 1-8km (p < 0.05). † Significantly greater than pre male data (p < 
0.05). ‡ Significantly greater than post male data (p < 0.05). 1 Interaction, 15% 
RR group data is significantly greater in pre 3/4km vs. pre and post 1km, pre 5-
7km vs. pre 1km and post 1/2km, pre 8/9km vs. pre 1/2km and post 1-3km, pre 
10km vs. pre 1-4km and post 1-3km (p < 0.05). 11 Interaction, 15% RR group 
data is significantly greater in post 4km vs. pre and post 1km, post 5-7km vs. 
pre 1km and post 1/2km, post 8/9km vs. pre 1/2km and post 1-3km, post 10km 
vs. pre 1-6km and post 1-5km (p < 0.05). 2 Interaction, 15% RR group data is 
significantly greater in pre 3/4km vs. pre 1km, pre 5-7km vs. pre 1/2km and post 
1km, pre 8km vs. pre 1/2/4km and post 1km, pre 9km vs. pre 1-4km and post 
1/2km, pre 10km vs. pre 1-7km and post 1-4km (p < 0.05). 22 Interaction, 15% 
RR group data is significantly greater in post 2km vs. pre 1km, post 3-6km vs. 
pre1/2km and post 1km, post 7km vs. pre 1/2/4km and post 1km, post 8km vs. 
pre 1-4km and post 1/2km, post 9km vs. pre 1-4km and post 1/2km, post 10km 
vs. pre 1-8 and post 1-7km (p < 0.05). 3 Interaction, control group data is 
significantly greater in pre 3km vs. post 1km, pre 4-7km vs. post 1/2km, pre 8km 
vs. pre 1km and post 1/2km, pre 9km vs. pre 1km and post 1-3km, pre 10km vs. 
pre 1/2km and post 1-4km (p < 0.05). 33 Interaction, control group data is 
significantly greater in post 3/4km vs. post 1km, post 5/6km vs. post 1/2km, post 
7km vs. pre 1km and post 1/2km, post 8km vs. pre 1km and post 1-3km, post 
9km vs. pre 1/2km and post 1-3km, post 10km vs. pre 1-5km and post 1-5km (p 
< 0.05). 
 
 146 
4.3.4.2 VO2 
Figure 4.7 shows change of VO2 in pre and post 10km TT. A significant main 
effect of VO2 between km number was present (F19, 808.319 = 22.169, p < 0.05). 
Post hoc indicates that VO2 is significantly greater in pre 9km vs. pre 1/2km (p < 
0.05), pre 10km vs. 1-8km and post 1/2km (p < 0.05), post 3km vs. pre 1/2 (p < 
0.05), post 4/6km vs. pre 1-6km and post 1km (p < 0.05), post 5km vs. pre 1-
6km and post 1/2km (p < 0.05), post 7/8km vs. pre 1-8km and post 1/2km (p < 
0.05), post 9 vs. pre 1-9km and post 1-3km (p < 0.05), post 10km vs. pre 1-
10km and post 1-9km (p < 0.05). There was also a significant main effect of sex 
(F1, 44.083 = 123.653, p < 0.05); post hoc indicates that male VO2 data is 
significantly greater than female VO2 data during each km in pre and post TT 
testing (p < 0.05). No significant main effect between groups was present (F2, 33 
= 1.29, p > 0.05). No significant interaction of sex*group (F2, 33 = 0.403, p > 
0.05) and group*sex*km (F6.231, 2 = 1.035, p > 0.05) was present. A significant 
interaction of sex*km was present (F3.115, 1 = 2.231, p < 0.05). Post hoc indicates 
that male VO2 data is significantly greater in pre 9km vs. pre 1km (p < 0.05), pre 
10km vs. pre 1-8km and post 1/2km (p < 0.05), post 3km vs. pre 1km (p < 0.05), 
post 4km vs. pre 1/2 and post 1km (p < 0.05), post 5km vs. pre 1-4km and post 
1km (p < 0.05), post 6km vs. 1-3km and post 1km (p < 0.05), post 7/8km vs. pre 
1-6km and post 1/2km (p < 0.05), post 9km vs. pre 1-7km and post 1/2km (p < 
0.05), post 10km vs. pre 1-10km and post 1-9km (p < 0.05); female VO2 data is 
significantly greater in pre 10km vs. pre 1-2km (p < 0.05), post 4-8km vs. pre 
1/2km (p < 0.05), post 9km vs. pre 1-8km and post 1km (p < 0.05), post 10km 
vs. pre 1-9km and post 1-3/5-8km (p < 0.05). Also, a significant interaction of 
group*km was present (F38, 808.316 = 1.506, p < 0.05). Post hoc indicates that 
15% group VO2 is greater than pre 10km and vs. pre 1/2km (p < 0.05), post 3 
vs. pre 1km (p < 0.05), post 4km vs. pre 1/2/6 (p < 0.05), post 5km vs. pre 1-
8km (p < 0.05), post 6/7km vs. pre 1/2km (p < 0.05), post 8km vs. pre 1/2/4-6km 
(p < 0.05), post 9km vs. pre 1-8km and post 1km (p < 0.05), post 10km vs. pre 
1-10km and post 1-3km (p < 0.05); 20% group VO2 data is significantly greater 
in pre 10km vs. pre 1-6km (p < 0.05), post 4km vs. pre 1-3km (p < 0.05), post 
5/6km vs. pre 1km (p < 0.05), post 7/8km vs. pre 1-4km (p < 0.05), post 9km vs. 
1-6km (p < 0.05), post 10km vs. pre 1-9km and post 1-9km (p < 0.05); control 
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group VO2 data is significantly greater in pre 9km vs. post 1km (p < 0.05), pre 
10km vs. pre and post 1-2km (p < 0.05), post 7/8km vs. post 1km (p < 0.05), 
post 9km vs. pre and post 1/2km (p < 0.05), post 10km vs. pre 1-9km and post 
1-6/8km (p < 0.05). 
Figure 4.7: VO2 rate during 10km TT in pre vs. post testing at each km for 15% 
males (A), 15% females (B), 20% males (C), 20% females (D), control males 
(E) and control females (F). * Significantly greater in pre 9km vs. pre 1/2km, pre 
10km vs. 1-8km and post 1/2km (p < 0.05). + Significantly greater in post 3km 
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vs. pre 1/2, post 4/6km vs. pre 1-6km and post 1km, post 5km vs. pre 1-6km 
and post 1/2km, post 7/8km vs. pre 1-8km and post 1/2km, post 9 vs. pre 1-9km 
and post 1-3km, post 10km vs. pre 1-10km and post 1-9km (p < 0.05). † 
Significantly greater than pre female data (p < 0.05). ‡ Significantly greater than 
post female data (p < 0.05). a Interaction, male data is significantly greater in 
pre 9km vs. pre 1km, pre 10km vs. pre 1-8km and post 1/2km (p < 0.05). b 
Interaction, male data is significantly greater in post 3km vs. pre 1km, post 4km 
vs. pre 1/2 and post 1km, post 5km vs. pre 1-4km and post 1km, post 6km vs. 
1-3km and post 1km, post 7/8km vs. pre 1-6km and post 1/2km, post 9km vs. 
pre 1-7km and post 1/2km, post 10km vs. pre 1-10km and post 1-9km (p < 
0.05). c Interaction, female data is significantly greater in pre 10km vs. pre 1-
2km (p < 0.05). d Interaction, female data is significantly greater in post 4-8km 
vs. pre 1/2km, post 9km vs. pre 1-8km and post 1km, post 10km vs. pre 1-9km 
and post 1-3/5-8km (p < 0.05). 1 Interaction, 15% RR group data is significantly 
greater in pre 10km and vs. pre 1/2km (p < 0.05). 11 Interaction, 15% RR group 
data is significantly greater in post 3 vs. pre 1km, post 4km vs. pre 1/2/6, post 
5km vs. pre 1-8km, post 6/7km vs. pre 1/2km, post 8km vs. pre 1/2/4-6km, post 
9km vs. pre 1-8km and post 1km, post 10km vs. pre 1-10km and post 1-3km (p 
< 0.05). 2 Interaction, 20% RR group data is significantly greater in pre 10km vs. 
pre 1-6km (p < 0.05). 22 Interaction, 20% RR group data is significantly greater 
in post 4km vs. pre 1-3km, post 5/6km vs. pre 1km, post 7/8km vs. pre 1-4km, 
post 9km vs. 1-6km, post 10km vs. pre 1-9km and post 1-9km (p < 0.05). 3 
Interaction, control group data is significantly greater in pre 9km vs. post 1km, 
pre 10km vs. pre and post 1-2km (p < 0.05). 33 Interaction, control group data is 
significantly greater in post 7/8km vs. post 1km, post 9km vs. pre and post 
1/2km, post 10km vs. pre 1-9km and post 1-6/8km (p < 0.05). 
 
Figure 4.8 shows percentage of VO2 peak in pre and post 10km TT. A main 
effect of km number was present (F 19, 808.63 = 12.95, p < 0.05). Post hoc 
indicates that percentage of VO2 peak is significantly greater in pre 9km vs. pre 
1/2km (p < 0.05), pre 10km vs. pre 1-8km and post 1-3km (p < 0.05), post 
4/5/7km vs. pre 1/2km and post 1km (p < 0.05), post 6km vs. pre 1/2km (p < 
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0.05), post 8km vs. pre 1-3km and post 1km (p < 0.05), post 9km vs. pre 1-8km 
and post 1/2km (p < 0.05), post 10km vs. pre 1-9km and post 1-9km (p < 0.05). 
No significant main effect of sex (F 1, 44.25 = 0.002, p > 0.05) and group was 
present (F 2, 44.253 = 0.55, p > 0.05). No significant interaction of group*km (F 38, 
808.625 = 0.42, p > 0.05), sex*group (F 2, 44.253 = 1.017, p > 0.05) and 
sex*group*km (F 38, 808.625 = 0.552, p > 0.05) was present. However, a significant 
interaction of sex*km was present (F 19, 808.63 = 3.988, p < 0.05). Post hoc 
indicates that male percentage of VO2 peak data is significantly greater in pre 5-
7km vs. post 1km (p < 0.05), pre 8km vs. post 1/2km (p < 0.05), pre 9km vs. pre 
1km and post 1/2km (p < 0.05), pre 10km vs. pre 1-8km and post 1-8km (p < 
0.05), post 5/7km vs. post 1km (p < 0.05), post 8/9km vs. post 1/2km (p < 0.05), 
post 10km vs. pre 1-9km and post 1-9km (p < 0.05); female percentage of VO2 
peak data is significantly greater in post 4-8km vs. pre 1/2km (p < 0.05), post 
9km vs. pre 1-8km (p < 0.05), post 10km vs. pre 1-9km and post 1-3km (p < 
0.05). 
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Figure 4.8: Percentage of VO2 peak during 10km TT in pre vs. post testing at 
each km for 15% males (A), 15% females (B), 20% males (C), 20% females 
(D), control males (E) and control females (F). * Significantly greater in pre 9km 
vs. pre 1/2km, pre 10km vs. pre 1-8km and post 1-3km (p < 0.05). + 
Significantly greater in post 4/5/7km vs. pre 1/2km and post 1km, post 6km vs. 
pre 1/2km, post 8km vs. pre 1-3km and post 1km, post 9km vs. pre 1-8km and 
post 1/2km, post 10km vs. pre 1-9km and post 1-9km (p < 0.05). a Interaction, 
male data is significantly greater in pre 5-7km vs. post 1km, pre 8km vs. post 
1/2km, pre 9km vs. pre 1km and post 1/2km, pre 10km vs. pre 1-8km and post 
1-8km (p < 0.05). b Interaction, male data is significantly greater in post 5/7km 
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vs. post 1km, post 8/9km vs. post 1/2km, post 10km vs. pre 1-9km and post 1-
9km (p < 0.05). d Interaction, female data is significantly greater in post 4-8km 
vs. pre 1/2km, post 9km vs. pre 1-8km, post 10km vs. pre 1-9km and post 1-
3km (p < 0.05). 
 
4.3.4.3 VCO2 
Figure 4.9 shows change of VCO2 in pre and post 10km TT. A significant main 
effect of VCO2 between km number was present (F19, 808.393 = 16.464, p < 0.05). 
Post hoc indicates that VCO2 is significantly higher in pre 10km vs. pre 1-9km 
and post 1/2km (p < 0.05), post 4km vs. pre and post 1km (p < 0.05), post 8km 
vs. pre 1/6 and post 1km (p < 0.05), post 9km vs. pre 1/2/4-8km and post 1km 
(p < 0.05), post 10km vs. pre 1-10km and post 1-9km (p < 0.05). In addition, a 
significant main effect between sex was present (F1, 44.126 = 113.858, p < 0.05); 
post hoc indicates that male VCO2 is significantly greater than female VCO2 in 
all pre and post km numbers (p < 0.05). No significant main effect between 
groups was present (F2, 44.128 = 0.873, p > 0.05). No significant interaction of 
group*sex (F2, 33 = 0.368, p > 0.05) and sex*group*km (F8.673, 2 = 0.765, p > 
0.05) was present. A significant interaction of sex*km (F4.337, 1 = 1.605, p < 0.05) 
was present. Post hoc indicates that male VCO2 data is significantly greater in 
pre 10km vs. pre 1-9km and post 1-3km (p < 0.05), post 8/9km vs. post 1km (p 
< 0.05), post 10 vs. pre 1-9km and post 1-9 (p < 0.05); female VCO2 data is 
significantly greater in pre 10km vs. pre 6/8km (p < 0.05), post 9km vs. pre 2/5-8 
(p < 0.05), post 10km vs. pre 1-10km and post 1-9km (p < 0.05). Also, a 
significant interaction of group*km was present (F8.673, 2 = 1.031, p < 0.05). Post 
hoc indicates that 15% group VCO2 data is greater in post 10km vs. pre 1-9km 
and post 1-3/6-8km (p < 0.05); 20% group VCO2 data is greater in pre 10km vs. 
pre 1-9km (p < 0.05), post 2/3/9km vs. pre 1/4km (p < 0.05), post 4km vs. pre 
1/3/4/6km (p < 0.05), post 8km vs. pre 1/3/4km (p < 0.05), post 10km vs. pre 1-
10km and post 1-9km (p < 0.05); control group VCO2 data is significantly 
greater in pre 10km vs. post 1km (p < 0.05), post 9km vs. post 1km (p < 0.05), 
post 10km vs. pre 1-9km and post 1-9km (p < 0.05). 
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Figure 4.9: VCO2 rate during 10km TT in pre vs. post testing at each km for 
15% males (A), 15% females (B), 20% males (C), 20% females (D), control 
males (E) and control females (F). * Significantly greater in pre 10km vs. pre 1-
9km and post 1/2km (p < 0.05). + Significantly greater in post 4km vs. pre and 
post 1km, post 8km vs. pre 1/6 and post 1km, post 9km vs. pre 1/2/4-8km and 
post 1km, post 10km vs. pre 1-10km and post 1-9km (p < 0.05). † Significantly 
greater than pre female data (p < 0.05). ‡ Significantly greater than post female 
data (p < 0.05). a Interaction, male data is significantly greater in pre 10km vs. 
pre 1-9km and post 1-3km (p < 0.05). b Interaction, male data is significantly 
greater in post 8/9km vs. post 1km, post 10 vs. pre 1-9km and post 1-9 (p < 
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0.05). c Interaction, female data is significantly greater in pre 10km vs. pre 
6/8km (p < 0.05). d Interaction, female data is significantly greater in post 9km 
vs. pre 2/5-8, post 10km vs. pre 1-10km and post 1-9km (p < 0.05). 11 
Interaction, 15% RR group data is significantly greater in post 10km vs. pre 1-
9km and post 1-3/6-8km (p < 0.05). 2 Interaction, 20% RR group data is 
significantly greater in pre 10km vs. pre 1-9km (p < 0.05). 22 Interaction, 20% 
RR group data is significantly greater in post 2/3/9km vs. pre 1/4km, post 4km 
vs. pre 1/3/4/6km, post 8km vs. pre 1/3/4km, post 10km vs. pre 1-10km and 
post 1-9km (p < 0.05). 3 Interaction, control group data is significantly greater in 
pre 10km vs. post 1km (p < 0.05). 33 Interaction, control group data is 
significantly greater in post 9km vs. post 1km, post 10km vs. pre 1-9km and 
post 1-9km (p < 0.05). 
 
4.3.5 Best self-regulated trial, session 1 and 8 normalised sprinting gas 
measures and heart rate 
4.3.5.1 VO2 data 
Figure 4.10 shows sprint data, sprint 1 vs. sprint 10 (A-B) and normalised VO2 
curve graphs (C-H). A significant main effect of normalised VO2 between best 
SR trial, session 1 (SES1) and 8 (SES8), sprint 1 (S1) and sprint 10 (S10 
(time4)) was present (F5, 145.33 = 28.371, p < 0.05), post hoc indicates that VO2 
S10 data is significantly greater than all S1 VO2 data (p < 0.05). In addition a 
significant main effect of sex was present (F1, 29.494 = 50.429, p < 0.05); post hoc 
indicates that all male VO2 sprint data is significantly greater than all female VO2 
sprint data. No significant main effect between groups was present (F1, 29.494 = 
1.290, p > 0.05). A significant interaction in time4*sex was present (F5, 145.33 = 
4.026, p < 0.05); post hoc indicates that both sexes VO2 S10 data is 
significantly greater than all their respected VO2 S1 data (p < 0.05). No 
significant interaction in sex*group (F1, 29.494 = 0.87, p > 0.05), group*time4 (F5, 
145.33 = 0.721, p > 0.05) and sex*group*time4 (F5, 145.33 = 0.467, p < 0.05). 
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Figure 4.10: Normalised VO2 in best SR trial, session 1 and 8, data shows 
sprint 1 vs. sprint 10 in (A) 15% group both sexes, (B) 20% group both sexes, 
(C) 15% group best SR trial curve both sexes, (D) 20% group best SR trial 
curve both sexes, (E) 15% group session 1 curve both sexes, (F) 20% group 
session 1 curve both sexes, (G) 15% group session 8 curve both sexes, and (H) 
20% group session 8 curve both sexes. * Significantly greater than females (p < 
0.05). † Significantly greater than all sprint 1 data (p < 0.05). ‡ Interaction, all 
sprint 10 data is significantly greater than all sprint 1 data in both males and 
females (p < 0.05). 
 
4.3.5.2 VCO2 data 
Figure 4.11 shows sprint data, sprint 1 vs. sprint 10 (A-B) and normalised VCO2 
curve graphs (C-H). A significant main effect of normalised VCO2 between time4 
was present (F5, 154.12 = 44.905, p < 0.05); post hoc indicates that VCO2 S10 
data is significantly greater than all S1 VCO2 data (p < 0.05). In addition a 
significant main effect of sex was present (F1, 31.37 = 32.245, p < 0.05); post hoc 
indicates that all male VCO2 sprint data is significantly greater than all female 
VCO2 sprint data. No significant main effect between groups was present (F1, 
31.37 = 0.107, p > 0.05). A significant interaction in time4*sex was present (F5, 
154.12 = 4.812, p < 0.05); post hoc indicates that both sexes VCO2 S10 data is 
significantly greater than all their respected VCO2 S1 data (p < 0.05). No 
significant interaction in sex*group (F1, 31.37 = 0.002, p > 0.05), group*time4 (F5, 
154.12 = 0.448, p > 0.05) and sex*group*time4 (F5, 154.12 = 0.448, p < 0.05). 
 156 
 157 
Figure 4.11: Normalised VCO2 in best SR trial, session 1 and 8, data shows 
sprint 1 vs. sprint 10 in (A) 15% group both sexes, (B) 20% group both sexes, 
(C) 15% group best SR trial curve both sexes, (D) 20% group best SR trial 
curve both sexes, (E) 15% group session 1 curve both sexes, (F) 20% group 
session 1 curve both sexes, (G) 15% group session 8 curve both sexes, and (H) 
20% group session 8 curve both sexes. * Significantly greater than females (p < 
0.05). † Significantly greater than all sprint 1 data (p < 0.05). ‡ Interaction, all 
sprint 10 data is significantly greater than all sprint 1 data in both males and 
females (p < 0.05). 
 
4.3.5.3 Heart rate data 
Figure 4.12 shows sprint data, sprint 1 vs. sprint 10 (A-B) and normalised HR 
curve graphs (C-H). A significant main effect of normalised HR between time4 
was present (F5, 148.566 = 27.988, p < 0.05); post hoc indicates that all S10 data 
is significantly greater than all S1 data (p < 0.05). No significant main effect of 
sex (F1, 32.683 = 0.16, p > 0.05) or group (F1, 32.683 = 1.727, p > 0.05) was present. 
No significant interaction in sex*time4 (F5, 148.566 = 0.829, p > 0.05), group*time4 
(F5, 148.566 = 1.09, p > 0.05), group*sex (F1, 32.683 = 0.003, p > 0.05) and 
time4*group*sex (F5, 148.566 = 1.078, p > 0.05) was present. 
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Figure 4.12: Normalised heart rate in best SR trial, session 1 and 8, data shows 
sprint 1 vs. sprint 10 in (A) 15% group both sexes, (B) 20% group both sexes, 
(C) 15% group best SR trial curve both sexes, (D) 20% group best SR trial 
curve both sexes, (E) 15% group session 1 curve both sexes, (F) 20% group 
session 1 curve both sexes, (G) 15% group session 8 curve both sexes, and (H) 
20% group session 8 curve both sexes. † Significantly greater than all sprint 1 
data (p < 0.05). 
 
4.3.6 Best self-regulated trial, session 1 and 8 normalised resting gas 
measures and heart rate 
4.3.6.1 VO2 data 
Figure 4.13 shows resting data, rest 1 vs. rest 9 (A-B) and normalised VO2 
curve graphs (C-H). A significant main effect of normalised VO2 between best 
SR trial, session 1 and 8, rest 1 and rest 9 (time5) was present (F5, 155.026 = 
30.167, p < 0.05), post hoc indicates that all VO2 rest 9 data is significantly 
greater than all rest 1 VO2 data (p < 0.05). In addition a significant main effect of 
sex was present (F1, 31.819 = 51.441, p < 0.05); post hoc indicates that all male 
VO2 is significantly greater than all female VO2 data. No significant main effect 
between groups was present (F1, 31.819 = 1.057, p > 0.05). A significant 
interaction in time5*sex was present (F5, 155.026 = 2.463, p < 0.05). Post hoc 
indicates that male rest 9 VO2 data is significantly greater than all rest 1 data (p 
< 0.05); female VO2 data is significantly greater in SR rest 9 vs. SR rest 1, 
SES1 rest 9 vs. SES1 rest 1, and SES8 rest 9 vs. SES8 rest 1 (p < 0.05). No 
significant interaction in sex*group (F1, 31.819 = 0.35, p > 0.05), group*time5 (F5, 
155.026 = 0.521, p > 0.05) and sex*group*time5 (F5, 155.026 = 2.169, p < 0.05). 
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Figure 4.13: Normalised VO2 in best SR trial, session 1 and 8, data shows rest 
1 vs. rest 9 in (A) 15% group both sexes, (B) 20% group both sexes, (C) 15% 
group best SR trial curve both sexes, (D) 20% group best SR trial curve both 
sexes, (E) 15% group session 1 curve both sexes, (F) 20% group session 1 
curve both sexes, (G) 15% group session 8 curve both sexes, and (H) 20% 
group session 8 curve both sexes. * Significantly greater than females (p < 
0.05). † Significantly greater than all rest 1 data (p < 0.05). ‡ Interaction, all rest 
9 data is significantly greater than all rest 1 data in males (p < 0.05). ** 
Interaction, female data is significantly greater in SR rest 9 vs. SR rest 1, SES1 
rest 9 vs. SES1 rest 1, and SES8 rest 9 vs. SES8 rest 1 (p < 0.05). 
 
4.3.6.2 VCO2 data 
Figure 4.14 shows resting data, rest 1 vs. rest 9 (A-B), normalised VCO2 curve 
graphs (C-H). A significant main effect of normalised VCO2 between time5 was 
present (F5, 155.901 = 30.069, p < 0.05); post hoc indicates that all rest 9 VCO2 
data is significantly greater than all rest 1 VCO2 data. In addition, a significant 
main effect of sex was present (F1, 31.723 = 46.159, p < 0.05); post hoc indicates 
that all male VCO2 is significantly greater than all female VCO2 data. No 
significant main effect between groups was present (F1, 31.723 = 0.237, p > 0.05). 
No significant interaction was present in sex*group (F1, 31.723 = 0.107, p > 0.05), 
group*time5 (F5, 155.901 = 0.6, p > 0.05), sex*time5 (F5, 155.901 = 1.078, p > 0.05). A 
significant interaction between group*sex*time5 was present (F5, 155.901 = 2.572, 
p < 0.05). Post hoc indicates that male 15% VCO2 data is significantly greater in 
SES1 rest 9 vs. SES1 rest 1 (p < 0.05); male 20% VCO2 data is significantly 
greater in SR rest 9 vs. SR rest 1, SES1 and SES8 rest 9 vs. SES1 and SES8 
rest 1 (p < 0.05); female 15% VCO2 data is significantly greater in SR rest 9 vs. 
SR rest 1, SES1 rest 9 vs. SES1 rest 1 (p < 0.05); female 20% VCO2 data is 
significantly greater in SES1 rest 9 vs. SES1 rest 1, and SES8 rest 9 vs. SES8 
rest 1 (p < 0.05).  
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Figure 4.14: Normalised VCO2 in best SR trial, session 1 and 8, data shows rest 
1 vs. rest 9 in (A) 15% group both sexes, (B) 20% group both sexes, (C) 15% 
group best SR trial curve both sexes, (D) 20% group best SR trial curve both 
sexes, (E) 15% group session 1 curve both sexes, (F) 20% group session 1 
curve both sexes, (G) 15% group session 8 curve both sexes, and (H) 20% 
group session 8 curve both sexes. * Significantly greater than females (p < 
0.05). † Significantly greater than all rest 1 data (p < 0.05). a Interaction, male 
15% RR group data is significantly greater in SES1 rest 9 vs. SES1 rest 1 (p < 
0.05). b Interaction, male 20% RR group data is significantly greater in SR rest 9 
vs. SR rest 1, SES1 and SES8 rest 9 vs. SES1 and SES8 rest 1 (p < 0.05). c 
Interaction, female 15% RR group data is significantly greater in SR rest 9 vs. 
SR rest 1, and SES1 rest 9 vs. SES1 rest 1 (p < 0.05). d Interaction, male 20% 
RR group data is significantly greater in SES1 rest 9 vs. SES1 rest 1, and SES8 
rest 9 vs. SES8 rest 1 (p < 0.05). 
 
4.3.6.3 Heart rate data 
Figure 4.15 shows resting data, rest 1 vs. rest 9 (A-B) and normalised HR curve 
graphs (C-H). A significant main effect of normalised HR between time5 was 
present (F5, 153.498 = 46.963, p < 0.05); post hoc indicates that all rest 9 data is 
significantly greater than all rest 1 data (p < 0.05). No significant main effect of 
sex (F1, 31.296 = 0.745, p > 0.05) or group (F1, 31.296 = 0.454, p > 0.05) was 
present. No significant interaction in sex*time5 (F5, 153.498 = 0.829, p > 0.05), 
group*time5 (F5, 153.498 = 1.09, p > 0.05), group*sex (F1, 31.296 = 0.003, p > 0.05) 
and time5*group*sex (F5, 153.498 = 1.078, p > 0.05) was present. 
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Figure 4.15: Normalised heart rate in best SR trial, session 1 and 8, data shows 
rest 1 vs. rest 9 in (A) 15% group both sexes, (B) 20% group both sexes, (C) 
15% group best SR trial curve both sexes, (D) 20% group best SR trial curve 
both sexes, (E) 15% group session 1 curve both sexes, (F) 20% group session 
1 curve both sexes, (G) 15% group session 8 curve both sexes, and (H) 20% 
group session 8 curve both sexes. † Significantly greater than all rest 1 data (p 
< 0.05). 
 
4.3.7 Gas and heart rate correlations 
Table 4.9 shows correlation of sprint and rest VO2, VCO2 and HR between 
percentage changes of performance measures. Gas and HR measures are 
overall total of sessions 1 and 8 rest 1 and 9 data (TOTAL). Significant 
correlation exist in sprint and rest TOTAL VO2 vs. VO2 peak (r = 0.4, p < 0.05; r 
= 0.47, p < 0.05), and TOTAL VCO2 vs. VO2 peak (r = 0.47, p < 0.05). 
 
Table 5.9: Correlation of sprinting and resting VO2, VCO2, and HR between 
percentage change of performance measures. 
Measure TTE CP VO2 peak TT 
VO2:     
Sprint TOTAL r = 0.03 r = -0.01 r = 0.4* r = -0.15 
Rest TOTAL r = 0.03 r = 0.16 r = 0.47* r = -0.04 
VCO2:     
Sprint TOTAL r = -0.11 r = 0.06 r = -0.07 r = -0.11 
Rest TOTAL r = 0.05 r = 0.12 r = 0.47* r = -0.01 
HR:     
Sprint TOTAL r = 0.01 r = -0.06 r = 0.3 r = -0.01 
Rest TOTAL r = 0.03 r = 0.23 r = 0.06 r = 0.07 
 
* Significant correlation (p < 0.05). 
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4.4 Discussion 
It has been suggested that people overestimate the amount of recovery 
required between sprints (Phillips, Thompson, Oliver., 2014). Therefore, the aim 
of this study was to determine the effect of reducing self-selected rest by 15 and 
20% has on endurance adaptation to repeated sprint training. Following 4 
weeks of training endurance adaptations were greater with 15% reduction for 
VO2 peak (males: 14%, females: -1%) and TTE (males: 6%, females: 8%) when 
compared to 20% reduction (VO2 peak: males, 9%; females, 0%; TTE: males, 
4%; females, 5%). However, endurance adaptations were greater with 20% 
reduction for CP (males: 8%, females: 10%) and TT (males: -8%, females: -
10%) when compared to 15% reduction (CP peak: males, 4%; females, 5%; TT: 
males, -6%; females, -9%). The magnitude in change for VO2 peak was 
significantly correlated to TOTAL resting VO2 after sprints (r = 0.47, p < 0.05) 
and TOTAL resting VCO2 after sprints (r = 0.47, p < 0.05) in both sexes. 
 
4.4.1 Change in aerobic demand in sprint/ rest 1 vs. sprint 10/ rest 9 
A significant increase from sprint 1/ rest 1 vs. sprint 10/ rest 9 for normalised 
best SR trial in HR, VO2 and VCO2 could indicate a similar trend to Gaitanos et 
al., (1993) despite the current study’s longer rest duration. Gaitanos et al., 
(1993) reported a dominance in anaerobic ATP production from PCr (80.1%) 
compared to glycolysis (16.1%) after 10 x 6 sec sprints with a 30 sec recovery. 
They also discuss that the latter sprints involved a larger aerobic demand and a 
significant drop in power output. It would appear that a similar drop in glycolysis 
and increase in PCr use for anaerobic ATP production may have occurred in 
the current study. Due to the larger aerobic and cardiovascular demand from 
VO2 and HR in sprint 10/ rest 9 vs. sprint 1 vs. rest 1. 
 
4.4.2 Pacing of sprints to maintain mean power output 
During the current study, it is thought both males and females have paced their 
sprints as neither maintained CS performance across trials 1-4 (Table 4.1). This 
may have occurred as an attempt to protect the body from any homeostatic 
disturbances (Edwards & Polman., 2013). The significant drop in MPO 
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compared to the CS (in trials 1-4) may display that participants are pacing their 
efforts during the 10 trial sprints in order to maintain their MPO. Pacing has 
previously been found to occur within a single sprint bout, with a 5 sec sprint 
producing a significantly greater amount of PPO compared to a 15, 30 and 45 
sec sprint (Wittekind, Micklewright, Beneke., 2011), despite PPO usually been 
achieved within the first 0-5 sec of a sprint (Vandewalle, Pérès, Monod., 1987). 
Similar to female participants in Study 1 and male participants in Study 2, 
participants in the current study may have paced their efforts as reproducing 
their CS effort over 10 sprints may have caused homeostatic harm (Edwards & 
Polman., 2013). This may explain why FI and CV is unaffected in trials 2-4 and 
trials 3-4 respectively. 
 
4.4.3 Self-regulated recovery times between males and females across 
the 10 sprints 
The findings of SR rest duration between males and females (Table 4.1) are 
consistent with Study 1, with no significant difference between trials or between 
sexes. Previously it would have been expected that females would have 
required a shorter SR rest duration vs. males, due to the female’s ability to 
resist peripheral fatigue being greater than males (Laurent et al., 2010; Smith & 
Billaut 2012). This is now the second study to find that there is no significant 
difference in SR rest time between sexes. In addition to this, in Study 1, males 
on average had a shorter SR rest duration compared to females and the 
opposite has occurred in the current study. Possibly demonstrating that SR rest 
is a personal selection based off each individual and could be controlled by 
many factors. Based off unrecorded observations these factors could include 
willingness to complete the next sprint (Edwards & Polman 2013), comfort, 
understanding how to maintain MPO (ie: rest for longer), and training level. 
Despite using self-selected rest, peripheral fatigue linearly increased during the 
10 x 6 sec sprints due to rise in HR, VO2 and VCO2 reflecting increasing aerobic 
contribution, which is consistent with previous research (Bishop., 2012; Goodall 
et al., 2015; Hureau et al., 2014; Perry et al., 2010; Racinais et al., 2007). This 
could suggest why the average SR rest duration increases from rest 1 to rest 9 
with trial 3 rest 9 been significantly greater than trial 3 rest 1 (Table 4.1) 
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(Bishop., 2012; Goodall et al., 2015; Hureau et al., 2014; Mendez-Villanueva, 
Hamer, Bishop., 2008; Perrey et al., 2010; Racinais et al., 2007). 
 
4.4.4 VO2 peak test 
After eight HIT sessions over a four week period it was found that females saw 
no increase in VO2 peak (female 15% group:  -1%; female 20% group: 0%), 
whereas males increased by 14% (male 15% group) and  9% (male 20% group) 
(Figure 4.2). Female VO2 peak results are similar to study 2, which found no 
improvement for the SR group. It would appear that reducing rest by at least 
15% allows improvements in VO2 peak for males but not females. Females may 
require a reduction in SR of > 20% to see an increase in VO2 peak, to create a 
larger aerobic response due to a shorter work:rest ratio (Gaitanos et al., 1993; 
Kavaliauskas, Aspe, Babraj., 2015). This is further suggested by the correlation 
data within the present study, indicating that increasing aerobic demand during 
the sprints (TOTAL VO2: r = 0.4, p < 0.05) and recovery periods (TOTAL VO2: r 
= 0.47, p < 0.05) is significantly correlated to the magnitude in change for VO2 
peak. Also, significant correlation data between TOTAL rest VCO2 (r = 0.47, p < 
0.05 (Table 4.8)) in VO2 peak percentage change. Indicating that males 
increased their VO2 peak due to a greater aerobic demand during HIT. Another 
possibility for females to increase VO2 peak could be increasing the intensity of 
the HIT by reducing the resistance (< 7.5% body mass (Granata et al., 2016)). 
Increasing the intensity during HIT (cycling at a greater RPM) is linked with an 
increase in both mitochondrial respiration and content (Granata et al., 2016; 
Hughes Ellefsen, Baar., 2017). Females may not have experienced as great an 
increase in mitochondrial respiration compared to males due to a lack of 
intensity during HIT (Huges Ellefsen, Baar., 2017). Granata et al., (2016) found 
that following HIT (4-10 x 30 sec sprints) citrate synthase activity and 
mitochondrial respiration increased by ~50%. With even short duration sprints 
(5 sec) during HIT leading to a ~6.8% increase in citrate synthase activity 
(Linossier et al., 1997). Increasing citrate synthase activity appears to be 
strongly linked to VO2 max increasing post HIT and endurance training in 
healthy sedentary or healthy trained young adult males (Vigelso, Andersen, 
Dela., 2014). There is also the possibility that females do not experience similar 
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improvements in VO2 peak that men experience following HIT. Research from 
Vigelso, Andersen, Dela., (2014) compared HIT and endurance training 
published research from 1983-2013. Vigelso, Andersen, Dela., (2014) speculate 
that females do not have the same link in improving citrate synthase activity 
along with VO2 max. An observation was made that research using females only 
improved citrate synthase activity along with VO2 max when male participants 
were also used within the same intervention group. However, the data 
suggesting that females do not see as strong a link in males in improved citrate 
synthase activity and VO2 max is due to a lack of HIT/ endurance training 
studies that have used females (Vigelso, Andersen, Dela., 2014). Therefore, 
based off previous research, females may increase their VO2 peak following 
HIT by increasing the intensity of their sprints during HIT (Granata et al., 2016; 
Huges Ellefsen, Baar., 2017; Vigelso, Andersen, Dela., 2014). 
 
Recent work from Kavaliauskas, Steer, Babraj., (2016) found no change in VO2 
peak in healthy untrained females post HIT. They also discuss that other 
research that recruited 6 males and 2 females saw no change in VO2 peak post 
HIT (Burgomaster et al., 2005). However, other studies increased VO2 peak by 
~ 6.9/ ~ 4.7% that have used competitive running female (n = 14) and male (n = 
10) participants (Kavaliauskas, Aspe, Babraj., 2015), also by ~ 12/ ~ 13% when 
using physically active females (n = 7) and males (n = 20) (Yamagashi & 
Babraj., 2017), and Hazell et al., 2010 increased VO2 max by ~ 9.3/ ~ 9.2/ ~ 
3.8% when also using physically active females (n = 13) and males (n = 35). 
Kavaliauskas, Steer, Babraj., (2016) discuss that training volume may play a 
key role in improving VO2 peak, specifically longer duration HIT studies (2 
sessions a week for 12 weeks) appear to have greater increases in VO2 max 
compared to short term HIT studies (6 sessions in 2 weeks). Astorino & 
Schubert., (2014) found a greater response in participants increasing VO2 max 
(78% of participants) when using a long term HIT protocol (12 weeks) when 
compared to participants (65%) using a short term protocol (2 weeks). 
Therefore, it would suggest that the females within the present study may 
experience an increase in VO2 peak if the duration of the present HIT protocol 
increased from 4-12 weeks. 
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Seeking to maintain power output during the training sessions has been 
suggested to be a potential link to improving power output and endurance 
measures (Hazell et al., 2010; Lloyd Jones, Morris, Jakeman., 2017; 
Yamagashi & Babraj., 2017). Hazell et al., (2010) found similar improvements in 
VO2 max using a 30sec and 10sec sprint and noted that the maintenance of 
power, through a longer rest, has similar training adaptations to protocols that 
seek to reduce power output to create a larger aerobic demand by using a 
shorter work to rest ratio. Yamagashi & Babraj., (2017) record similar PPOs 
between using a 15sec sprint and 30sec sprint in all sessions. However, they 
also record a larger significant total work (KJ) in the 30sec group compared to 
the 15sec group. This indicates that similar training adaptations can be 
achieved using half the length of a sprint by maintaining PPO and reducing total 
work (KJ). However, the current study has found that maintenance of MPO 
through comparing percentage change from the CS to each MPO in the 
sessions, seeking a lower CV% and FI% is not related to any improvements in 
VO2 peak, TTE, TT or CP (Table 4.7). Table 4.7 indicates no significant 
correlation to any measure related to maintenance of power output and 
percentage change of performance measures. Therefore, maintenance of 
maximal MPO is not essential for improving VO2 peak. 
 
4.4.5 Time to exhaustion test 
TTE increased in all training groups and sexes following 4 weeks of HIT (male 
15%: ~ 6%, female 15%: ~ 8, male 20%: ~ 4%, female 20%: ~ 5%), regardless 
of females seeing no increase in VO2 peak. (Figure 4.3). HIT research has 
found a mixture in TTE percentage increases, Burgomaster et al., (2005) found 
a ~100% increase in the duration of maintaining 85% VO2 max  following 6 HIT 
sessions over a two week period. This study and others have observed similar 
percentage increases in incremented TTE after HIT when using competitive 
male and female runners and triathletes (~ 5%; ~ 6.4/ 4.4/ 1.9% (Jakeman, 
Adamson, Babraj., 2012; Kavaliauskas, Aspe, Babraj., 2016)). Greater 
increases appear in untrained healthy females (~ 12% (Kavaliauskas, Steer, 
Babraj., 2016)), and physically active (3 hours per week) males and females (~ 
16/ 13% (Yamagashi & Babraj., 2017)). Improving TTE could be due to 
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increased muscle citrate synthase activity after HIT, which would increase 
mitochondrial activity (Burgomaster et al., 2005), increased resting glycogen 
and PCr stores (Burgomaster et al., 2005; Rodas et al., 2000). Even increasing 
resting PCr stores decreases an onset of fatiguing mechanisms such as 
lowering pH (~ 0.5 units), build up in Pi and a reduction in impeded Ca2+ 
dynamics (Balsom et al., 1992; MacLaren & Morton., 2012; Westerblad, Allen, 
Lannergren., 2002). In addition, Perry et al., (2008) found a ~9% increase in 
VO2 peak and an increase of ~78% in PCr during the 5 minute stage of a TTE 
post HIT. PCr and citrate synthase were not measured in the present study. 
However, given the strong link in resting PCr content and VO2 peak (Kent-
Braun & Alexander., 2000), the greater male TOTAL VO2 data been significantly 
correlated with the increase in VO2 peak, it is possible that the male participants 
within this study increased their PCr content and citrate synthase activity. This 
would explain the increase in TTE and VO2 peak in males. The current study 
found a significant correlation in VO2 peak and TTE (r = 0.4, p < 0.05). Driller., 
(2012) found a link between VO2 max and PPO, indicating that when PPO 
increases during a increment test so does VO2. An increase in PPO would allow 
a longer TTE, allowing participants to cycle against a greater increment, and 
therefore an increased VO2 peak (Driller., 2012). However, it has previously 
been demonstrated that TTE has increased when there is no increase in VO2 
peak (Kavaliauskas, Steer, Babraj, 2016; Study 2), even when there was also 
an increase in PPO post HIT (Study 2). 
 
Jakeman, Adamson, Babraj., (2012) found a significant rightward shift in the 
lactate curve which resulted in an increase of power by ~30 watts following 6 
sessions of 10 x 6 sec cycle sprints. Indicating that both training groups may 
have increased their TTE by changes in lactate metabolism, which would lead 
to a greater power output during the test. Post HIT has also shown to increase 
glycogen in rest and during exercise states, and increase lactate transporter 
activity MTC1 and MTC4 (Bishop et al., 2008; Burgomaster et al., 2005; Perry et 
al., 2008). It is thought that MTC1 and MTC4 activity may have increased in the 
current study due to the substantial rest duration, which would allow time for 
lactate removal after each sprint (Bishop et al., 2008; Sahlin et al., 1976). 
Indicating that females may have increased their TTE by an increase in lactate 
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metabolism, via increased MTC1 and or MTC4 activity, which would lead to a 
greater power maintenance during the test. With even short duration sprints (5 
sec) during HIT leading to a significant increase in the enzyme lactate 
dehydrogenase (LDH) (Linossier et al., 1993). If LDH activity increased in the 
present study this would have caused a greater exchange of lactate-pyruvate 
(Hashimoto, Hussien, Brooks., 2006).  As the LDH enzyme is located on the 
outside of the inner mitochondrial membrane this would allow a greater 
intracellular lactate shuttle and greater ATP production via oxidation 
(Hashimoto, Hussien, Brooks., 2006). 
 
Correlation data between tests further suggests that TTE was increased due to 
an increase in power output (Table 4.8). Increasing TTE is also significantly 
correlated to decreasing TT (r = -0.43, p < 0.05), and decreasing TT is 
significantly correlated to increasing CP (r = -0.47, p < 0.05). The increase in 
CP indicates an increase in maximal production rate of oxidative 
phosphorylation and a higher sustainable work rate (Vanhatalo, Doust, Burnley., 
2008). Suggesting that both males and females were able to cycle longer in 
their TTE test due to an increase in a higher sustainable work rate (Vanhatalo, 
Doust, Burnley., 2008). The sexes within both training groups appear to 
experience a similar HR in all measures, with both experiencing a significant 
increase from rest/ sprint 1 to rest 9/ sprint 10 (Figures 4.12, 4.15). The 
increase in HR could reflect an increase in aerobic demand, with Yamagishi & 
Babraj., (2017) finding similar lactate measures along with similar HR measures 
between their two training groups despite a different of 15 sec sprinting between 
the groups. Potentially explaining why both sexes increased TTE despite only 
males increased in VO2 peak. 
 
4.4.6 Time trial test 
Both training groups and sexes improved their 10km TT test (Figure 4.4) by 
~6% (male 15% group), ~8% (male 20% group), ~9% (15% female group), and 
~10% (female 20% group). This is consistent with the findings of Jakeman, 
Adamson, Babraj., (2012), who significantly improved 10km TT performance 
(~10%), which is similar to using a 30 sec sprint protocol (Burgomaster et al., 
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2006; Gibala et al., 2006; Hazell et al., 2010; Kavaliauskas, Steer, Babraj., 
2016; Lloyd Jones, Morris. Jakeman., 2017; Yamagashi & Babraj., 2017; 
Yamagashi & Babraj., 2016). A significant correlation between TT and CP (r = -
0.47, p < 0.05 (Table 4.8)) indicates that TT decreased due to a greater 
sustainable work rate (Vanhatalo, Doust, Burnley., 2008). This greater 
sustainable work rate suggests that both sexes and training groups were able to 
maintain a higher RPM whilst cycling (Driller., 2012). Previous research has 
shown that with a larger or maintained RPM comes a greater aerobic demand 
(Marsh & Martin., 1997). The work of Kavaliauskas, Steer, Babraj., (2016) 
speculate that their improved 10km TT performance could be due to larger 
oxygen kinetics given the work of Marsh & Martin., (1997) and the no change in 
VO2 peak found in their female participants. This speculation that TT 
performance improved due to faster oxygen kinetics is supported by 
Christensen et al., (2016), who found an increase in oxygen on kinetics 
following HIT (8-10 x 60 sec sprints separated by 75 sec against ~271 W), with 
no change in either citrate synthase activity or VO2 peak. The no change in VO2 
peak and citrate synthase activity further implies that female participants in the 
present study possibly did not experience an increase in citrate synthase 
activity but may have improved oxygen on kinetics leading to greater endurance 
performance (Jones & Burnley., 2009). 
 
A possible explanation for why females improved their 10km TT performance 
could be due to increased MTC1 and or MTC4 activity, lactate metabolism, and 
oxygen kinetics (Christensen et al., 2016; Jakeman, Adamson, Babraj., 2012; 
Juel et al., 2004; Marsh & Martin., 1997; Pilegaard et al., 1999). Given that 
increasing TT and TTE performance is significantly correlated (r = -0.43, p < 
0.05) it would suggest that TT performance improved due to similar factors to 
increasing TTE (Bogdanis et al., 1996; Creer et al., 2004; Ørtenblad et al., 
2000). TT in the present study was against a fixed resistance, an increase in 
sustained work rate would allow participants to pedal faster and therefore 
decrease their TT (Driller., 2012; Vanhatalo, Doust, Burnley., 2008). The work 
of Haverty, Kenny, Hodgson., (1988) used trained runners and compared gas 
analysis data (using VO2 and VCO2) against blood lactate data to establish a 
link. During long distance running events (5km), participants will eventually 
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experience a greater aerobic demand to help deal with the energy demands 
(Haverty, Kenny, Hodgson., 1988). At this point lactate levels plateau and VO2 
reaches a steady demand (Haverty, Kenny, Hodgson., 1988). Increasing VCO2 
would suggest an increased buffering of lactate by the bicarbonate system 
(Wasserman et al., 1973). When comparing each km in pre and post testing 
(eg. VO2/ VCO2/ at pre testing km 1 vs. post testing km 1), VO2 is significantly 
greater in post testing from 4km – 10km; and VCO2 post 10km (females), 4km 
and 10km (20% group). Given the increase in VO2 and VCO2, and previous 
research (Haverty, Kenny, Hodgson., 1988; Linossier et al., 1997; Wasserman 
et al., 1973), it can be speculated that a greater amount of lactate was present 
in the post TT vs. pre TT for both sexes and training groups. Possibly indicating 
an increase in lactate metabolism (Jakeman, Adamson, Babraj., 2012). 
 
4.4.7 Critical power test 
CP (figure 4.1) also saw an increase in both training groups and sexes (male 
15%: ~ 4%; female 15%: ~ 5%; male 20%: ~ 8%; female 20%: ~ 10%), a 
significant main effect of group and interaction (group*time1) shows that the 
20% group improved significantly greater than the control group (p < 0.05 (male 
control: ~ -2%; female control: ~ -6%)). The 15% group percentage increase is 
close to a significant interaction of group*time1 (p = 0.062). Finding a significant 
increase in CP, using both males and females, post HIT is consistent with 
recent findings from Kavaliauskas, Steer, Babraj., (2016 (~ 27%)) and 
Yamagashi & Babraj., (2017 (~ 7.8% and ~ 7.4%)). Interestingly the current 
study only consisted of 60sec of high intensity work each session, whereas 
previous research using physically active participants (Yamagashi & Babraj., 
2017) involved 60sec – 90sec and 120sec – 180sec of high intensity work. The 
current study also found a greater percentage increase in the 20% group 
compared to both of Yamagashi & Babraj., (2017) training groups. Yamagashi & 
Babraj., (2017) discusses the purpose to using a 15sec sprint is due to the 
majority of PCr degradation and lactate accumulation occurs within the first 15 
seconds of a sprint and has similar effects to a 30sec sprint. The current study 
could suggest that seeking to maintain MPO when reducing SR by 20% may 
potentially lead to a greater or similar degradation in PCr and lactate 
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accumulation when using 10 x 6sec sprints. This may explain the slightly 
greater percentage increase for the 20% group. The greater percentage 
increase in CP found Kavaliauskas, Steer, Babraj., (2016) compared to the 
current study and Yamagashi & Babraj., (2017) could be due to participant 
choice. Kavaliauskas, Steer, Babraj., (2016) participants took part in the least 
amount of physical activity in a week (< 3 hours) when compared to the current 
study (~ 6 hours) and Yamagashi & Babraj., (2017 (≥ 3 hours)). Suggesting that 
Kavaliauskas, Steer, Babraj., (2016) participants were less when trained, which 
would potentially allow a greater improvement in CP. 
 
There are potentially sex differences in how the participants have improved the 
CP. Kavaliauskas, Steer, Babraj., (2016) speculates that their female 
participants may have improved CP due a greater mitochondrial capacity 
indirectly measured from maximal citrate synthase activity (Green et al., 1999). 
Thought to occur given the research that has found increase in citrate synthase 
activity post HIT (Burgomaster et al., 2005; Linossier et al., 1993). However, as 
discussed earlier, there is potential that the female participants within the 
current study may not have increased their citrate synthase activity given the no 
change in VO2 peak (Vigelso, Andersen, Dela., 2014). Instead, females may 
have seen an improvement in CP due to increased lactate transporter activity 
which have both been found to increase post HIT (Burgomaster et al 2008; 
Perry et al., 2008; Rodas et al., 2000). This would allow the resistance of fatigue 
from an accumulation of Pi and lead to a greater sustained power and velocity 
during the CP test (Jones et al., 2010; Westerblad, Allen, Lannergren., 2002). 
 
4.4.8 Limitations 
The current study did not take into account what sport or activity the participants 
partake in. The males within the control group may have entered an intense 
training phase of their normal training due to their sport/activity, possibly 
explaining their ~ 6% increase in TTE test. Dietary intake before each trial/ 
session/ test was not strictly monitored, the mood state of the participants may 
have had an affect when self-regulating their own rest periods (Adan., 1994; 
Davis., 1995). It has been shown that stimulants high in caffeine, such as 
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coffee, tea and cola, reduce the release of serotonin that cause lethargic states 
(Davis., 1995). It is also established that humans take these stimulants to self-
regulate their energy level in normal work schedules (Adan., 1994). Participants 
who regularly take stimulants could possibly gain an advantage over 
participants that don’t during SR HIT. 
 
4.4.9 Conclusion 
For the first time, this study has demonstrated that reducing self-selected rest 
times by 15% and 20%, during repetitive short sprint duration HIT, leads to 
increased performance adaptions in VO2 peak (males), TTE, 10km TT and CP. 
This study has also demonstrated that creating specific rest times for each 
participant has similar effects to using work to rest ratios that are designed for 
improving endurance performance measures. Further research should identify if 
reducing female self-selected rest duration by > 20% or reducing the resistance 
of the sprint (< 7.5% body mass) leads to an improvement in VO2 peak. Further 
research should also seek to identify why a participant has selected a rest 
period and why they deem it sufficient to maintain maximal MPO. This may aid 
practitioners in using self-regulated rest as a training tool. 
 
4.4.10 Practical implications 
The present study has identified four major findings. 1) Reducing SR rest by 
20% leads to greater improvements in performance measures compared to 
15% reduction and still have an increase in VO2 peak of ~8.9% in males. 2) 
Using an extra two HIT sessions (eight sessions) and reducing SR rest during 
HIT leads to greater and significant increases in endurance measures when 
compared to not reducing SR over six HIT sessions (Study 2). 3) Maintenance 
of CS MPO during the HIT sessions doesn’t appear to be a major factor for 
increasing endurance measures, which is in contrast to the proposed 
importance given by others (Hazell et al., 2010; Lloyd Jones, Morris, Jakeman., 
2017). 4) Further evidence that a 30 sec sprint during HIT is not required and 
that the early part of a 30 sec sprint is a major factor for improving performance 
measures (Jakeman, Adamson, Babraj., 2012). From this information 
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practitioners should understand that reducing SR by 20% leads to an individual 
response during HIT. 
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5 Chapter 5 - General discussion 
5.1 Introduction 
The key aims of this PhD thesis was to identify the effects of using self-
regulated (SR) rest in relation to maintaining mean power output (MPO) 
between sexes and its potential use during high intensity training (HIT) to create 
positive performance adaptations. Within HIT research it has been previously 
speculated that the maintenance of power during HIT is a main factor for 
increasing performance measures (Hazell et al., 2010; Lloyd Jones, Morris, 
Jakeman., 2017; Yamagishi & Babraj., 2017). Yet little research is available to 
indicate if maintenance of power output during HIT is an important factor for 
performance adaptation. Traditionally HIT research involves a decrement in 
power output during HIT to create a greater aerobic response during the sprints 
(Bogdanis et al., 1996; Gaitanos et al., 1993), which is thought increase 
endurance measures such as VO2 max (Sloth et al., 2013). These studies have 
used 30 sec sprints to create a greater aerobic response, with the last 15 sec of 
a 30 sec sprint been predominantly aerobic (> 50% (Parolin et al., 1999)). 
However, there is emerging research that indicates that the duration of the 
sprint is not vital, with durations of 6-15 sec finding similar adaptations to that of 
a 30 sec sprint protocol (Hazell et al., 2010; Kavaliauskas, Aspe, Babraj., 2015; 
Kavaliauskas, Steer, Babraj., 2016; Jakeman, Adamson, Babraj., 2012; Lloyd 
Jones, Morris, Jakeman., 2017; Yamagishi & Babraj., 2017). If maintenance of 
power is a main factor for increasing performance measures then allowing 
participants to SR their recovery to maintain MPO may also lead to an 
improvement in VO2 peak, time to exhaustion, time trial, and power output. 
Therefore, using SR rest within HIT would create specific work to rest ratios for 
each individual participant. There is also debate regarding the resistance 
applied to the sprint during HIT, with 7.5% body mass (BM) traditionally used 
(Table 1.1 and 1.2), and emerging research indicating that females should 
adopt a lower resistance (6.5-7% BM (Kavaliauskas, Steer, Babraj., 2016; 
Yamagishi & Babraj., 2017)). This is due to morphological differences between 
sexes such as greater fat mass in females and greater muscle mass in males 
(Perez-Gomez., 2008). Lowering the resistance will allow the intensity of the 
HIT to increase (i.e. a greater pedal frequency during the sprints) which may 
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reflect into greater power outputs for females (Billaut & Bishop., 2009). This 
thesis will identify sex differences in maintaining MPO and magnitude in change 
in performance measures using SR rest and 7.5% BM resistance. 
 
5.2 Summary of main findings 
5.2.1 Self-regulated recovery 
In Studies 1-3 there was no significant difference in trial average SR rest 
duration between SR trials and between sexes (Studies 1 and 3 (Tables 3.1 and 
5.1)). In Study 1 it was hypothesised that females would require a shorter SR 
rest duration potentially due to differences in percentage area of skeletal muscle 
fibre type between males and females (Glenmark, Hedberg, Jansson., 1992; 
Hicks, Kent-Braun, Ditor., 2001). Females have been found to have a 
significantly greater percentage area of type I muscle fibres with males showing 
a significantly greater percentage area of type IIa muscle fibres in the vastus 
lateralis (Roepstorff et al., 2006; Staron et al., 2000). The greater recruitment of 
type I muscle fibres leads to a greater fat oxidation capacity (Roepstorff et al., 
2006; Staron et al., 2000), which is associated with developing less peripheral 
fatigue compared to a greater recruitment of type IIa muscle fibres which leads 
to higher glycolytic enzyme activity (Roepstorff et al., 2006; Russ et al., 2005). 
Repeat sprint activity research has shown that males are able to produce 
greater absolute power outputs then females but they also see a greater 
decrement in power output when compared to females (Billaut et al., 2011; 
Laurent et al., 2010). This could be due to females having the capacity to 
recover phosphocreatine (PCr) at a greater rate compared to males (Kent-
Braun & Alexander., 2000), which would aid repeat sprint ability performance 
(Gaitanos et al., 1993; Rodas et al., 2000). Therefore, it was thought that 
females would self-select a shorter SR rest duration when compared to males. 
However, Studies 1 and 3 have consistently found no significant difference 
between sexes in duration of SR rest, and found inconsistencies in average SR 
rest duration between sexes, with males demonstrating a shorter SR rest 
duration in Study 1 and vice versa in Study 3. The similar SR rest duration 
between sexes could be due to the high intensity nature of the study (Knechtle 
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et al., 2004). Sex peripheral fatiguing differences (males: greater carbohydrate 
oxidation, females: greater fat oxidation) appear to diminish the closer 
participants exercise to their maximal intensity (55 vs. 75% of VO2 peak 
(Knechtle et al., 2004)). Therefore, during this thesis participants would may 
have exercised at ≥ 75% of their VO2 peak during sprints. Potentially explaining 
the similar duration in SR rest duration despite females been viewed as more 
fatigue resistant than males (Billaut & Bishop., 2009). 
 
It is not firmly understood as to what regulates self-selected rest periods and 
what indicates to a participant that they have rested adequately to repeat 
another sprint bout that replicates their criterion sprint MPO effort. It is 
understood that exercise induced skeletal muscle fatigue is caused by 
peripheral (depletion in glycogen and PCr) and central fatigue (decreased firing 
rate (Amann., 2011; Amann., 2012; Amann & Dempsey., 2008; Decorte et al., 
2012; Froyd et al 2016; Froyd, Millet, Noakes., 2013; Kent-Braun., 1999; 
Mendez-Villanueva et al., 2012)). This research shows that during maximal 
intensity exercise and self-paced cycling that peripheral fatigue occurs and 
progressively increases as the number of completed bouts or duration of 
exercise increases. An increase in peripheral fatigue during Studies 1-3 is 
suggested by the significant increase in VO2, VCO2 and heart rate (HR) from 
rest 1/ sprint 1 to rest 9/ sprint 10 (Figure 2.1-3, 3.4-5, and 4.10-15). These 
increases in VO2, VCO2 and HR suggest an increase in peripheral fatigue due 
to greater use of peripheral organs (heart and lungs), which also leads to an 
increase in oxygen delivery to ensure that skeletal muscle can still contract at a 
high rate (Marcora., 2009; Zając et al., 2015). With an increase in aerobic 
demand during repeat sprint activity demonstrating a decrease power output, 
PCr availability and inhibition of glycolysis (Bogdanis et al., 1996; Gaitanos et 
al., 1993; Parolin et al., 1999). Once peripheral fatigue has already been firmly 
established central fatigue is thought to occur and overall only accounts for 
~20% of fatigue after maximal voluntary contractions (Kent-Braun., 1999). The 
perception of effort is thought to come from peripheral mechanisms known as 
afferent feedback, which senses effort from the heart, lungs and from muscle 
spindles and Golgi tendon organs (Marcora., 2009). Participants within the 
present studies could be self-regulating their rest until this sense of effort has 
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reduced, which might be decisive in a participant deciding when they wish to 
begin their next sprint. Study 3 shows that SR rest duration on average is 
greater in rest 9 compared to rest 1 and rest 9 is significantly greater in rest 9 
vs. rest 1 in trial 3 for both males and females (Table 4.1). With HR, VO2 and 
VCO2 significantly increasing it suggests that rest 9 SR rest duration increases 
due to a greater sense of effort (Marcora., 2009), and or based off previous 
research it could suggest that central fatigue became established by rest 9 
(Kent-Braun., 1999). 
 
Study 1 is consistent with previous research that participants who can 
successfully maintain their MPO are over estimating their SR recovery by at 
least 10% (Phillips, Thompson, Oliver., 2014). However, when average SR 
recovery was reduced by 15% in Study 1 it was found that MPO was 
significantly less when compared to the criterion sprint, more so in females 
(~9.8% decrease) than males (~1.2% decrease (Table 2.1)). The significant 
improvements in endurance measures in Study 3 (HIT with reduced SR rest of 
15-20% (Figure 4.1-4)) vs. the non-significant increase in endurance measures 
in Study 2 (HIT with SR rest (Figure 3.1)) could indicate that the 10% over-
estimation in SR recovery effects HIT negatively. The findings of Yamagishi & 
Babraj., (2017) indicate a plateau in VO2 peak changes after six sessions, 
which indicates that the use of an extra two HIT sessions in Study 3 compared 
to Study 2 is not a factor for the magnitude in change differences between the 
two studies. If the greater improvement in endurance measures is caused by a 
reduction in SR rest (15-20%) then seeking to further identify at what point a 
participant is able to reproduce their maximal MPO during SR rest might be vital 
for obtaining the greatest magnitude in change in endurance measures. 
 
5.2.2 Self-regulated recovery and reduced self-regulated rest vs. fixed 
rest on performance adaptations 
Traditionally HIT research uses fixed rest periods between sprints in relation to 
the sprint duration to create a work to rest ratio, with a 1:8 work to rest ratio 
been commonly used (Tables 1.1 and 1.2). Study 2 has consistencies with the 
work of Kavaliauskas, Aspse, Babraj., (2015 (6 x 10 sec sprints, 7.5% BM 
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resistance)) who found that using specific work to rest ratios (1:3, 1:8, 1:12) 
leads to specific performance outcomes. With shorter work to rest ratios finding 
greater improvements in VO2 peak (1:3, ~6.9%; 1:8, ~4.7%; 1:12, ~0.3%), time 
to exhaustion (TTE (1:3, ~6.3%; 1:8, ~4.4%; 1:12, ~1.9%)) and time trial (1:3, 
~3.1%; 1:8, ~2.4%; 1:12, ~2.4%). Whereas longer work to rest ratios found 
greater improvements in Wingate peak power output (PPO (1:3, ~4.3%; 1:8, 
~7.1%; 1:12, ~8.5%)) and Wingate MPO (1:3, ~0.3%; 1:8, ~4.6%; 1:12, ~5.3%). 
The fixed rest (FR (30 sec)) training group in Study 2 found only an 
improvement in VO2 peak (~5%), which is consistent with Kavaliauskas, Aspse, 
Babraj., (2015) who speculate that endurance testing increased due to a greater 
aerobic response during HIT due to a short work to rest ratio. Similar to 
Kavaliauskas, Aspse, Babraj., (2015), the SR group (~1:17) experienced 
greater improvements in Wingate PPO (SR: 1.1%; FR: -4%) and Wingate MPO 
(SR: 0.4%; FR: -2.1%). It is thought that the improvement in power output in the 
SR group is linked with a greater improvement in TTE (SR: ~3%; FR: ~0%) and 
TT (SR: ~-3%; FR: ~3%) compared to the FR group (Bulbulian, Wilcox, 
Darbos., 1986; Noakes., 1988). Increasing Wingate PPO or MPO may not be 
strongly correlated to increasing TTE (PPO: r = 0.05; MPO: r = 0.03) or TT 
(PPO: r = -0.26; MPO: r = -0.31) but a moderate correlation indicates a link 
between improving TTE is linked with improving TT (r = -0.41). Given that TT 
performance can be increased due to an increased sustained work rate due to 
an increased power output (Driller., 2012) and TTE has been found to increase 
through an increase in power (Jakeman, Adamson, Babraj., 2012), it is thought 
that this moderate correlation is a reflection of the SR group’s increase in power 
output. 
 
In Study 3 participants completed eight sessions of HIT (10 x 6 sec sprints 7.5% 
BM resistance) but with a reduction in SR rest of 15 and 20% due to the known 
10% over-estimation in required recovery (Phillips, Thompson, Oliver., 2014; 
Study 1). These reductions led specific work to rest ratios for each individual 
participant, with average work to rest ratios of ~1:16.3 (male 15% (M15)), 
~1:12.2 (female 15% (F15)), ~1:12 (male 20% (M20)) and ~1:12.8 (female 20% 
(F20)). In contrast to Kavaliauskas, Aspse, Babraj., (2015), both training groups 
and sexes in Study 3 found improvements in TTE (M15: ~6.4%; F15: ~7.6%; 
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M20: ~4.1%; F20: ~5%), TT (M15: ~6%; F15: ~8.7%; M20: ~8%; F20: ~10.4%) 
and critical power (M15: ~4.1%; F15: ~5%; M20: ~8.2%; F20: ~9.6%), with only 
the male training groups finding an improvement in VO2 peak (M15: ~13.8%; 
F15: ~-0.6%; M20: ~8.9%; F20: ~0%). Hazell et al., (2010) speculates that the 
reproduction of power output during HIT is a key factor for improving 
performance measures, and found improvements in performance measures 
when using 1:8 (30 sec sprint), 1:12 (10 sec sprint) and 1:24 (10 sec sprint) 
work to rest ratios. The 1:24 work to rest ratio found greater improvements than 
1:12 work to rest ratio in VO2 max (1:12, ~3.8%; 1:24, ~9.2%) TT (1:12, ~3%; 
1:24, ~3.5%), Wingate PPO (1:12, ~4.2%; 1:24, ~8.5%) and Wingate MPO 
(1:12, ~2.9%; 1:24, ~6.5%). The 1:12 and 1:24 training groups experienced a 
significantly greater reproducibility of training PPO, MPO and minimum power 
output compared to the 1:8 group, with the 1:24 group producing slightly greater 
power reproducibility than the 1:12. From this data Hazell et al., (2010) 
speculates that the increased rest duration in the 1:24 group led to greater 
improvements than the 1:12 group and some similar improvements to the 1:8 
group (VO2 max: ~9.3%; TT: ~5.2%; PPO: ~9.5%; MPO: ~12.1%). Study 1 
found a significant correlation with maintaining trial MPO and increasing VO2 
and VCO2 response (r = 0.78 and r = 0.73) respectively (Tables 2.3-5). 
Suggesting that a longer rest duration to allow greater reproducibility of MPO is 
potentially linked with improving endurance measures, given that a greater 
aerobic response during HIT is thought to increase these endurance measures 
(Bogdanis et al., 1996; Gaitanos et al., 1993; Kavaliauskas, Aspse, Babraj., 
2015). 
 
5.2.3 Maintenance of power output 
The use of self-regulated rest and the effects of maintaining MPO appear to be 
inconsistent between Studies 1-3. In Study 1 it was demonstrated that males 
could maintain their criterion sprint (CS) MPO greater than females (Table 2.1). 
The SR group in Study 2 were unable to maintain their CS MPO as well as the 
males in Study 1 (Tables 3.1). In Study 3 both males and females were unable 
to maintain their CS MPO by a similar amount (Table 4.1). This could indicate 
that the ability to maintain MPO through SR rest is different for each individual, 
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possibly explaining why these three studies found multiple participants that 
could not maintain their MPO (n = 11) in two out of four trials. This individual 
difference might explain why Phillips, Thompson, Oliver., (2014) and Glaister et 
al., (2010) found that all their participants could maintain MPO or sprint speed 
respectively across all trials. What appears to be consistent between the three 
studies and the work of Hopkins, Schabort, Hawley (2001) is that participants 
are able to maintain their MPO more effectively (lower coefficient of variation 
between the 10 x 6 sec sprints MPO) in the latter trials compared to the earlier 
trials. Study 1 found that a greater sum of MPO during the trials is significantly 
correlated to increasing VO2 (r = 0.78) and VCO2 (r = 0.73) but not HR (r = 0.3). 
Whilst VO2, VCO2 and HR was significantly greater in sprint 10/ rest 9 vs. sprint 
1/ rest 1, male VO2 and VCO2 data was significantly greater then female data at 
all measured points (Studies 1-3). This potentially explains why male training 
group participants in Study 3 saw significant increases in VO2 peak whereas 
females saw no change (Figure 4.2). Given that increasing aerobic demand 
during HIT is thought to be a key factor for increasing endurance measures 
(Bogdanis et al., 1996; Gaitanos et al., 1993; Kavaliauskas, Aspse, Babraj., 
2015; Sloth et al., 2013). The significant increase in VO2, VCO2 and HR from 
sprint 1/ rest 1 to sprint 10/ rest 9 could indicate that despite using SR rest 
(Study 1: ~100 sec; Study 2: ~104 sec; Study 3: ~94 sec), seeking to maintain 
MPO could lead to similar adenosine triphosphate (ATP) turnover changes from 
PCr and glycolysis as found by Gaitanos et al., (1993). Gaitanos et al., (1993) 
conducted 10 x 6 sec (7.5% BM resistance) cycle sprints separated by a 
recovery (30 sec) that was deemed insufficient for optimal recovery to 
reproduce maximal power output. They found that PPO and MPO significantly 
declined by 15.9% and 12.6% after sprint 5, and by 33.4% and 26.6% after 
sprint 10 respectively. They also reported that ATP turnover from PCr increased 
from sprint 1 (49.6%) to sprint 10 (80.1%), ATP turnover from glycolysis 
decreased from sprint 1 (44.1%) to sprint 10 (16.1%), and suggest that aerobic 
metabolism increased significantly from sprint 1 to sprint 10 with an total ATP 
turnover of 13.1 mmol. kg dry wt-1. s-1. This may suggest that maintaining MPO 
leads to similar metabolic demand then seeking to decrement power output 
during HIT, and explain why endurance measures improved in Studies 2-3. 
However, Studies 2-3 found no significant correlation between maintaining CS 
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MPO during trials/ sessions and performance measures (Tables 3.2 and 4.7). A 
negative moderate correlation in Study 2 indicates that seeking to decrement 
MPO is linked to increasing VO2 peak (Table 3.2). Therefore, correlation data in 
Studies 2-3 indicates that the speculative suggestion from Hazell et al., (2010) 
and Lloyd Jones, Morris, Jakeman., (2017), that maintenance of power output 
could be a key factor for improving performance measures, is incorrect. 
However, when giving participants the instruction to maintain their MPO during 
HIT causes an increase in VO2 peak (males), TTE, TT, and CP from pre to post 
testing measures regardless of the participants successfully or unsuccessfully 
maintaining their CS MPO. 
 
5.2.4 Sex specific improvements in endurance following reduced self-
regulated high intensity training 
Despite no significant difference between the second CS and session MPO for 
both sexes and training groups in Study 3, the results from Study 3 possibly 
indicate that the reduced SR rest sessions lead to different metabolic 
responses. This is indicated by the significant improvement from pre to post 
testing in both sexes and training groups in TTE and TT, significantly (20% 
group, p < 0.05)/ closely significantly (15% group, p = 0.062) greater increase in 
critical power (CP), but only a significant increase and magnitude in change in 
VO2 peak for males (Figure 4.2). There is the potential that females in Study 3 
did not have elevated citrate synthase activity as an adaptation to the training, 
which may explain why there was no change in VO2 peak post HIT (Vigelso, 
Andersen, Dela., 2014). Vigelso, Andersen, Dela., (2014) compared HIT and 
endurance research from 1983-2013 and concluded that increasing citrate 
synthase activity is linked with an increase in VO2 max and that females do not 
see the same increase in citrate synthase activity compared to males. This 
observation may not be reliable, as Vigelso, Andersen, Dela., (2014) point out 
that there is a lack of female participants in HIT and endurance research from 
1983-2013. Kavaliauskas, Aspse, Babraj., (2015) speculated that increasing 
aerobic demand during HIT could be a key factor for improving endurance 
performance. Table 4.9 in Study 3 further indicates this to be true as increased 
total VO2 and VCO2 during rest periods (VO2 r = 0.47; VCO2 r = 0.47) and 
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sprints (VO2 r = 0.4) is significantly correlated to increasing VO2 peak in both 
sexes. VO2 and VCO2 measures may be significantly greater in males than in 
females (Studies 1, 3), however, males do not increase their VO2 and VCO2 
measures greater than females. Table 2.2 in Study 1 indicates that the 
significantly greater VO2 and VCO2 measures in males is due to a reflection of a 
greater VO2 peak. This indicates that males and females are working to a 
similar percentage of their VO2 peak within Study 3. Similar heart rate is 
consistently recorded between males and females in Study 1 and 3, further 
indicating that both sexes are exercising at a similar capacity. It is also possible 
that a greater aerobic demand could be achieved by reducing SR rest by > 
20%, which in turn would create a smaller work to rest ratio (Kavaliauskas, 
Aspse, Babraj., 2015). Therefore, the greater aerobic demand during HIT to 
create a greater improvement in VO2 peak may only work for males. The 
highest female percentage of VO2 peak data during SR rest periods in Study 1 
was recorded at ~61%, possibly indicating that females have to create an 
aerobic demand beyond ~61% of their VO2 peak (Table 2.2) in order to increase 
VO2 peak following HIT with reduced SR rest. There is also the possibility that 
females in Study 3 and the SR group in Study 2 did not increase their VO2 peak 
due to the duration of the study (Astorino & Schubert., 2014). Astorino & 
Schubert., (2014) found that the number of participants that increased their VO2 
max following 12 weeks of HIT was ~78%, whereas the number of participants 
that increased their VO2 max following two weeks of HIT was ~65%. Potentially 
explaining the significant increases in VO2 peak (~12.1% and ~12.8%) with 
Yamagishi & Babraj., (2017) following nine weeks of HIT when using male and 
female participants. Therefore, it is possible that females in Study 3 and the SR 
group in Study 2 could have increased their VO2 peak if the duration of the 
study was longer (Astorino & Schubert., 2014). 
 
5.3 Considerations of procedure protocols 
5.3.1 Sex differences in selected resistance 
Traditionally within HIT research a resistance of 7.5% BM is used for both 
males and females (Tables 1.1 and 1.2), with recent HIT research adopting less 
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resistance (6.5-7%) for female participants (Kavaliauskas, Steer, Babraj., 2016; 
Yamagishi & Babraj., 2017). The reduced resistance for females might be more 
appropriate due to the morphological differences between sexes, with females 
having a greater fat mass and males having a greater muscle mass, which is in 
keeping with greater PPO (Perez Gomez et al., 2008). A significant interaction 
(sex*trial) in MPO data from Study 1 (Table 2.1) indicates that females have a 
greater percentage change from the CS MPO when compared to average trial 
MPO when compared to males. Although, the post hoc was unable to identify 
were the significance lies it would suggest it lies within trial 6 (15% reduced SR 
rest), which shows a ~9.8% decrease in MPO from the CS in females and 
~1.2% decrease in males. It would suggest that in Study 1 females should have 
adopted a lighter resistance to allow them to maintain their CS MPO within trials 
1-6 (Billaut & Bishop., 2009). However, in Study 3 the first CS was significantly 
greater than trials 1-4 average MPO in both sexes and the second CS was not 
significantly different from sessions 1-8 in both sexes. This could suggest that 
the greater inability for females to maintain their CS MPO (Study 1) is a 
reflection of pacing tactics rather than the selected resistance (Wittekind, 
Micklewright, Beneke., 2011). Given that males and females trial MPO has 
similar changes from CS one (Table 4.1) in Study 3. However, reducing the 
resistance for females may aid increase the intensity of the sprints during HIT, 
which may increase both mitochondrial respiration and content (Granata et al., 
2016). By decreasing the intensity (using 7.5% BM resistance), it would suggest 
that females only increase mitochondrial respiration (Granata et al., 2016). This 
may explain why females improved in every performance measure apart from 
VO2 peak in Study 3. This is to be debated as Kavaliauskas, Steer, Babraj., 
(2016) used a 7% BM resistance during HIT for female participants and saw no 
change in VO2 peak. However, this could indicate that 7% BM resistance is still 
too great and needs to be further reduced. Possibly explaining why Yamagishi 
& Babraj., (2017) found an increase in VO2 peak in both training groups that 
included males and females, when using 6.5% BM resistance for females and 
7.5% BM resistance for males. Comparing Kavaliauskas, Steer, Babraj., (2016) 
and Yamagishi & Babraj., (2017) research could be unfair as the former study 
was only two weeks long and the latter study was nine weeks long, which may 
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affect how many participants respond to increasing their VO2 peak (Astorino & 
Schubert., 2014). 
 
5.3.2 Reliable measure for maintenance of power 
In previous research achieving a coefficient of variation (CV) of ≤ 5.2% was 
used to identify if participants were successful in maintaining sprint speed or 
MPO (Gliaster et al., 2010; Phillips, Thompson, Oliver., 2014). However, this CV 
of ≤ 5.2% is based off the MPO for the final three sprints of 10 x 7 sec sprints 
(0.5 kp resistance separated by 30 sec) and not over all ten sprints (Capriotti, 
Sherman, Lamb., 1999). Using small data samples of three sprints for CV would 
create a greater bias and smaller degrees of freedom (Hopkins., 2000), which 
would suggest that the CV of ≤ 5.2% is an unreliable method for identifying 
maintenance of MPO. Using CV to calculate the maintenance of MPO also 
appears to be an unreliable measure for identifying a participant’s true reflection 
of maintaining their MPO. This is suggested by the CS MPO data compared to 
the decrease in trial average MPO data in Studies 1-3 (Tables 2.1, 3.1, and 
4.1), despite CV being ≤ 5.2%. The best example of this is in Study 1 with 
female trial 6 MPO been ~9.8% lower than the CS MPO but CV is reported as 
~3.4%. Therefore, using percentage change from the CS might be a more 
reliable method for measuring maintenance of MPO or speed. Until further 
research is conducted regarding what percentage of the CS is classified as 
reliably maintaining MPO, the present study can only recommend a percentage 
reduction based on the 3 current studies. In Study 1 the average percentage 
drop from CS MPO was 3.0%, Study 2 had a percentage drop of 3.3% and 
Study 3 had a percentage drop of 6.6%. Given that people have a tendency to 
pace repeated sprints, it may be that the actual value should be lower than the 
average percentage drop. In addition, given that the standard deviation across 
the 3 studies for percentage drop is 8% then a decrease less than 2.75% from 
CS MPO may be appropriate for determining successful self-regulation. 
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5.4 Future direction 
5.4.1 Maintaining criterion sprint mean power output using self-regulated 
rest 
The above has suggested that participants can maintain a MPO over 10 x 6 sec 
sprints with an average change of -2.75% from the CS, with Study 1 finding that 
male participants being able to produce an average MPO that is 2.5% greater 
than their CS (trial 3; Table 2.1). Given that maintaining power output is 
speculated as a key factor for seeking to improve endurance and power output 
testing (Hazell et al., 2010; Lloyd Jones, Morris, Jakeman., 2017), seeking to 
identify at what percentage participants can maintain of their CS using SR 
recovery would allow a bench mark for participants to aim towards during their 
training. At the moment limited research can only indicate that maintaining 
repeat sprint ability MPO or sprint speed time with a CV of ≤ 5.2% is classified 
as successfully maintaining maximal MPO or sprint time (Glaister et al., 2010; 
Phillips, Thompson, Oliver., 2014). Whereas Studies 1-3 found that using CV to 
identify if a participant is maintaining their MPO is not a true indication of a 
participant maintaining their true maximal MPO, but rather a reduction from their 
CS potentially due to pacing tactics. Recruiting a large population (100-300) of 
male and female participants completing three trials (two familiarisation trials) of 
10 x 6 sec sprints (against 7.5% body mass) with the aim of self-regulating their 
recovery to repeatedly reproduce their CS MPO. Given that participants are 
likely to pace their efforts during repeat sprint activity (Phillips, Thompson, 
Oliver., 2014; Study 1-3) and that removing an over-estimation in recovery 
leads to greater improvements in endurance measures (Studies 2 and 3), then 
seeking to identify recovery patterns may aid in removing over-estimation of SR 
recovery. Therefore, within the proposed trial 3 measuring VO2, VCO2, HR, 
breathing rate, and core body temperature (physiological measures) between 
each sprint could identify recovery patterns. For example if the above measures 
reach a plateau during SR recovery this could indicate that the participant is 
ready to start their next sprint and therefore aid in removing any over-estimation 
in required recovery. Given that not every participant can maintain their CS 
sprint MPO, using multiple participants will allow average physiological 
measures readings for those that can maintain above their CS, with the 2.75% 
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bracket and below. This will identify 1) if a majority of participants can maintain 
their CS MPO; and 2) if the physiological measures are affected by participants 
who can and cannot maintain their CS MPO. In addition to this, performing 
maximal voluntary contractions prior to the start of trial 3 and post-trial 3 (use an 
average SR recovery of trial 3 post sprint 10) in the form of a single isometric 
leg extension whilst using electromyography (EMG) measures. Using EMG 
measures of root mean squared and medium frequency from the quadriceps 
pre and post-trial 3 will identify changes in voluntary maximal isometric 
contraction. If there is no change in EMG measures pre to post and if CS MPO 
is maintained (≤ 2.75%) then it could suggest that the participants are pacing 
their efforts, if there is a drop in EMG measures in opposite circumstances then 
it could indicate that they are not pacing as much. If average MPO is less than 
CS (≥ 2.75%) and EMG is unchanged then it also suggests pacing. If average 
MPO is less than CS (≥ 2.75%) and EMG measures are reduced then it could 
suggest that the participant is unable to maintain their MPO. This study will 
identify what percentage change from the CS within trial average MPO is 
classified as maintaining MPO reliably. 
 
5.4.2 Effects of resistance during cycle sprints on endurance measures 
over 12 weeks in females 
Study 3 found that females increased their performance in all endurance testing 
measures but were unable to see an increase in VO2 peak following SR 
reduced rest (RR (15-20%)) HIT. It is speculated from this thesis and others 
(Vigelso, Andersen, Dela., 2014) that VO2 peak did not increase due to the 
potential that females do not see a meaningful increase in citrate synthase 
activity post HIT, the resistance of the HIT is too great, and the duration of 
Study 3 is too short. Purely recruiting female participants for this further 
research study may remove the hypothesis that females do not see as great an 
increase in citrate synthase activity than males, which is based off a lack of 
female participants within HIT research (Vigelso, Andersen, Dela., 2014). 
Testing measures would involve a similar process to Burgomaster et al., (2005), 
with a testing weeks (pre testing and weeks 4, 8, 12) consisting of VO2 peak, 
TTE and CP testing, along with muscle biopsy testing. Muscle biopsy testing 
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would seek to measure resting glycogen (mmol/kg-1 dry wt), ATP, PCr and 
creatine stores (mmol/kg dry wt), along with citrate synthase activity (mol.kg 
protein-1-h-1ww). The use of muscle biopsy testing would further explain 
potential changes in VO2 peak, TTE and CP testing, and disprove the potential 
hypothesis that females do not see as strong a change in citrate synthase 
activity and VO2 peak post HIT (Vigelso, Andersen, Dela., 2014). In addition to 
this, using a long term study (12 weeks) would also identify if increasing the 
intensity of the sprints during HIT, by using three training groups using 6.5, 7 
and 7.5% BM resistance, leads to an increase in citrate synthase activity and 
VO2 peak over three post testing points (weeks 4, 8 and 12). The HIT within this 
new research plan would be separated by 15-20% SR RR to identify why 
females did not experience an increase in VO2 peak in Study 3. This would 
allow further direction to HIT research and or practitioners to reliably increase 
VO2 peak in females for performance or health benefits. 
 
5.4.3 Human muscle metabolism during self-regulated repeat sprint 
activity 
Hazell et al., (2010) speculates that maintaining power output during HIT might 
be responsible for similar training adaptations to seeking to decrement power 
output during HIT and therefore create a larger aerobic demand during the 
sprint (Bogdanis et al., 1996; Gaitanos et al., 1993). Both Bogdanis et al., 
(1996) and Gaitanos et al., (1993) have identified what occurs in muscle 
metabolism and what causes the majority of ATP turn over during 2 x 30 sec (4 
min rest) and 10 x 6 sec (30 sec rest) sprints respectively. Despite the 
differences in sprint durations between the two studies, both these studies 
found an increased contribution in aerobic metabolism from the first to the final 
sprint (29-43% Bogdanis et al., 1996), with a significant decrease in PPO 
(33.4%) and MPO (26.6% (Gaitanos et al., 1993)). However, research is limited 
on the effects of muscle metabolism when participants are maintaining their 
power output. Significant increases in VO2, VCO2 and HR from sprint 1/ rest 1 to 
sprint 10/ rest 9 in Studies 1-3 in both males and females in SR and RR trials 
when maintaining MPO would suggest that muscle metabolism could be similar 
to previous research (Bogdanis et al., 1996; Gaitanos et al., 1993). Future 
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research could complete a similar protocol to Gaitanos et al., (1993) and have 
participants complete three trials of 10 x 6 sec sprints (7.5% body mass 
resistance), using SR recovery and aim to maintain MPO. The first two trials 
would be completed as a familiarisation procedure with trial three involving 
muscle biopsies. To be consistent with Gaitanos et al., (1993), muscle biopsies 
would be taken before sprint one, post sprint 1, pre sprint 10 and post sprint 10. 
With blood samples been taken before sprint one, post sprint 1, post sprint 5, 
post sprint 10, and 1, 3, 5, 10 minutes after the completion of sprint 10. At these 
time points the muscle biopsies and blood samples will measure changes in 
blood lactate, blood pH. ATP, adenosine diphosphate, adenosine 
monophosphate, PCr, creatine, glycogen, and glucose 6 phosphate. These 
muscle biopsies would allow an estimate of ATP production from PCr and ATP, 
glycolysis, and aerobic metabolism between sprint 1 and sprint 10. If 
maintaining power output and decreasing power output (due to an insufficient 
rest) leads to similar muscle metabolism then it would indicate maintaining 
power output during HIT is responsible for increases in performance measures, 
as speculated by Hazell et al., (2010). This would also indicate that the use of 
specific work to rest ratios during HIT are not vital and or could create specific 
work to rest ratios for each individual based off their current level of fitness. 
 
5.4.4 Is self-regulated rest controlled by peripheral or central feedback? 
There appears to be little research specifically based on how self-selected rest 
periods during exercise is regulated. Within this thesis it is hypothesised that SR 
rest, when a participant has an understanding of been able to reproduce their 
maximal MPO, is mainly controlled by afferent feedback with some contribution 
from central feedback possibly in the latter sprints/ recoveries (Kent-Braun., 
1999). Studies 1-3 found a consistent significant increase in VO2, VCO2 and HR 
from the early stages to the latter stages of a SR trial in Studies 1-3, and the 
greater increase in SR recovery from rest 1 to rest 9 (significantly greater in trial 
3 Study 3). This could suggest that SR recovery is controlled by afferent 
feedback (Gallagher et al., 2001) but does not take into account any possible 
increase in central feedback. Identifying how SR recovery is controlled could aid 
the understanding of when a participant would be ready to reproduce their 
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maximal effort and potentially remove any over-estimation in rest that may 
occur (Phillips, Thompson, Oliver., 2014; Study 1). Removing this over-
estimation in SR recovery duration might be responsible for greater increases in 
endurance measures in Study 3 compared to Study 2. Previous research has 
found that during moderate cycling (7 min at 20% VO2 max) found significantly 
greater measures of lactate and noradrenaline concentration, HR, and 
perceived exertion when participants neuromuscular pathways had been 
blocked when compared to the control period (Gallagher et al., 2001). 
Suggesting that perceived exertion is regulated by afferent feedback, given that 
increases in HR and increased glycolysis use is related to greater perceived 
exertion (Marcora., 2009). Neuromuscular junction had been blocked by 
participants been administered a small dose of curare, which would not affect 
afferent pathways (Gallagher et al., 2001). In future research, participants would 
undergo a trial of maintaining MPO using SR rest under no condition and then 
under a small dose of curare. Between the two conditions, SR recovery duration 
between sprints and the MPO of each sprint would be recorded and compared 
against. If maintaining MPO and SR recovery duration is unaffected under the 
curare condition compared to the control condition then it would suggest that 
SR recovery is controlled by afferent feedback. If participants SR recovery is 
increased and or MPO decreases under the curare condition then it would 
suggest that SR recovery is controlled by central feedback. 
 
5.5 Overall conclusion 
The overall aims to this thesis were: 1) To determine if males and females can 
maintain mean power output during repeated sprints with self-regulated rest 
(Study one). 2) To identify male and female response in mean power output 
when self-regulated rest is reduced (Study one). 3) Compare endurance and 
Wingate power output adaptations to HIT with a fixed rest (30 sec) or self-
regulated rest (Study two). 4) To identify if reproducibility of mean power output 
is correlated to endurance adaptation to HIT (Studies two and three). 5) To 
compare the magnitude in change of VO2 peak, time to exhaustion, 10km time 
trial, and critical power between 15 and 20% reduced self-regulated rest during 
repeat sprint training between males and females (Study three). It was found 
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that males can maintain their MPO greater than females when using SR rest, 
and males can also maintain their MPO greater than females when SR rest is 
reduced by 10 and 15% (Study one). Using SR rest during a HIT intervention 
leads to greater improvements in TTE, TT and Wingate power output compared 
to using a fixed rest (1:5 work to rest ratio), whereas a fixed rest leads to greater 
improvements in VO2 peak (Study two). Reducing SR rest by 15 and 20% in a 
HIT intervention leads to greater improvements in both sexes for VO2 peak (no 
change in females), TTE and TT when compared to SR rest during HIT in Study 
two. CP also increased significantly and near significantly for both 20 and 15% 
reduced SR rest groups respectively (Study three). Studies two and three were 
unable to find an association between maintaining MPO and increasing 
endurance measures or Wingate power output measures. However, Study 3 
indicates that increasing VO2 peak is associated with increasing aerobic 
demand during HIT. Correlation data indicates that TTE and TT improvements 
are due to improvements in power output and CP (Study two and three). 
 
5.6 Overall practical implications 
This thesis is able to offer the following practical implications to practitioners: 1) 
using CV method of ≤ 5.2% to identify if a participant can maintain their MPO 
when using SR rest is unreliable as it does not take into account the 
participant’s greatest single MPO value. Until further research is developed this 
thesis can only recommend that maintaining ≤ 2.75% of a participant’s CS MPO 
is deemed as successfully maintaining MPO within a trial or session. 2) 
Females may require a reduction in the typically prescribed 7.5% of their body 
mass as a resistance to maintain their MPO when using SR rest, due to 
morphological differences between males and females (Perez Gomez et al., 
2008). 3) Using SR rest can lead to greater adaptations in TTE, TT and Wingate 
power output testing, and also increase haemoglobin measures greater than 
using a fixed work:rest ratio (1:5). 4) Practitioners seeking to increase VO2 peak 
should use a work to rest ratio of 1:3 – 1:8 (Kavaliauskas, Aspe, Babraj., 2015). 
5) Reducing SR by 15 and 20% leads to greater adaptations in VO2 peak, TTE 
and TT compared to non-reduced SR during HIT. However, females see no 
change in VO2 peak when SR rest is reduced by 15 or 20%. Based off previous 
 195 
research (Yamagishi & Babraj., 2017), this thesis can only suggest that 
reducing the cycling resistance to 6.5% of a female participant’s body mass 
may increase VO2 peak. 6) Increasing VO2 peak is significantly correlated to 
increasing aerobic demand during HIT. Therefore, practitioners should actively 
seek to achieve a greater aerobic demand during HIT for their athletes if they 
are seeking to increase their VO2 peak. 7) This thesis provides further evidence 
that using high intensity sprints as short as 6 sec leads to significant 
improvements in endurance measures. 
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